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A general outcome of plant-pathogen interactions is the oxidative and nitrosative 
burst, characterized for the accumulation of reactive oxygen and nitrogen species 
(ROS and RNA) which coordinate signalling cascades. Among RNS, Nitric oxide (NO) 
stands as a key signalling molecule in different physiological processes including 
plant immunity. An established mechanism for the transfer of NO bioactivity is S-
nitrosylation (SNO), the reversible binding of a NO molecule to the thiol group of a 
susceptible cysteine, allowing specific proteins to respond to changes in the cellular 
REDOX state.  
The first genetic evidence about the role of NO in plant immunity was noted in 
Arabidopsis thaliana plants carrying a loss-of-function mutation of the S-
nitrosoglutathione (GSNO) reductase 1 (GSNOR1) gene. This mutation resulted in 
increased total cellular S-nitrosylation and compromised basal, non-host and R-gene 
mediated immunity, and impaired synthesis and accumulation of the immune activator 
salicylic acid (SA). SA plays a pivotal role in the regulation of basal and systemic 
resistance. It is mainly produced by the activity of the enzyme Isochorismate Synthase 
1 (ICS1) in response to pathogens.  
To date, significant progress has been achieved in understanding the mechanisms by 
which S-nitrosylation regulates SA signalling. However, the molecular mechanisms 
by which NO regulates SA biosynthesis remains elusive.  
To investigate if NO mediates transcriptional or posttranscriptional regulation over 
ICS1 expression we generated the reporter line ICS1::GUS. Our data suggest that 
ICS1 is subjected to transcriptional repression by S-nitrosylation. In agreement with 
previous observations about inhibition of the DNA-binding of SARD1 to the ICS1 
promoter upon S-nitrosylation of SARD1 at Cysteine 438. We observed a significant 
reduction in the binding affinity of recombinant wild type (WT) SARD1 but not in 
SARD1 with a Cystein 438 to Serine mutation. To expand this observations and 
investigate the biological relevance of S-nitrosylation of Cys438 we generated 
transgenic lines expressing a C-terminal HA and Nano luciferase SARD1 and 
SARD1C438S fusion proteins.  
We showed that SARD1 can be S-nitrosylated in vivo. We did not observe any 
difference in local immunity against Pseudomonas syringae infection between the WT 
and C438S lines. Interestingly, the SARD1C438S lines showed impaired activation of 
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systemic acquired resistance (SAR) compared to the WT. In addition, we observed 
that SARD1 protein level follows a circadian rhythm after SA treatment, which was 
impaired in the C438S mutant, suggesting that S-nitrosylation of SARD1 is necessary 
for optimal activation of SAR. It is possible that S-nitrosylation of SARD1 coordinates 
protein-protein interactions between SARD1 and other SAR activators.  
We developed a strategy to express and purify recombinant SARD1 for structural 
studies. Solving the three-dimensional structure of SARD1 can foster our 
understanding on the molecular interactions behind the regulation of SARD1. Finally, 
we designed a forward mutant screening to search for second-site mutations that can 
suppress the gsnor1 phenotype, which we speculate could be related with a novel 
mechanism for GSNO-turnover or NO metabolism. Collectively, our work can 
contribute to integrate NO cues in the regulation of SA biosynthesis and suggests a 





Through their lifetime, plants interact with a diverse collection of potentially pathogenic 
microorganisms. Plant disease represents one of the main threats to crop 
productions. However, plants have evolved sophisticated defence mechanisms to 
prevent microbial infection. In response, some few specialised microorganisms have 
developed strategies to overcome plant defences and promote disease. The 
activation of plant defences encompasses the production and accumulation of 
signalling molecules, such as reactive oxygen and nitrogen species (ROS and RNS) 
and salicylic acid (SA), to activate the expression of defence genes at the infection 
site. SA is a plant hormone considered as a master activator of plant defences against 
biotrophic microorganisms, including local defence and priming defences in 
uninfected leaves allowing plants to respond faster in the case of a secondary 
infection. SA is produced in response to pathogens via the activity of the enzyme 
isochorismate synthase 1 (ICS1).  Given its importance in immunity, plants must 
ensure that SA is produced rapidly after the infection occurs, and its accumulation is 
stopped after the infection has been contained.  
To do this, plants incorporate ROS and RNS mediated posttranslational protein 
modifications (PTMs) into the signalling events during plant immunity. Among the 
PTMs, S-nitrosylation, the addition of a Nitric Oxide (NO) molecule to a protein, stands 
as a central mechanism to regulate plant immunity. It is well documented that S-
nitrosylation plays a significant role in controlling the expression of defence genes 
downstream of SA accumulation. However, the mechanism by which S-nitrosylation 
controls SA biosynthesis remains poorly understood. Our research suggests that S-
nitrosylation can contribute to regulating SA biosynthesis by controlling the activity of 
the protein SARD1 (Systemic Acquired Resistance 1), one of the main proteins that 
promote the expression of ICS1. We observed that upon S-nitrosylation the ability of 
SARD1 to bind to its target DNA is reduced, potentially influencing the timing and the 
extent of SA accumulation during the immune response. The tight regulation of SA 
accumulation allows plants to efficiently fight infections without significantly 
compromising development. Further research is needed to understand if S-
nitrosylation of SARD1 is required to prime defences in systemic leaves after a 
primary infection. Our work can contribute to expanding our understanding of how 
plants regulate the activation of plant immunity, potentially allowing us to engineer 
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Chapter 1 Introduction 
 
Introduction 
During their lifetime, plants encounter a vast number of potentially pathogenic 
microorganisms. However, plants have evolved a sophisticated and efficient network 
of defence mechanisms resulting in plant disease being a rare outcome (Spoel & 
Dong, 2012). 
Plant defences are organised as sequential layers of protection. As a first layer, plants 
develop physical barriers to prevent the entrance of microbial pathogens into the 
plants. In the second level of defence, plants incorporated pathogen recognition 
receptors (PRR) that recognise highly conserved pathogen/microbe-associated 
molecular patterns (PAMPs or MAMPs). The activation of the PRR by the recognition 
of a potential pathogen induces PAMP-triggered immunity (PTI), which encompass 
the expression of defence genes and the accumulation of antimicrobial compounds 
to prevent further colonisation of the pathogen (Dodds & Rathjen, 2010).  
In response, some specialised pathogens evolved effector proteins aimed to highjack 
PTI and promote infection. Plants have counteracted this threat by developing a third 
layer of defence, consisting of R-proteins, which are cytoplasmic receptors that can 
recognise effectors directly or effectors’ activity indirectly. The recognition of an 
effector initiates effector-triggered immunity (ETI) characterised by a stronger immune 
response accompanied by the hypersensitive response (HR) that results in localised 
cell death at the infection site to prevent further spread. As an additional level of 
defence, plants developed systemic acquired resistance (SAR) that provides a long-
lasting and broad-spectrum immunity allowing plants to initiate a faster and stronger 
response against secondary infections (Kachroo & Kachroo, 2018; Fu & Dong, 2013). 
The activation of immune responses depends on a complex network of physiological 
changes and molecular interactions mediated in a significant part by the production 
of reactive oxygen and nitrosative species (Mittler, 2017). Also, the immune activator 
salicylic acid (SA) plays a central role in mediating resistance against biotrophic 
pathogens and in the establishment of (SAR) (Fu & Dong, 2013). 
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Plant defences are very effective at repelling potential infections, with only a small 
subset of highly specialised pathogens being able to overcome plants defences and 
promote disease. Significant progress has been made in understanding the molecular 
mechanisms behind the activation of plant immunity (Spoel & Dong, 2012). Recent 
research highlights the importance of redox-based post-translational modification in 
the fine-tuning and regulation of immune responses (Mittler, 2017). Among these 
modifications, S-nitrosylation, the reversible binding of a nitric oxide (NO) molecule to 
a rare, highly reactive protein Cysteine (Cys) thiol (SH) group to form an S-nitrosothiol 
(SNO), enables a protein to function as a molecular switch mediating signalling 
cascades in response to changes in the redox state (Yu et al, 2012; 2014). 
The first genetic evidence of S-nitrosylation modulating plant immunity was noted in 
Arabidopsis plants with a knock-out mutation of the S-nitrosoglutathione reductase 1 
(gsnor1) gene. These plants exhibited increased cellular S-nitrosylation and 
compromised basal, non-host, and R-gene mediated immunity, linked with reduced 
and delayed SA-biosynthesis and signalling (Feechan et al, 2005).  
To date, the development of molecular and biochemical techniques for the 
identification of S-nitrosylation such as the biotin-switch assay (Jaffrey & Snyder, 
2001) have contributed to insights into how NO mediates SA-signalling via S-
nitrosylation. However, the mechanisms by which this post-translational modification 
regulates SA-biosynthesis remain unexplored.   
This chapter will focus on introducing the current knowledge on the role of NO and 
SA in the regulation of plant immunity and the establishment SAR. 
Nitric Oxide 
NO is a highly active gaseous molecule recognised as an essential signalling 
regulator in both plants and animals. It has been associated with the regulation of 
different physiological and cellular responses (Hancock & Whiteman, 2016). In 
mammals, NO is mainly produced by the activity of the enzyme nitric oxide synthase 
(NOS). In humans, the NOS family consists of three main isoforms. The neuronal 
(nNOS/NOS1) and endothelial (eNOS/NOS3) isoforms are expressed constitutively, 
and their activity relies on intracellular calcium (Ca2+) levels. 
In contrast, inducible NOS (iNOS/NOS2) ACTIVITY IS Ca2+-independent. The 
structural analysis of the three mammalian isoforms showed that they share a similar 
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overall structure, consisting of an N-terminal oxygenase domain (NOSoxy) and a C-
terminal reductase domain (NOSred) linked by a calmodulin-binding motif. The N-
terminal domain mediates homodimerization and protein-protein interactions. The 
binding of calmodulin promotes conformational changes of the homodimer required 
for the enzymatic activity (Jeandroz et al, 2016; Santolini et al, 2017).  
The NOS enzymes catalyse the conversion of L-arginine to L-citrulline and NO in a 
two-step oxidation reaction. During catalysis, the NOSoxy domain binds a heme 
prosthetic group and the redox factor tetrahydrobiopterin (BH4). The NOSred domain 
transfer electrons provided by NADPH to the heme group via the cofactors Flavin 
mononucleotide (FMN) and Flavin adenine dinucleotide (FAD) in the presence of 
oxygen.   
NO production in plants 
Given the physiological importance of NO, intensive work has been undertaken to 
identify the mechanisms for NO production in plants. However, the precise molecular 
mechanisms for NO production in plants are not fully understood. The evidence 
suggests that NO can be produced by two main routes; a reductive route via the 
reduction of nitrites to NO and an oxidative route via the oxidation of aminated 
molecules (Astier et al, 2017). 
Reductive pathway for NO production 
Nitric oxide can be produced from different routes and different substrate in non-
enzymatic reactions under specific conditions. For instance, the reduction of nitrite 
(NO2-) to NO can occur under actively reducing or under low pH environments in the 
presence of a high nitrite concentration (Astier et al, 2017). 
Nitrate Reductase (NR) 
In addition, different enzymes have been reported to mediate the reduction of NO2- to 
NO. The cytoplasmic enzyme nitrate reductase (NR) catalyses the reduction of nitrate 
(NO3-) to NO2- in an NADH dependent reaction, also using molybdopterin, heme and 
FAD as cofactors. NR represents the first rate-limiting step for nitrate assimilation. 
Notably, this enzyme can also exhibit NO2- to NO reductase (Ni-NR) activity. Under 
normal conditions, the alternative Ni-NR activity occurs with lower efficiency 
compared to the NO3- to NO2- conversion, exhibiting a Km of 100 µM for NO2- 
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compared with 10 µM for NO3-. However, the Ni-NR activity can be increased under 
low oxygen or an acidic environment. 
In Arabidopsis, the genes NIA1 and NIA2 code for NR, with NIA2 playing a more 
significant role for the NR activity. The genetic evidence for the importance of NR in 
the production of NO comes from the fact that the nia1, nia2 and the nia1nia2 plants 
are severely impaired in NO production in different physiological processes, including 
stomatal movement, hormonal responses, abiotic stress responses and floral and root 
development (Wilkinson & Crawford, 1991; Astier et al, 2017). 
NO:NOFNiR mechanism in Chlamydomonas reinhardtii 
An additional mechanism for NO production by NR was discovered recently in the 
microalgae Chlamydomonas reinhardtii. It was observed that NR could interact with 
the partner protein NOFNiR (nitric oxide-forming nitrite reductase) and catalyse the 
reduction of NO2- to NO in an NADPH dependent reaction using electrons supplied by 
the diaphorase activity of NR (NADPH -> NR -> electron acceptor). The NOFNiR 
enzyme belongs to the family of the amidoxime reducing component (ARC) protein 
family. Currently, two mitochondrial Arabidopsis ARC genes have been identified 
(Chamizo-Ampudia et al, 2016), with mARC isoform 2 exhibiting in-vitro NO-
producing activity when incubated with NO2- in a reducing environment (Yang et al, 
2015). Currently, a NO:NOFNiR mechanism similar to that present in C reinhardtii has 
not been described in higher plants. However, further research may demonstrate the 
role of this mechanism to fine-tune NO production in plants (Chamizo-Ampudia et al, 
2016, 2017). 
Ni:NOR plasma membrane-bound NR 
Additional to the cytoplasmic NR enzyme, a nitrite to NO reduction activity was 
observed in membrane fractions obtained from Nicotiana tabacum roots. The putative 
enzyme was defined as plasma membrane-bound nitrite:NO reductase (NiNOR) and 
was proposed to reduce NO2- to NO using cytochrome C as an electron donor and 
showed maximum activity at low oxygen concentrations and under acidic conditions 
(Stöhr et al, 2001). The underlying mechanism suggests that NiNOR would reduce 
NO2- produced from NO3- by an apoplastic membrane-bound nitrate reductase (PM-
NR). However, the identity of NiNOR remains unknown (Astier et al, 2017; Santolini 




A common feature between NR and NOFNiR is the existence of a molybdenum 
cofactor (Moco) in their structure, which acts as a redox chromophore (Yang et al, 
2015). In plants, different Moco containing enzymes have been described with a 
potential NO-producing activity (Astier et al, 2017; Santolini et al, 2017).  
Xanthine oxidases (XO) 
The enzyme xanthine oxygenase (XO) was first described in mammals and is the 
enzyme responsible for purine catabolism, the conversion of hypoxanthine to xanthine 
and subsequently xanthine into urea. Plants contain two XO genes which are 
proposed to contribute to REDOX homeostasis during immune reactions by 
promoting the production of superoxide anions (O2-) during the ROS burst and ureic 
acid-mediated hydrogen peroxide removal in chloroplasts (Ma et al, 2016). Notably, 
phosphorus deprived white lupin (Lupinus albus) roots showed increased NO 
production which was reduced when the samples were treated with the XO and NOS 
inhibitors, but not with a NR inhibitor. Furthermore, it was also observed that the gene 
LaXDH was overexpressed in phosphorus deprivation, suggesting that the XO 
pathway was involved in NO production under these conditions (Wang et al, 2010). 
However, evidence of the role of XO in NO production in other plants is limited and 
the in vitro experiments to produce NO by recombinant XO were unsuccessful (Astier 
et al, 2017). 
Aldehyde oxidases (AOs) and Sulphite oxidases (SOs) 
The AO enzymes exhibit significant structural similarity with XOs; they participate in 
the production of O2- by catalysing the oxidation of aldehydes into carboxylates. 
Additionally, their NO2- into NO reduction activity has been reported in mammalian 
systems. In plants, they participate in abscisic acid (ABA) and indole-3-acetic acid 
(IAA) synthesis and ROS production. However, no direct evidence has been reported 
about their capacity to produce NO in plants  (Astier et al, 2017). 
Similarly, SOs catalysed the oxidation of sulphite to sulphate in an O2-dependent 
mechanism, and the mammalian isoform has been shown to reduce NO2- into NO in 
vitro under low oxygen conditions. No evidence about its participation in NO-
production in plants is available, and its role is thought to be in the sulphate 
assimilation pathway (Yarmolinsky et al, 2012; Astier et al, 2017). 
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Mitochondrial electron transport chain  
In addition, Gupta et al, (2005) described an alternative NO2- to NO production 
mechanism involving the mitochondrial electron transport. They observed that root 
segments of NR knockout plants could produce NO under anoxic conditions, which 
was blocked by the addition of mitochondrial electron transport inhibitors. Further 
characterisation of the mechanism showed that the reaction occurred at the 
mitochondrial membrane but not at the mitochondrial matrix and was restricted to root 
tissue, considering that the reaction is inhibited by oxygen (Gupta & Kaiser, 2010; 
Gupta & Igamberdiev, 2011). The production of NO from mitochondria electron 
transport components has been shown to occur in different higher plant species, 
including Arabidopsis, barley, pea and tobacco and may play a role in signalling 
regulation processes (Astier et al, 2017).    
Oxidative pathway for NO production 
In mammals, NOS plays a significant role in NO production. Pioneering work using 
plant extracts in a reaction containing all the NOS cofactors and using radiolabelled 
arginine as a substrate to measure the conversion of arginine into citrulline suggested 
the existence of NOS-like activity in plants. A protein displaying NOS-like activity was 
isolated from tobacco extracts by this biochemical approach. Further characterisation 
of the protein demonstrated that the protein belongs to the glycine decarboxylase 
complex and that it is not involved in NO production (Santolini et al, 2017; Astier et al, 
2017). 
Guo F.Q. et al, (2003) used a genetic approach and identified a gene with sequence 
similarity to a protein implicated in NO biosynthesis from the snail Helix pomatia. They 
observed that an Arabidopsis line carrying a T-DNA insertion in the second exon of 
the target gene showed impaired NO production and named the gene as NOS1. 
Further characterisation of the gene revealed that the gene belonged to the GTPase 
family and was renamed as NO-associated 1 (NOA1). In subsequent experiments, a 
NOS gene was identified from the marine unicellular algae Ostreococcus tauri which 
exhibit significant sequence similarity to the human eNOS. Arabidopsis plants 
expressing the OtNOS gene under the control of the inducible promoter of the 
sunflower Hahb-4 gene displayed higher NO accumulation compared with plants 
transformed with the empty vector, suggesting that higher plants contain all the 
necessary cofactors to support NOS-like activity (Foresi et al, 2015). 
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The evidence mentioned above demonstrates the existence of NOS-like activity in 
plants. However, significant debate arises from the approaches used to measure 
NOS-like activity. For instance, the arginine assay is based on measuring the 
reduction of the radiolabelled arginine and not in the formation of radiolabelled 
citrulline as a product. The inaccuracy of the arginine assay was later demonstrated 
by the fact that the arginine-dependent activity measured from Arabidopsis extract 
produced argininosuccinate (AS) instead of citrulline. In subsequent experiments, the 
production of NO was measured using chemiluminescent methods and electron 
paramagnetic resonance, demonstrating the existence of NOS-like activity in plants 
extract, strictly dependent on the presence of arginine, NADPH and different NOS 
cofactors. These observations, together with the finding of a NOS gene from O. tauri 
suggests the existence of a NOS gene in the plant lineage, however, no homologous 
gene has been found in higher plants (Santolini et al, 2017; Astier et al, 2017)   
In a recent study, Jeandroz et al, (2016) used the datasets generated from the 1000 
Plants international consortium (1KP) to search for transcripts coding for plant NOS-
like proteins. From their analysis, no related NOS-like sequence was identified from 
the 1080 sequenced transcriptomes of land plants, and only 15 out of 265 of the 
analysed algal genomes contained NOS-like sequences. This fact suggests that 
instead of producing NO through NOS-like enzymes, land plants may have evolved 
regulated NO3- assimilation and reduction mechanisms for NO production. 
Additionally, the possibility of a protein, or complex of proteins with NOS-like activity 
conformed by the interactions of different protein domains, not evident at the 
sequence level, cannot be discarded (Jeandroz et al, 2016; Santolini et al, 2017). 
Evidence for oxidative NO-production pathway 
The existence of NOS-like activity in plants has been described by different 
approaches and for different plant species. For instance, the measurement of NO 
produced by chemiluminescent means rather than on arginine reduction provides a 
more accurate visualisation of the NOS-like enzymatic activity. Additionally, different 
reports using a pharmacological approach based on the use of NOS inhibitors, mainly 
arginine analogues such as NG-Nitro-L-arginine methyl ester (L-NAME), convey in 
the general conclusion of impaired NO production mediated by NOS inhibition (Astier 
et al, 2017). 
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Arginine mediated NO-production 
The observed reduction of NO production upon NOS inhibition suggests the existence 
of a possible arginine-mediated route for NO-production. Interestingly, the 
Arabidopsis mutant nox1, which exhibits high NO production, carries a loss-of-
function mutation in a chloroplast phosphoenolpyruvate/phosphate translocator, 
which results in higher arginine accumulation (Frungillo et al, 2014). In plants, arginine 
metabolism involves the activity of arginase, which catalyse the conversion of arginine 
into ornithine and urea. Interestingly, Arabidopsis plants with reduced arginase activity 
displayed higher NO production, while overexpression resulted in impaired NO 
accumulation (Flores et al, 2008; Shi et al, 2013). 
Additionally, arginine can be decarboxylated into agmatine by the activity of the 
enzyme arginine decarboxylase (ADC). In Arabidopsis, agmatine is the primary 
precursor for the biosynthesis of polyamines (PA), and two ADC genes of 
chloroplastic origin have been reported. The overexpression of the pepper ADC gene 
in tobacco cells resulted in increased PA accumulation and higher NO production. 
Conversely, the Arabidopsis adc2.1 mutant, impaired in PA synthesis, showed 
impaired NO accumulation in response to iron deficiency (Zhou et al, 2016).  The 
central PAs found in plants are spermine, spermidine and putrescine. Previous 
research has shown that exogenous spermine application can induce NO production 
in Arabidopsis seedlings, consistent with the genetic evidence regarding PA 
synthesis. Furthermore, the compiled data supports the existence of an oxidative 
pathway for NO production in plants, connected to arginine metabolism. However, the 
precise molecular mechanism remains elusive (Santolini et al, 2017; Astier et al, 
2017).    
NO Signalling 
RNS and ROS interactions 
NO has been the focus of intensive research over the past decades. However, the 
molecular mechanisms behind its production, sensing and signal transduction remain 
poorly characterised. A hallmark of aerobic metabolism is the formation of oxygen and 
nitrogen derived free radicals (ROS and RNS, respectively), which play a critical role 
in signalling during different physiological processes. The interplay between ROS and 
RNS, together with the source of ROS/RNS, cellular localisation and the turnover of 
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ROS/RNS pools determine the specificity of REDOX signalling (Foyer & Noctor, 
2015).  
The interactions of RNS, ROS and other reactive groups form the cornerstone to 
address the complexity of NO signalling. For instance, O2- and NO interact with each 
other to form peroxynitrite (ONOO-), the reaction of NO with a thiol group (SH) forms 
an S-nitrosothiol (SNO), and glutathione (GSH) and NO react to form S-
nitrosoglutathione (GSNO). The products of these reactions have potential signalling 
activities on their own, and the individual forming components are removed from the 
cell during the reaction (Hancock et al, 2018).  
The spatial and temporal distribution of the reactive molecules in the cell promotes 
the formation of specific signalling products that determine a specific cellular outcome. 
Commonly, NO and SNO are present in minimal concentrations in the cell under basal 
conditions; their concentrations increase in response to different stimuli. Importantly, 
other reactive molecules, such as hydrogen sulphide (H2S), can suppress NO/ROS-
mediated signalling, suggesting that the signalling event is arrested until a threshold 
level is achieved (Hancock, 2019).    
Hancock, (2019) describes the consideration of REDOX chemistry to determine how 
NO impacts on REDOX state and the REDOX state influence NO signalling. The 
outcome of ROS and NO interaction depends on which reactive species are present 
at a specific time. NO can exist in the radical form (NO) but also as nitroxyl (NO-), and 
nitrosonium (NO+) and the cellular REDOX state can influence the presence of an 
isoform of NO.   
The cellular REDOX state can be estimated from the total concentration of 
glutathione, taking as input both the reduced (GSH) and oxidised (GSSG) glutathione 
concentration expressed as an oxidised:reduced (ox:red) ratio.  
The redox status of an experimental solution (Eh) can then be estimated using the 
ox:red ratio and the mid-point potential (Em) of the reactive species being studied. 
These values are subsequently used in the Nernst equation to calculate the REDOX 
potential Eh (Hancock, 2019). 
 
    E = E  (  . ) +
𝑅𝑇
nF
× 2.303  Log
[OX]
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Eh = Redox potential 
Em(pH7.4) = Midpoint potential of the REDOX couple at pH 7.4 
R = Gas constant 
T = Temperature (Kelvin) 
F = Faraday constant 
n = number of electrons used in oxidation/reduction 
 
The cellular REDOX potential estimated from GSH concentrations indicates that the 
cellular state is modified depending on the increase or decrease of GSH 
concentrations. Also, signalling molecules can modify the GSH ratio. For instance, 
the formation of GSNO from NO and GSH will reduce the GSH availability, affecting 
and the overall REDOX ratio (Hancock et al, 2018; Hancock, 2019). Various signalling 
molecules, including NO, can exist as REDOX couples in an oxidised/reduced state 
in response to the cellular environment. Each redox couple has an Em associated with 
their interconversion and the change between states allow them to exert their 
biological function. The cellular REDOX state can favour the formation of one member 
of the REDOX couple over the other.  
An example of how the REDOX state can influence RNS couples comes from the NO-
/NO- singlet couple, with an estimated Em of -350 mV. The cellular REDOX status has 
been estimated in different systems with a cellular average of -242 mV. Interestingly, 
the cellular environment was observed to become more oxidising during cell 
differentiation (-200 mV) and apoptosis (-170 mV). Therefore, the change from -242 
mV to – 200 or -170 mV during the transition from normal to differentiation or 
apoptosis REDOX state of the cell will promote the NO state, which is considered to 
be the signalling form of this molecule, suggesting that a more oxidising state 
promotes NO signalling to drive differentiation and apoptosis (Hancock, 2019).  
Additionally, cells have evolved specialised buffering systems to regulate the cellular 
REDOX homeostasis, including the GSH:GSSG, the ascorbate: dehydroascorbate 
(AsA:DHA) system, and also other low molecular weight (LMW) thiols, all present in 
millimolar cellular concentrations. The high concentrations of GSH, AsA and LMW 
thiols suggest that ROS alone will not be sufficient to generate a significant impact in 
the global REDOX state. A possibility to explain the oxidising environment in 
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differentiation and apoptosis can be as a mechanism to promote the existence of a 
partner in a REDOX couple over the other (Hancock et al, 2018).  
Cells maintain a highly reduced cellular state to allow physiological functions and 
stabilise cofactors, such as NADH, and to allow REDOX signalling. Driving the cellular 
fate toward an oxidising environment is commonly recognised as oxidative stress. 
Also, the formation of NO and RNS under reducing conditions will shorten NO/RNS 
half-life further.  
The fact that different intracellular pathways are compartmentalised suggests that the 
REDOX status can also be compartmentalised (Hancock, 2019). Therefore, a small 
increase in REDOX amount in a specific cellular compartment (organelle or a 
cytoplasmic section) can have a significant effect on the proteins and molecules in 
the proximity, despite it representing a minimum effect in the global cellular REDOX 
state (Hancock, 2019). Therefore, the compartmentalisation of NO and interacting 
partners could play a critical role in triggering signalling events and aiding signalling 
specificity (Hancock, 2019). 
NO bioactivity 
A proposed mechanism by which plants interpret these RNS and ROS cues, and 
transfer their bioactivity to trigger specific responses is through REDOX bases post-
translational modifications (PTMs) (Umbreen et al, 2019). Generally, amino acids 
containing sulphur, such as cysteine (Cys) are targets for PTMs. The hydrogen atom 
in the sulfhydryl (-SH) of Cys residues facilitates the interaction of this amino acid with 
other reactive groups. For instance, the interaction of two SH groups forms a 
disulphide (S-S) bond, which helps to stabilise protein structure (Umbreen et al, 2019).  
The three-dimensional structure of proteins is determined by the interaction of the 
amino acid sequence and their intrinsic hydrophilic/hydrophobic properties. As a 
result, most Cys residues are embedded within the secondary protein structure, and 
only a small subset of proteins contain rare surface exposed Cys residues that exhibit 
a low pKa SH group to support REDOX modifications. This characteristic allows 
specific proteins to act as molecular switches, sensing the cellular REDOX state (Yu 
et al, 2014; Spadaro et al, 2010). 
Likewise, both ROS and RNS can promote PTMs targeting the SH group of the 
susceptible cysteine residues. For example, H2O2 can oxidise the SH group to sulfenic 
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acid (SOH), sulfinic acid (SO2H) and sulfonic acid (SO3H) depending on the H2O2 
concentration, with SO3H being an irreversible modification (Yu et al, 2014). Also, the 
SH group can be targeted by NO (S-nitrosylation), glutathione (S-glutathionylation) 
and H2S (S-sulfhydration), resulting in a competition between the reactive molecules 
for the susceptible thiol groups. Each modification will trigger a different outcome, 
potentially altering the protein function. However, a particular modification can be 
favoured by the cellular REDOX state, the concentration and the proximity of the 
reactive partners (Hancock et al, 2018; Hancock, 2019). 
S-nitrosylation 
Among these modifications, S-nitrosylation stands as a central mechanism to transfer 
NO bioactivity. S-nitrosylation refers to the covalent and reversible binding of a NO 
molecule to the SH group of a susceptible Cys to form an S-nitrosothiol (SNO), 
consistently altering protein function (Frederickson Matika & Loake, 2014). Growing 
evidence highlights the importance of S-nitrosylation mediating NO bioactivity. It has 
been shown to regulate diverse protein functions. For instance, it can promote protein 
translocation (Tada et al, 2008), regulate DNA binding (Tavares et al, 2014; Cui et al, 
2018), enzymatic activity (Wang et al, 2009b; Yun et al, 2011), repress signalling 
(Feng et al, 2013), modify transcriptional dynamics (Chaki et al, 2015; Begara-
Morales et al, 2014; Hussain et al, 2016), among other activities (Feng et al, 2019). 
Interestingly, the S-nitrosylated/reduced state of a protein (R-SNO:R-SH) couple has 
an estimated Em of -400 mV. An increasing cellular oxidising state will favour the R-
SNO form, potentially driving S-nitrosylation signalling under cellular events such as 
cell differentiation, apoptosis or other physiological processes. Taken together, it is 
suggested that an increase in NO levels in response to an increasing oxidising state 
and compartmentalised NO and interacting protein partners can promote SNO 
signalling, driving a specific cellular outcome (Hancock et al, 2018; Hancock, 2019). 
NO and GSNO 
NO is a molecule with a relatively short half-life. The formation of SNO can increase 
its half-life and mediate the establishment of cellular SNO pools to aid signalling 
specificity. For instance, S-nitrosylation of the tripeptide GSH produces S-
nitrosoglutathione (GSNO). GSH is considered as the most abundant source of thiol 
groups in the cell. Upon S-nitrosylation, GSNO acts as stable storage and transporter 
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of NO bioactivity by significantly extending its half-life, and allowing diffusion to 
different cellular compartments (Espunya et al, 2012). Additionally, GSNO can act as 
a selective trans-nitrosylating agent by transferring the SNO group to other 
susceptible proteins (Frungillo et al, 2014; Hancock et al, 2018). 
Nitric Oxide in Plant immunity  
The first genetic evidence about a link between plant immunity and S-nitrosylation 
came from the identification by a reverse genetic approach of the gene GSNOR1 
which controls the global cellular turnover of GSNO. GSNO is formed by S-
nitrosylation of the antioxidant compound GSH, and it comprises a stable reservoir of 
NO bioactivity. Previous reports have shown that NR-derived NO inhibits GSNOR1 
function through S-nitrosylation, which may be necessary to amplify the NO signal. 
Also, GSNO can act as a NO-donor and trans-nitrosylate other proteins (Feechan et 
al, 2005; Frungillo et al, 2014).  
Interestingly, a loss-of-function mutation in GSNOR1 resulted in an increased total 
cellular level of GSNO, comprising multiple aspects of plant immunity, including PTI 
and ETI. Furthermore, it was noted that the absence of GSNOR1 negatively affected 
the immune activator salicylic acid (SA) accumulation and produced delayed and 
reduced expression of SA-dependent genes (Feechan et al, 2005).  
SABP3 carbonic anhydrase activity 
Currently, molecular techniques such as the biotin-switch have allowed expanding our 
understanding of the molecular mechanism by which SNO regulated SA downstream 
signalling. For instance, S-nitrosylation of Cys280 of the SA binding protein 3 (SABP3) 
blocks the binding of SA to SABP3 and inhibits its carbonic anhydrase activity, 
required for lipid synthesis and the expression of defence genes. Therefore, S-
nitrosylation of SABP3 can act as a negative feedback loop to modulates defence 
response (Wang et al, 2009b). 
NPR1 
Additionally, the central regulator of plant immunity response Non-expresser of 
pathogenesis-related genes 1 (NPR1) is proposed to localise to the cytoplasm under 
basal conditions, existing as an oligomer stabilised by disulphide bonds, presumably 
via Cys82 and Cys216. Upon pathogen infection, changes in the REDOX status 
promotes the reduction of the disulphide bonds by thioredoxin (TRX-h5) and allows 
monomerisation of NPR1 and its translocation into the nucleus to help drive SA-
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dependent gene expression. Moreover, S-nitrosylation of Cys156 of NPR1 is thought 
to promote the formation of disulphide bonds and favour oligomer conformation, 
helping to maintain oligomer-monomer homeostasis of NPR1 (Tada et al, 2008; Spoel 
& Dong, 2012; Yu et al, 2014). 
TGA1 
Upon translocation into the nucleus, NPR1 interacts with the TGACG (TGA) 
transcription factors to drive the expression of PR genes. TGA1 has been shown to 
be S-nitrosylated at Cys260 and S-glutathionylated ay Cys266, which is thought to 
protect TGA from oxidative damage. In vitro characterisation of TGA1 in ab=n 
electromobility shift assay (EMSA) after treatment with GSNO, suggests the formation 
of disulphide bonds between Cys172 and Cys287. Additionally, enhanced DNA 
binding was observed upon GSNO treatment. Further experiments expressing TGA1 
with Cys to serine (Ser) substitution of Cys172 and Cys287 in Arabidopsis plants tga1 
tga4 double mutants exhibited enhanced expression of PR genes, indicating that a 
reduced state of TGA1 is necessary for bioactivity and that GSNO-mediated 
modification positively affects its DNA binding (Lindermayr et al, 2010). 
RBOH 
During ETI, plants exhibit localised cell death (hypersensitive response) at the 
infection site to prevent further biotrophic pathogen growth. This outcome is supported 
by increased ROS accumulation via the activity of NADPH oxidases (AtRBOH). The 
observation that gsnor1-3 plants, with high GSNO accumulation, showed accelerated 
HR formation and also increased resistance to the avirulent pathogen 
Hyaloperonospora arabidopsidis Emwa1 as a result of the enhanced HR, indicating 
that NO can modulate cell death. The enzyme RBOH was found to be S-nitrosylated 
in vivo at Cys890. It is predicted that this modification prevents the interaction with the 
cofactor Flavin adenine dinucleotide (FAD) reducing ROS production and acting as a 
negative feedback regulation loop during late stages of the hypersensitive response 
(Yun et al, 2011). 
SRG1 
A recent publication has shown that the zinc finger transcription factor SRG1 can be 
S-nitrosylated both in vitro and in vivo preferentially at Cys87. SRG1 expression is 
induced by NO accumulation. Subsequently, SRG1 binds to the promoter region of 
its target genes, where it recruits the repressor TOPLESS, blocking gene expression. 
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Upon S-nitrosylation at Cys87, SRG1 binding affinity for its target promoters is 
reduced, removing the transcriptional repression. S-nitrosylation of SRG1 may 
participate in a negative feedback loop to regulate the extent of the immune response 
(Cui et al, 2018). 
Significant progress has been made in understanding the role of S-nitrosylation in the 
modulation of SA-signalling and in regulating the activation and duration of the 
immune response (Fig 1.1). However, the molecular mechanisms by which this 
























Figure 1.1. S-nitrosylation in plant immunity. The figure summarisea the role of S-
nitrosylation in plant immunity. S-nitrosylation of the SA-binding protein 3 (SABP3) inhibits its 
carbonic anhydrase activity, preventing defence gene expression. Additionally, S-nitrosylation 
of NPR1 promotes its oligomer conformation. After pathogen challenge, SA-mediated REDOZ 
changes promote the reduction of NPR1 allowing its translocation into the nucleus, where 
NPR1 interacts with TGA TF to drive PR expression. S-nitrosylation of TGA1 enhances DNA 
binding to its target promoters. Additionally, S-nitrosylation of RBOHS prevents the interaction 
with cofactors and inhibits ROS production. Furthermore, SRG1 binds to its target promoters 
and recruits the repressor TOPLESS to transcriptionally repress its target genes. Upon S-
nitrosylation of SRG1 its DNA-binding is reduces allowing the expression of immune 




SA is a key hormone in plants, it is known to participate in the regulation of diverse 
physiological processes, involving development and defence (Vlot et al, 2009; 
Dempsey & Klessig, 2017). In plant immunity, SA mediates resistance against 
biotrophic pathogens. Upon pathogen infection, SA accumulation is required to induce 
the expression of PR genes and the biosynthesis of defence compounds.  
In previous studies, Arabidopsis plants expressing the bacterial salicylate hydroxylase 
(nahG) gene which encodes an enzyme that hydrolases SA, are unable to accumulate 
SA and show enhances susceptibility to virulent and avirulent pathogens (Delaney et 
al, 1994). Interestingly, exogenous application of SA to these plants restores 
resistance against pathogen infection. Further, it has been shown that exogenous 
application of SA promotes the expression of SA-dependant defence genes and the 
establishment of systemic acquired resistance (SAR), providing broad-spectrum 
protection against different pathogens (Zhang et al, 2010). 
SA biosynthesis in plant immunity 
SA can be synthesised by two different metabolic pathways, from cinnamic acid via 
the enzyme Phenylalanine ammonia lyase (PAL) and from chorismate by the activity 
of the enzyme isochorismate synthase 1 (ICS1) (Dempsey et al, 2011; Wildermuth et 
al, 2001).  
Also, it has been reported that some bacteria such as the Pseudomonas aeruginosa 
and Pseudomonas fluorescence can synthesise SA from chorismate in a two steps 
reaction involving the isomerisation of chorismate into iso-chorismate by the enzyme 
ICS and the consecutive processing into SA and pyruvate by the enzyme pyruvate 
lyase (IPL). Likewise, in Yersinia enterocolitica and Mycobacterium tuberculosis SA 
is produced directly from chorismate in a single coupled reaction catalysed by the bi-
functional enzyme SA synthase (SAS) (Dempsey et al, 2011; Vlot et al, 2009).  
In plants, chorismate is produced in the plastid (Fig 1.2). The fact that some plastid 
derived-pathways have a prokaryotic endosymbiotic origin suggested the possibility 
of the existence of a plant ICS gene. Wildermuth et al, (2001) identified two ICS genes 
(ICS1 and ICS2) in the Arabidopsis genome by genetic analysis. The ICS genes share 
83% sequence similarity (Dempsey et al, 2011). Further, the expression of ICS1 was 
increased after infection with the pathogen Golovinomyces orontii and P. syringae pv 
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maculicula (Psm). It was also noted that the ICS1 expression correlated with the 
expression of the PR1 gene and with the accumulation of SA (Wildermuth et al, 2001).   
Moreover, the Arabidopsis mutants SA induction-deficient 2 (sid2-1) and enhanced 
disease susceptibility 16 (eds16) accumulated only 5 to 10% SA after induction with 
virulent or avirulent pathogens relative to wild-type plants. These plant lines were 
shown to contain mutations in the ICS1 gene. This evidence suggested that a 
significant proportion of SA produced in response to pathogen occurs through the 
ICS1 pathway (Wildermuth et al, 2001; Kumar, 2014; Zheng et al, 2012a; Dempsey 
et al, 2011). 
Interestingly, the plant ICS1 contains a sixty-six N-terminal amino acid extension 
absent in the bacterial isoforms. This N-terminal peptide shows identity with the typical 
chloroplast transit sequence and is followed by a putative cleavage site, consistent 
with the proposed plastid origin of SA (Wildermuth et al, 2001). Significant efforts have 
been made to identify an enzyme exhibiting isochorismate pyruvate lyase activity to 
complete the metabolic pathway downstream of isochorismate for SA biosynthesis. 
However, despite the exhaustive search, no gene or enzyme had been identified 
(Dempsey & Klessig, 2017).  
Different genetic evidence suggested an essential role for the MATE-transporter 
Enhanced Disease Susceptibility 5 (EDS5) and AvrPphB Susceptible 3 (PBS3) for SA 
accumulation in response to pathogens. EDS5 is localised on the chloroplast 
envelope and was thought to mediate the export of SA from the chloroplast to the 
cytoplasm (Serrano et al, 2013), while PBS3, which belongs to the GH3 acyl-
adenylase enzyme family (Nobuta et al, 2007).  
It was recently reported by two independent groups that EDS5 mediates the export of 
isochorismate to the cytoplasm and PBS3 promotes the conjugation of glutamate to 
isochorismate yielding isochorismate-9-glutamate. Notably, the product of this 
reaction was shown to decompose spontaneously into SA and enolpyruvyl-N-
glutamate both in vitro and in vivo, completing the pathway for SA biosynthesis from 

























Regulation of ICS1 expression for SA biosynthesis 
To date, the critical role of ICS1 on SA biosynthesis and accumulation in response to 
pathogens has led to an intense search to identify transcription factors that can 
regulate ICS1 expression. 
Upstream SA biosynthesis 
Different studies using Arabidopsis mutants have led to the identification of molecular 
components of SA-mediated signalling. The proteins enhanced disease susceptibility 
1 (EDS1) and non-specific disease resistant 1 (NDR1) have been proposed to act 
upstream of SA accumulation preferentially during R-protein mediated immunity. 
EDS1 is associated with toll-interleukin-1 (TIR) receptor pathway and NDR1 with 
coiled-coil (CC) R-proteins (Aarts et al, 1998). EDS1, a putative lipase, physically 
Figure 1.2. Schematic representation of Salicylic acid biosynthesis in plants in 
response to pathogens. Isochorismate Synthase 1 (ICS1), Enhanced Disease Susceptibility 
5 (EDS5) and avrPphB susceptible 3 (PBS3). Adapted from Rekhter et al, 2019  
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interacts with phytoalexin deficient 4 (PAD4) and senescence-associated gene 101 
(SAG101) (Feys et al, 2001; Feys, 2005). EDS1 and PAD4 are proposed to act 
upstream of SA accumulation, eds1 and pad4 plants showed compromised SA 
accumulation in response to Pseudomonas infection, which could be reversed by 
exogenous SA application (Feys et al, 2001). Additionally, ndr1 plants showed 
impaired PR1 expression and SAR in response to avirulent Pseudomonas infection 
(Fig 1.3) (Shapiro & Zhang, 2001). 
SARD1/CBP60g 
The transcription factors SAR-Deficient 1 (SARD1) and Calmodulin Binding Protein 
60g (CBP60g) stand as critical players driving ICS1 expression. SARD1 was identified 
from a mutant screen of over 200 T-DNA insertion mutants looking for compromised 
systemic acquired resistance. Two SALK lines with an insertion in the gene 
At1g73805 showed compromised SAR and was named as SAR-Deficient 1 (SARD1). 
Overexpression of SARD1 led to enhanced resistance to pathogens and increased 
free, and total SA. SARD1 belongs to the ACBP60 protein family. It was noted that 
cbp60g plants also showed impaired SAR development, which was further increased 
in the sard1cbp60g double mutant, linked with a dramatic reduction in both free and 
total SA accumulation. Both proteins were shown to bind to the GAAATT motif in the 
ICS1 promoter in vitro, and the binding to the ICS1 promoter was confirmed in vivo 
(Zhang et al, 2010). These proteins are also suggested to be involved in the regulation 
of different aspects of plant immunity on the grounds of their ability to bind to the 
promoter of different genes related to both positive and negative regulation of plant 
immunity (Sun et al, 2015).  
WRKY  
The transcription factors WRKY28 and WRKY46 were identified to coexpress with 
ICS1 under certain conditions in a coexpression analysis using 372 publicly available 
microarray data sets (van Verk et al, 2011a). It was later shown that WRKY28 and 
WRKY46 were able to induce the expression of GUS under the control of the ICS1 
promoter in a transactivation assay using Arabidopsis protoplasts. The binding site of 
WRKY28 was mapped to two WK-like boxes (TGAC) located at position -445 and -
460 in the ICS1 promoter (van Verk et al, 2011b).  
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TCP8 and TCP9   
Wang et al (2015) performed a yeast one-hybrid approach to screen for ICS1 
regulators. They identified the transcription factor teosinte branched1/cycloidea/PCF 
8 (TCP8) as a potential regulator if ICS1 expression. The binding of TCP8 to the ICS1 
promoter was confirmed by EMSA and chromatin immunoprecipitation (ChIP) assays. 
Another member of the TCP family, TCP9 was observed to coexpress with TCP8 and 
ICS1 during plant immunity. Additionally, the tcp8 tcp9 double mutant showed 
reduced ICS1 expression together with higher susceptibility to Pseudomonas 
syringae infection (Wang et al, 2015).  
NTL9 and CHE 
In a similar experiment, Zheng et al (2015) identified the transcription factors NTM-
like 9 (NTL9), and Circadian Clock Associated 1 (CCA1) hiking expedition 
(CHE/TCP21) as regulators of ICS1 expression during specific immune responses 
following a yeast one-hybrid approach. NTL9 was related to ICS1 expression in guard 
cells, mediating stomata closure during PTI. The ntl9 mutant plants showed 
compromised stomata function, which could be rescued upon exogenous application 
of SA, linking NTL9 with ICS1 expression in PTI. Additionally, CHE was found to 
participate in the circadian regulation of SA levels, which serves as a mechanism to 
prime defences at times of the day where pathogens show higher activity (Karapetyan 
& Dong, 2018). Also, CHE was proposed to regulate ICS1 expression in distal leaves 
during SAR. Interestingly, the che mutant showed reduced SARD1 and CBP60g 
expression, suggesting that the molecular mechanisms behind CHE regulation of 
ICS1 could occur probably by modulating SARD1 and CBP60g expression. 
Interestingly, no TCP cis-elements are found within the promoter region of SARD1 
and CBP60g, suggesting an indirect regulatory mechanism (Zheng et al, 2015). 
EIN3 and EIL1 
In addition, different transcription factors involved in ICS1 repression have been 
described. For instance, the ethylene insensitive 3 (EIN3) and EIN3-like 1 (EIL1) 
which are involved in the regulation of ethylene (ET)-dependent gene expression 
were found to repress ICS1 expression. The Arabidopsis double mutant ein3 eil1 
showed constitutive activation of immune responses in the absence of a pathogen, 
whereas overexpression of these proteins increased susceptibility to bacterial 
infection. Additionally, both EIN3 and EIL1 were shown to bind to the ICS1 promoter 
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in vitro and in vivo, together with higher ICS1 expression and accumulation of free 
and total SA in the double mutant (Chen et al, 2009a).  
ANAC019, ANAC055 and ANAC072 
A study aiming to elucidate the coronatine-mediated virulence mechanisms of some 
virulent Pseudomonas strains led to the identification of the NAC (NAM/ATAF1, 
ARAF2/CUC2) family members ANAC019, ANAC055 and ANAC072 as negative 
regulators of ICS1 expression. A common virulent strategy of adapted pathogens is 
to highjack hormonal signalling pathways to favour infection. It was observed that 
coronatine treatment induce the expression of ANAC019, 055 and 072, and plants 
showed reduced accumulation of SA via repression of ICS1. Additionally, the 
nac019/055/072 triple mutant showed higher ICS1 expression under basal conditions, 
and NAC019 was shown to bind to the ICS1 promoter in vivo (Zheng et al, 2012).  
  
Figure 1.3. Schematic representation of SA-mediated signalling. The detection of a 
pathogen by pathogen recognition receptors triggers a signalling cascade that induces SA 
biosynthesis via the activity of ICS1. After accumulation of SA, SA mediates REDOX changes 
that promote the reduction of NPR1 oligomer and its translocation into the nucleus where it 
interacts with TGA TFs to drive SA-mediated gene expression.   
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SA signalling   
The best characterised mechanism for SA-dependent gene expression is the NPR1-
dependent pathway. Notably, npr1 Arabidopsis plants are impaired to activate 
immune responses in response to pathogen infection or exogenous SA-treatment, 
indicating that NPR1 acts downstream of SA accumulation. NPR1 contains two 
protein-protein interaction domains,  ankyrin repeat and BTB/POZ domains, and a C-
terminal nuclear localisation and trans-activation domain (Cao et al, 1997; Mou et al, 
2003). Under basal conditions, NPR1 localises in the cytoplasm in an oligomeric 
conformation, stabilised by disulphide bonds. Upon infection, SA-mediated REDOX 
changes promote monomerisation of NPR1 via the activity of (TRXh5) and 
translocation into the nucleus where NPR1 acts as a cofactor for TGA TFs to drive 
the expression of SA-dependent genes (Fig 1.3) (Tada et al, 2008; Kneeshaw et al, 
2014).  
Additionally, NPR1 and its homologue proteins NPR3 and NPR4 are proposed as SA 
receptors and show opposite transcriptional roles. NPR1 acts as a transcriptional 
activator and NPR3/4 as a transcriptional repressor of defence genes. NPR1, NPR3 
and NPR4 bind SA through the conserved arginine (Arg) residue 432, 428 and 419, 
respectively. The mutation of this amino acid renders the NPR proteins unable to bind 
SA and compromise its transcriptional activity. It was shown that NPR3 and NPR4 
repress the expression of important SA-signalling components such as SARD1 via 
interaction with TGA2, 5 and 6, and the transcriptional repression is released upon 
SA binding. Similarly, NPR1 and SA binding is a critical requirement for the expression 
of SA-mediated genes (Ding et al, 2018). The transcriptional dynamics mediated by 
NPR1/3/4 help fine-tune SA-mediated immunity.     
ICS1 network 
Different studies suggest a complex network of interaction and 
overlapping/complementary functions between these transcription factors to precisely 
modulate ICS1 expression. For instance, SARD1 and CBP60g play a central role in 
ICS1 expression in response to pathogens and SAR. Additionally, both proteins can 
bind to the promoter of regulators of different nodes of plant immunity, covering both 
positive and negative regulators (Sun et al, 2015). Also, TCP8 was found to interact 
with SARD1, WRKY28, TCP8, TCP9, TCP20, and also with the negative regulator 
ANAC019 (Wang et al, 2015). CHE is proposed to regulate the circadian oscillation 
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of ICS1 expression and SAR induction by modulating SARD1 and CBP60g 
expression (Zheng et al, 2015). 
Additionally, changes in the Ca2+ signature contribute to regulating the timing of ICS1 
expression. Ca2+ is thought to activate CBP60g through calmodulin binding and 
WRKY28 via phosphorylation mediated by Ca2+ -dependent protein kinases (CPK), 
linking calcium influxes with SA biosynthesis (Wang et al, 2009a; Gao et al, 2013). 
NTL9 is thought to mediate stomatal closure during PTI and is expressed mainly in 
guard cells, implying a tight regulation depending on the desired cellular outcome 
(Zheng et al, 2015). The negative regulators of ICS1 expression are involved in the 
signalling pathways of other plant hormones. The repression of ICS1 by these TF may 
mediate cross-talk between SA, ET and JA pathways fine-tuning the immune 
response (Dempsey & Klessig, 2017). 
Project Aims 
The fact that the loss-of-function gsnor1 Arabidopsis mutant exhibit increased cellular 
S-nitrosylation levels and reduced SA biosynthesis and accumulation in response to 
pathogens suggests the possibility of a NO-mediated regulatory mechanism of SA 
biosynthesis. Current findings have helped to elucidate the molecular mechanisms by 
which S-nitrosylation regulates SA-signalling. However, our understanding of how S-
nitrosylation regulates SA biosynthesis during plant immunity is limited.  
In previous work, Li (2015) observed delayed ICS1 expression in gsnor1-3 
Arabidopsis plants. We speculated that ICS1 could be subjected to transcriptional or 
posttranscriptional regulation. In addition, Li (2015) observed that the TF SARD1 can 
be S-nitrosylated at Cys438 and that SARD1 binding to the ICS1 promoter was 
reduced upon S-nitrosylation. Investigate the extent of S-nitrosylation of Cys438 on 
SARD1 binding-affinity. 
Project goals 
Differentiate between transcriptional and posttranscriptional repression of ICS1 
expression by S-nitrosylation using the reporter line ICS1::GUS par2-1. 




Generate Arabidopsis transgenic lines to investigate if SARD1 can be S-nitrosylated 
in vivo and investigate what is the biological relevance of this modification. 
Design a genetic screening using the PR1::LUC line to search for second-site 
mutations that can regulate GSNO-turnover or reduce total cellular S-nitrosylation in 




Chapter 2 Materials and Methods 
Plant material 
The Arabidopsis thaliana accessions used (Columbia (Col-0), gsnor1-3, par2-1, 
sard1-1 (SALK_138476), sard1-2 (SALK_052422), Landsberg erecta (Ler-0) and 
Ler1-3) were grown in long day conditions, consisting in 16 hours light at 22°C and 8 
hours darkness at 18°C. Plants were grown in soil mix containing Levington F2 + sand 
(150L), horticultural sand (40L), Sinclair standard grade Perlite (60L) and Everris 
Exemptor (75g). The F2+S is a peat, sand mix with fertiliser, pH 6.5. 
For growth in sterile conditions, seeds were surface sterilised with 75% ethanol for 5 
minutes, followed by 20% bleach + 0.02% Tween 20 and five subsequent washes in 
sterile water. The seeds were stratified for four days at 4°C. The seeds were grown 
in half-strength MS (2.2 gL-1 MS basal salts, 1% sucrose and 0.8% agar).  
Generation of transgenic lines 
For the generation of the SARD1::SARD1-HA and SARD1:SARD1-nLUC genomic 
DNA was extracted from Col-0 plants. The primers used to isolate the native SARD1 
promoter and terminator were used by Zhang et al (2010) before. For the genetic 
constructions, the sequences of interested were amplified with gene-specific primers 
adding BpiI restriction sites plus compatible overhangs for modular cloning using the 
MOCLO toolkit (Engler et al, 2014). 
Bacterial growth conditions.  
The bacterial strains used were grown in lysogeny broth (LB) at 37°C media unless 
stated differently. General cloning and plasmid propagation were done in Escherichia 
coli DH5 α.  
Bacterial strains for recombinant protein expression 
BL21 (DE3) Competent E. coli NEBC2527I 
BL21 Shuffle T7 express E. coli NEBC3029J -Growth at 30°C 
 
Pseudomonas strains grown on LB media supplemented with 10mM magnesium 
chloride + corresponding antibiotics, grown at 28°C 
Pseudomonas syringae p.v. maculicula ES4326  Strep 100mg/L 
26 
 
Pseudomonas syringae p.v. maculicula ES4326 (avrB) Strep 100 mg/L + Kan 50mg/L 
Pseudomonas syringae p.v. tomato DC3000 Rif 100mg/L 
Pseudomonas syringae p.v. tomato DC3000 (avrB) Rif 100 mg/L + Kan 50mg/L  
 
Pathogen infiltration 
Psm ES4326 were grown overnight at 30°C and diluted to a final OD600 of 0.0002 in 
10 mM MgCl2. The leaves were infiltrated by pressure infiltration using a 1ml 
needleless syringe against the abaxial part of the leave.  
RNA extraction and cDNA synthesis 
RNA was extracted using the Trizol™ method according to the manufacturer protocol. 
Briefly, 100 mg of grounded tissue was resuspended in 1 ml of Trizol™ and was 
incubated for 10 minutes at room temperature. The suspension was centrifuged at 
12,000 g for 5 minutes, and the supernatant was transferred to a fresh tube, all 
centrifugations were performed at 4°C. 200 µL of chloroform per ml of Trizol™ used 
were added to the supernatant and were shaken by hand for 20 seconds and 
incubated at room temperature for 2 minutes. After incubation, the samples were 
centrifuged for 15 min at 12,000g.  The aqueous phase was transferred to a new 1.5 
ml Eppendorf tube, and the RNA was precipitated with 500 µL of isopropanol. 
Samples were shaken and incubated for 10 minutes at room temperature followed by 
centrifugation at 12,000 g for 10 minutes. The supernatant was discarded, and the 
pellet was washed twice with 1 ml of 75% ethanol in DEPC water, mixed briefly by 
vortex and centrifuged at 7,500 g for 5 minutes. Next, the pellet was air-dried and 
resuspended in 50 µL of RNase free water and incubated for 10 minutes at 55°C. 
Finally, the RNA concentration and purity were determined by absorbance at 260nm, 
and the integrity was evaluated in 1% agarose gel stained with ethidium bromide. 
The first cDNA strand was synthesised using the High-capacity cDNA reverse 
transcription Kit from Applied Biosystems. 1.5 µg of pure RNA was used in a 20 µl 
reaction, incubated for 2 hr at 37°C. The enzyme was inactivated at 85°C for 5 
minutes, and samples were stored at -20°C until use.   
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Semi-quantitative PCR and competitive PCR 
The differences in gene expression were determined by semi-quantitative PCR in a 
25 µL reaction (1X Crimson buffer, 200µM dNTPs, 1 µM forward primer, 1 µM reverse 
primer, 1.25 units Crimson TAQ DNA polymerase, 1 µM template DNA) using 25-28 
cycles of 94°C for 40 sec, 57°C for 1 minute and 72°C for 40 seconds, followed by a 
final extension of 72°C for 5 minutes. The genes ACTIN2 and UBIQUITIN10 were 
used as internal standards. The primers used are listed in table 2.  
 
GUS staining 
For histological GUS staining, seedlings or three-week-old plants were sprayed with 
SA solution or infiltrated with a virulent/avirulent Pseudomonas suspension. The plant 
tissue was harvested 24, 48 and 72 hours after treatment. The plant tissue was rinsed 
in staining buffer without X-gluc (20 mM NaPO4 pH 7.2, 0.2 mM EDTA, 0.1% Triton 
X-100, 1 mM potassium ferrocyanide (K4[Fe(CN)6]·3H2O) and 1 mM potassium 
ferricyanide). Subsequently, the samples were submerged and vacuum infiltrated in 
staining buffer containing 1 mM X-gluc substrate. After infiltration, the samples were 
incubated at 37ºC for 24 or 48 hours. Finally, the chlorophyll was washed with serial 
95% EtOH washes and leaves stored in EtOH at 4ºC until imaging. 
Quantitative GUS activity assay  
GUS activity was quantified from intact plant tissue following the protocol described 
by Blazquez (2007). The protocol is based on the hydrolysis of the substrate 4-
methylumbelliferyl β-D-glucuronide (4-MUG) by GUS to produce 4-
methylumbelliferone (4-MU). 4-MU is a fluorescent compound with excitation and 
emission at 365 and 455 nm, respectively. To measure GUS activity, leaf discs from 
induced ICS1::GUS Col 0 and ICS1::GUS par2-1 plants were placed at the bottom of 
the well of a 96-well plate. The tissue was covered with 100 µL of GUS extraction 
buffer (50 mM NaPO4 pH 7.2, 10 mM EDTA, 0.1% SDS, 0.1% Triton X-100 and 1 
mM PMSF) including 1 mM 4-MUG. The samples were incubated at 37ºC for 16 
hours. After incubation, 50 µL of stop reagent (1 M sodium carbonate) was added to 
each well. A 4-MU standard curve covering a range from 0 to 500 nM was prepared 
in stop reagent. Finally, 100 µL per each sample were transferred to a new 96-well 
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plate well, and the fluorescence was measured using excitation 365 nm and emission 
at 455 nm with a 430 nm filter. The GUS activity was quantified by linear regression 
from the standard curve and reported as nmol 4-MU per surface area.  
Recombinant protein expression, extraction and purification 
MBP-SARD1: E. coli BL21 strain (DE3) cells carrying the plasmid pDEST0his-MBP 
with the SARD1 insert were grown overnight at 37°C in 5ml of LB media containing 
100µg/ml ampicillin. 1 ml of the overnight culture was used to inoculate 100 ml of LB 
media in a 250 ml flask. The culture was grown at 37°C with constant agitation until it 
reached an OD600 between 0.6 - 0.7. Protein expression was induced by adding 
IPTG to a final concentration of 0.5 mM and incubated at room temperature for 3 
hours.  
The MBP-SARD1 fusion protein was purified using amylose resin (NEB E8021S). 1 
ml of amylose resin was loaded into a 5 ml Pierce™ centrifugation column. The resin 
was equilibrated with 5 column volumes of column buffer (20 mM Tris-HCl, 200 mM 
NaCl, 1 mM EDTA). The crude extract was then loaded into the column. The resin 
was washed with six volumes of column buffer. The fusion protein was eluted with 3 
ml of 10 mM maltose in column buffer. Finally, 0.5 ml fractions were collected and 
stored at 4°C until use.  
Western Blot 
The protein concentration in the fractions was calculated by Bradford assay (Bradford, 
1976). The protein containing fractions were loaded in an SDS- PAGE gel (10% 
Acrylamide resolving gel, 5% stacking gel, run at 90V). The gels were transferred 
overnight to a nitrocellulose membrane at a constant current of 0.13 A in 20% 
methanol transfer buffer. The transfer was verified by Ponceau stain. The membrane 
was then blocked with 5% milk in PBS-T for 20 minutes, followed by a 1-hour 
incubation with 1/10,000 anti-MBP-HRP conjugated antibody, or anti-HA 1/2,000 
mouse primary antibody followed by 1/3,000 anti-mouse-HRP conjugated secondary 
antibody. The membrane was washed at least three times with fresh PBS-T. 1 ml of 
Thermo Scientific Supersignal West Pico Chemiluminescent Substrate was added to 
the membrane. X-ray films were exposed to the membrane for specific time intervals.  
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In vivo Imaging 
Arabidopsis plants containing the PR1::LUC transgene was grown as previously 
described.  1-week old plants were sprayed with a 5 mM luciferin solution in distilled 
water plus 0.01% Triton X-100 and screened for LUC activity using an EM-CCD ultra-
low-light imaging camera system (Hamamatsu C9100-1). Images were collected over 
10 seconds exposition and processed for background subtraction (Murray et al, 
2002). 
In vivo luminometer assay 
Arabidopsis seedlings expressing the SARD1::SARD1 Nano luciferase construction 
were germinated in 96-well plates. Each well contained 100 µL of half-strength MS 
media plus 50 µg/ml Kanamycin. The seedlings were germinated in long day 
conditions. 1-week old seedlings were sprayed with a 10 mM salicylic acid solution 
and 1:50 furimazine in 0.01% Triton X100 solution. Bioluminescent measures were 
collected every hour for a total of 7 days.  
Pathogen challenge and SAR assay 
Pseudomonas syringae a) p.v. Tomato DC300 or b) p.v. Maculicula ES4326 were 
grown overnight in LB supplemented with 10mM MgCl2 and the appropriate 
antibiotics. Cells were harvested by centrifugation at 5000 G for 10 minutes and 
washed with sterile 10mM MgCl2. The O.D.600 was adjusted to 0.0002 for the virulent 
pathogen, 0.002 for avirulent growth assay and 0.025 for avirulent SAR induction. To 
induce SAR, one bottom leaf was infiltrated with a high dose of avirulent 
Pseudomonas. Three days afterwards, three distal leave were infiltrated with 0.0002 
virulent solutions. For control, the initial infiltration was done with 10 mM MgCl2.  
After the defined incubation time, two leaf discs from independent leaves were ground 
together in 500 mL of 10mM MgCl2 for a total of six independent samples per 
genotype. Following homogenisation, six serial dilutions were prepared for each 
sample, and 10 uL were plated per dilution for a total of six repetitions of each dilution 
per plate. When the plates contain well-defined colonies, the colonies were counted 




To detect S-nitrosylated proteins. The protein samples were incubated with GSNO or 
CysNO 1 mM for 20 minutes in the dark. The NO-donor was removed by gel filtration 
using a Zeba column. Subsequently, free thiols were blocked with 25 mM NEM with 
continuous mixing for 30 minutes at 50°C. The proteins were precipitated with a 2X 
volume of 100% acetone and centrifuged at 15,000 G for 10 minutes. Following 
precipitation, the samples were resuspended in labelling buffer and 0.45 µM Biotin 
HPDP and ascorbate. The biotin labelled proteins were mixed with SDS-loading buffer 
and boiled for 10 min at 95°C. Subsequently, the fractions were resolved by SDS-
PAGE and the nitrosylated proteins detected by western blot.  
In vivo S-nitrosylation.  
SARD1::SARD1-HA plants were induced with 1mM SA for 12 hours. Upon induction, 
the leaves were infiltrated with 1mM GSNO in 10mM MgCl2. Following 1 hours 
incubation, the samples were harvested in liquid nitrogen and ground to a fine powder. 
All this process was done in the dark. The tubes were covered with foil. The samples 
were resuspended in HEN buffer + 1mM PSMF + 0.5% Triton X100 + 25 mM NEM. 
After resuspension, the samples were incubated at 50°C for 30 minutes with constant 
mixing. For negative control, the samples were incubated for 30 minutes with 50mM 
DTT. After incubation, the samples were centrifugated at 15,000 G for 10 minutes and 
the supernatant transferred to a new tube. The protein samples were then precipitated 
with acetone 100% and resuspended in labelling buffer with 1 mM Biotin HPDP. After 
Labelling, with 1mM Biotin-HPDP the biotinylated proteins were pulled down using an 
agarose streptavidin resin and blotted against HA or pulled down HA and blotted 
against biotin. 
Electrophoretic Mobility Shift Assay (EMSA) 
To evaluate the effect on the DNA-binding of SARD1 to the ICS1 promoter upon S-
nitrosylation we used EMSA, following the protocol described by Zhang et al., (2010) 
with minor modifications. A 25 bp forward and reverse fragments of the ICS1 promoter 
containing the GAAATTT motif and a fragment with a mutation in the binding site 
GAAGGGT (Sun et al, 2015) were ordered from Integrated DNA Technologies (IDT). 
The double-stranded probe was annealed by incubating equimolar concentrations of 
the forward and reverse strands at 95 ºC for 20 min and reducing temperature to room 
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temperature at a rate of 0.5ºC per minute. The probe was end-labelled in a 40 µL 
reaction containing ten pmol of double-stranded DNA, 100 units of T4 polynucleotide 
kinase  (NEB) and 40 µCi of [γ-32P] ATP (PerkinElmer) incubated at 37ºC for 30 
minutes. The unincorporated labelled nucleotides were removed using an illustra 
MicroSpin G-50 Spin Column (GE healthcare). The probe was diluted to a final 
concentration of 0.1 pmol/ µL.  
For the binding reaction, 100 ng of purified MBP-SARD1 or MBP-SARD1C438S were 
mixed with 4 µL of 5X binding buffer (50 mM HEPES pH 7.7, 375 mM KCL, 6.25 mM 
MgCl2, 25% glycerol and 100 ng of poly[dI-dC] (LightShift Pierce) and 5 mM DTT), the 
volume was adapted to 19 µL with sterile water and the reaction was incubated on ice 
for 20 min. Subsequently, 1 µL of the labelled probe (0.1pmol) was added per reaction 
and mixed by pipetting up and down. The reaction was incubated for 30 min at 37ºC. 
The mix was loaded into a 5% polyacrylamide gel in 1X TGE buffer (25 mM Tris pH 
8.3, 190 mM glycine, 1 mM EDTA). After electrophoresis, the gel was dried for 2 hours 
at 60ºC under vacuum. Finally, an X-ray film was exposed to the gel in the dark at -
80ºC overnight (different exposure times) and developed afterwards.  
EMSA after S-nitrosylation 
To evaluate the changes of DNA binding of the recombinant protein after S-
nitrosylation, we first diluted the recombinant SARD1 or SARD1C438S fractions to 
100 ng/µL and transferred 9 µL into seven 0.2 mL PCR tubes. The NO donor was 
diluted in the 1X binding buffer to final 1, 2.5, 5, 10 and 50 mM concentrations. Two 
different 5X binding buffer were prepared, containing + DTT or – DTT. Subsequently, 
1 µL of each NO donor dilution was added to each independent protein tube to obtain 
a final concentration of 0.1, 0.25, 0.5, 1.0 and 5.0 mM. The reaction was incubated 
for 20 min at room temperature in the dark. Finally, 9 µL of the reaction mix (4 µL of 
5X DNA binding buffer, 1 µL poly[dI-dC] and 4 µL water) were added to each protein-
NO-donor tube to obtain a final volume of 19 µL. Finally, 1 µL of 0.1 pmol DNA probe 
was added to each tube, and the reaction was incubated at room temperature for 20 
min and loaded for electrophoresis separation as mentioned above.  
Equilibrium dissociation constant    
To calculate the equilibrium dissociation constant before and after S-nitrosylation of 
SARD1, we titrated increasing protein concentrations covering a range from 30 to 600 
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nmol of protein under NO-donor treatment and control conditions. Briefly, 49 µL of 
quantified protein fractions were placed into two independent test tube. For the NO-
donor treatment, 1 µL of 50 mM GSNO was added to the 49 µL of the protein fraction 
(1 mM GSNO), and 1 µL of water was added to the control. After mixing, the S-
nitrosylated/control protein was transferred in increasing volumes into seven 0.2 mL 
PCR tube and the volume adjusted to 10 µL with sterile water to obtain the desired 
concentrations (covering from 30 to 600 nmol). Simultaneously, we prepared a master 
mix consisting of 5X DNA- binding buffer (without DTT), poly [dI-dC] and 0.1 pmol of 
fluorophore-labelled DNA probe. 10 µL of the master mix was added to each reaction 
tube. After mixing, the reaction was incubated for 20 min at room temperature 
following gel electrophoresis as described above. After running, the gel was scanned 
using a LiCOR Odyssey system. The intensity of the DNA-protein and free probe 
bands was quantified using the software ImageJ. The fraction of DNA-bound and 
unbound were plotted following the protocol described by Heffler, Walters, & Kugel, 




Chapter 3 Transcriptional Regulation of ICS1 expression by S-nitrosylation 
Introduction 
Salicylic acid 
Salicylic acid (SA) is a vital defence hormone in plants. Upon pathogen infection, SA 
accumulation in leaves is a critical requirement to induce the expression of 
pathogenesis-related genes and the biosynthesis of defence compounds (Loake & 
Grant, 2007; Vlot et al, 2009; Dempsey & Klessig, 2017). Plants can produce SA by 
two independent metabolic pathways. The first one derived from cinnamate catalysed 
by the enzyme phenylalanine ammonia lyase (PAL) and the other pathway via 
chorismate catalysed by the activity of the enzyme Isochorismate Synthase I (ICSI). 
It is now known that the major proportion of SA produced in response to pathogen 
infection occurs via the ICS1 pathway, considering that the Arabidopsis thaliana  ics1 
mutant plants exhibit dramatically reduced SA accumulation after pathogen infection 
(Lawton et al, 1995; Wildermuth et al, 2001). 
Our current understanding of the molecular mechanisms underlying SA-mediated 
immunity suggests that the proteins Enhanced Disease Susceptibility 1 (EDS1) and 
Phytoalexin Deficient 4 (PAD4) act upstream of SA accumulation, promoting ICS1 
expression during basal and Pathogen Associated Molecular Pattern (PAMP) 
Triggered Immunity (PTI) (Cui et al, 2017). After accumulation, SA mediates 
transcriptional reprogramming via direct interaction with Non-Expresser of 
Pathogenesis-Related Genes 1 (NPR1) and TGA transcription factors (Tada et al, 
2008) to promote the expression of defence genes.    
ICS1-Associated transcription factors 
To better understand how SA coordinates these mechanisms, numerous studies have 
focused on identifying transcription factors (TFs) that regulate ICS1 expression, 
finding proteins that have been shown to bind to the ICS1 promoter in vivo and exert 
a positive or negative transcriptional effect on ICS1 expression. For instance, the 
absence of the TF SAR-deficient 1 (SARD1) and its homologue, calmodulin-binding 
protein 60g (CBP60g), drastically compromises ICS1 expression in response to 
pathogen infection and severely increases the susceptibility to Pseudomonas 
infection (Zhang et al, 2010). Also, the TF WRKY28 was reported to bind and 
upregulate the activity of the ICS1 promoter in a protoplast assay (van Verk et al, 
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2011b). The teosinte branched1/cycloidea/PCF 8 (TCP8) and TCP 9 were found to 
co-express with ICS1 and bound to the ICS1 promoter in vivo. Further, the tcp8 tcp9 
double mutant exhibited a significant reduction in ICS1 expression during immune 
responses (Wang et al, 2015). Similarly, the TF NTM-like 9 (NTL9) was found to drive 
ICS1 expression in guard cells to mediate stomatal closure during plant immunity and 
the CCA1-hiking expedition (CHE/TCP21) TF was shown to control ICS1 expression 
in association with the circadian oscillation of SA concentrations (Zheng et al, 2015). 
Interestingly, the che mutant also showed reduced ICS1 expression and 
compromised expression of SARD1 and CBP60g, suggesting that CHE regulation of 
ICS1 may depend on modulation of SARD1 and CBP60g (Zheng et al, 2015).  
TFs reported to exert transcriptional repression of ICS1 include Ethylene Insensitive 
3 (EIN3) and EIN3-like 1 (EIL1), which are known to regulate ethylene (ET)-dependent 
gene expression. Constitutive SA accumulation and expression of SA-dependent 
gene expression have been observed in the ein3 eil1 double mutant (Chen et al, 
2009a). Likewise, the NAC (NAM/ATAF1, ARAF2/CUC2) family members ANAC019, 
ANAC055 and ANAC072, which are involved in jasmonic acid (JA)-mediated 
signalling were reported to repress ICS1 expression and promote stomatal re-opening 
in response to the bacterial toxin, coronatine (Zheng et al, 2012b). Further, the spatial 
and temporal interactions of these TF’s are thought to mediate cross-talk between 
SA, ET and JA pathways (Dempsey & Klessig, 2017).  
Transcriptional and posttranscriptional regulation of gene expression 
The transcriptional reprogramming is regulated at different levels. Transcriptional 
regulation occurs mainly through the binding of gene-specific TFs to cis-regulatory 
elements located within the promoter region of certain genes (Lee et al, 2006; Hong 
et al, 2003). The process is coordinated by the enzyme RNA polymerase II (RNAPII) 
which binds to the promoter of target genes assisted by general transcription factors 
(GTFs). The Mediator complex interacts with gene-specific transcription factors and 
binds to RNAP11 to mediate its transcriptional activity and specificity (Li et al, 2016). 
The Mediator core is composed of over twenty subunits, organised into three modules 
named head, middle and tail. The head and middle modules interact with GTFs and 
RNAPII, and the tail interacts gene-specific TF. Additionally, the mediator core 
contains a separable cyclin-dependent kinase 8 (CDK8) module which blocks the 
interaction with RNAPII leading to transcriptional repression, allowing the Mediator to 
35 
 
act as a transcriptional activator or repressor depending on the subunit composition 
(Zhang et al, 2013c; Shaikhali & Wingsle, 2017).  
In Arabidopsis, the mediator has been associated with the transcriptional regulation 
of different signalling processes including plant immunity (Shaikhali et al, 2015). The 
mediator subunits MED15, MED16 and MED14, were identified as critical regulators 
of SA and systemic acquired resistance (SAR) signalling pathways. The med14 
mutation resulted in reduced and delayed expression of central genes for SA 
biosynthesis and signalling, including ICS1, PBS3, EDS5, NPR1/3/4, and PR1, 
together with higher susceptibility to Pseudomonas infection and reduced 
accumulation of free and total SA (Zhang et al, 2013c). Contrary, Arabidopsis med16 
plants showed normal SA accumulation but compromised in SAR and SA-dependant 
genes expression, including NPR1 and PR1 (Zhang et al, 2012).  
After transcription, the expression profile can be modified by different 
posttranscriptional regulatory mechanisms which include microRNA-mediated 
degradation, nonsense-mediated mRNA decay, nuclear export control, translation 
efficiency control, intracellular protein trafficking, and regulated nuclear localisation 
(Lee et al, 2006). Both transcriptional and posttranscriptional mechanisms are 
regulated by RNA binding proteins (RBPs), which participate in mRNA export from 
the nucleus to the cytoplasm by interacting with the nuclear pore complexes (NPCs) 
(Staiger et al, 2013). 
S-nitrosoglutathione in plant immunity 
In Arabidopsis, the absence of the enzyme S-nitrosoglutathione reductase 1 
(GSNOR1) resulted in increased total cellular S-nitrosylation and compromised basal, 
non-host, and R-gene mediated immunity. Furthermore, atgsnor1-3 plants showed 
reduced SA-mediated gene expression and reduced SA biosynthesis and 
accumulation (Feechan et al, 2005). This observation suggests the possibility of a 
regulatory mechanism of SA biosynthesis mediated by S-nitrosylation, potentially by 
transcriptional repression of ICS1 expression, control of ICS1 mRNA stability or 
translation or alternatively, the post-translational regulation of ICS1 activity. 
A well-established method to study temporal and spatial gene expression in plants is 
the application of the bacterial reporter gene, β-glucuronidase (GUS). GUS catalyses 
the hydrolysis of β-O-glycosidic linkages from a broad range of substrates, allowing 
histological and quantitative analysis of the associated plant promoter activity in 
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different situations. In addition, plants lack endogenous GUS activity, making this 
approach reliable to assess qualitatively or quantitatively gene expression patterns in 
plants (Kim et al, 2005).   
To determine if SNO accumulation in gsnor1 plants reduces SA levels by repressing 
the transcription of ICS1, rather than an alternative post-transcriptional mechanism 
we prepared an Arabidopsis line possessing a GUS reporter gene under the control 
of the ICS1 promoter (ICS1::GUS) (Li, 2015). The reporter line was subsequently 
crossed into the par2-1 genetic background, which is an ethane methyl sulphonate 
(EMS) mutant containing a G to A mutation in the GSNOR1 gene, that renders the 
corresponding protein inactive. Importantly, the par2-1 mutants exhibit an 
indistinguishable phenotype to the gsnor1-3 line (Chen et al, 2009b). Both lines exhibit 
increased overall S-nitrosylation, short roots, loss of apical dominance and reduced 
SA accumulation and signalling, compromising different modes of plant immunity 
(Feechan et al, 2005; Yun et al, 2016). The application of the par2-1 line enabled us 
to avoid generating a line with more than one transgene because this might result in 
gene silencing (Gelvin, 2003).  
Results 
Characterisation of ICS1::GUS transgenic lines 
In previous work undertaken in our lab, a 1,500 bp fragment of the ICS1 promoter 
including the 5’-untranslated region and sequences including the binding sites for 
most of the TF known to regulate ICS1 expression was amplified from Arabidopsis 
Colombia 0 genomic DNA and cloned into the pGWB3 vector to transcriptionally fuse 
GUS to the ICS1 promoter. The pGB3 ICS1::GUS plasmid was introduced into 
Agrobacterium tumefaciens GV3101 strain and subsequently used to transform 
Arabidopsis plants by floral dipping (Li, 2015). From the 24 T1 plants obtained, we 
selected four lines that express GUS in response to Pseudomonas syringae pv 
maculicula ES4326 (Psm ES4326) infection for further screening.  
To characterise these lines, we compared the expression profile of transgene 
expression to that of the endogenous ICS1 gene, following inoculation with Psm 
ES4326. Thus, we inoculated ICS1::GUS T3 homozygous plants with Psm ES4326 
and compared transcript levels by semi-quantitative PCR. The expression of the ICS1 
gene steadily increased from 3 hours post inoculation (HPI), reaching a maximum 
expression level between 12 and 24 HPI. The temporal expression of the transgene 
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was found to be congruent with the expression of the endogenous ICS1 gene (Fig 
3.1A).  
We then analysed the spatial kinetics of transgene expression following pathogen 
challenge or induction by exogenous SA application. Thus, we inoculated a single leaf 
of a 3-week-old ICS1::GUS plant with a high concentration of Psm ES4326 (avrB) or 
sprayed this line with a SA solution. Subsequently, we performed histological GUS 
staining of whole plants at 24 and 72 hours post-inoculation / treatment.  
The challenged leaves showed strong GUS induction flanking the infection site and 
interestingly, displayed GUS accumulation in areas surrounding the vascular tissue 
at 24 HPI (Fig 3.1B). In the distal leaves, localised GUS activity spots were observed 
at this time point. Interestingly, we observed less GUS activity at 72 HPI than at 24 
HPI (Fig 3.1C), in agreement with the temporal dynamics of ICS1 expression following 
Psm inoculation, in which the ICS1 transcript accumulation decreases after 48 HPI 
(Li, 2015).   
The plants treated with exogenous SA showed GUS activity regions that resemble 
the GUS expression pattern in distal leaves (Fig 3.1 D). Interestingly, we observed 
localisation of GUS activity in the vascular tissue mainly in the leaves from primary 
infection and only in some specific leaves after SA treatment, including the first two 
true leaves from the rosette (Fig 3.2 A to E). The spatial and temporal profile we 
observed is compatible with the ICS1::GUS spatial kinetics described in previous 
reports (Hunter et al, 2013; Lv et al, 2015). Collectively, these experiments suggest 
that transgenic ICS1::GUS lines function as a robust reporter of the expression of the 
endogenous ICS1 gene. 
Transcriptional repression of ICS1 by S-nitrosylation 
The fact that the atgsnor1-3 plants showed reduced total SA levels (Feechan et al, 
2005) suggests the existence of regulatory mechanisms for SA biosynthesis resulting 
from increased GSNO levels. Further, it has been shown that ICS1 transcript levels 
are reduced in gsnor1 plants, implying increased GSNO levels result in reduced ICS1 
transcription, increased ICS1 turnover or perhaps both. To differentiate between 
these possibilities, we crossed the ICS1::GUS transgene into par2-1 plants, as a 
reduction in GUS transcription and by extension, GUS activity, would indicate 





























Figure 3.1. Characterisation of ICS1::GUS transgenic Col-0 plants. A) Semi-quantitative 
PCR to compare ICS1 and GUS transcript levels in T3 homozygous ICS1::GUS Col 0 plants. 
Samples were collected at the stated hours post-infection (HPI) with Pseudomonas syringae 
pv maculicula ES4326 (Psm) (O.D.600 = 0.002). B to E) Histological GUS staining of 
ICS1::GUS Col 0 plants at B) 24 HPI and C) 72 HPI of a single leaf with Psm ES4326 (avrB), 



















    
  
Figure 3.2 Spatial profile of ICS1::GUS transgene expression. Histological GUS staining 
of ICS1::GUS Col-0 plants after: A) local leaf at 24 HPI or B) 72 HPI, C) distal leaf at 24 HPI 
with Pseudomonas syringae ES4326 (avrB) O.D.600 = 0.025 and D, E) exogenous SA 1mM 
treatment.     
A B C D E 
Figure 3.3. Transcriptional repression of ICS1 in par2-1 plants. Histological GUS staining 
of ICS1::GUS Col-0 and ICS1::GUS par2-1 plants. Leaves were harvested and stained with 2 
mM X-Gluc solution 24 hours after treatment with 1 mM SA and 24 HPI with Psm ES4326 and 












As expected, the heterozygous F1 ICS1::GUS par2-1 plants showed a wild-type (WT) 
phenotype as a single functional GSNOR1 allele from the WT parental is enough to 
mask the par2-1 phenotype. The F2 seeds were then screened on selective MS 
plates, and seeds from homozygous par2-1 plants exhibiting the gsnor1 phenotype 
were collected. We then identified F3 double homozygous ICS1::GUS par2-1 plants 
by scoring for kanamycin resistance and confirmed their identity by genotyping the 
ICS1::GUS insertion and monitoring the gsnor1 phenotype. 
Subsequently, we induced ICS1 expression in the resulting ICS1::GUS Col-0 and 
ICS1::GUS par2-1 plants by exogenous application of 1 mM SA. Following 
histological GUS staining with X-gluc, we observed strong ICS1 induction in the wild-
type background, but no GUS activity was visible in par2-1 plants (Fig 3.3).  
 
To confirm and extend these results, we challenged both reporter lines with Psm 
ES4326 and with a Psm ES4326 (avrB). We observed strong GUS activity in Col-0 in 
response to both virulent and avirulent pathogens, but no GUS activity was detected 
in the par2-1 genetic background. We also performed a quantitative GUS assay, a 
fluorometric method with higher sensitivity than X-gluc staining. The analysis of GUS 
activity from leaf discs of Col-0 and par2-1 plants 24 hrs after induction with SA 1 mM 
showed similar results to our previous observations; wild-type plants exhibited 
significantly higher GUS activity than gsnor1 plants after SA treatment. However, no 





































48 hrs after SA
4-MU Standard curve      
Figure 3.4. Quantitative of ICS1 expression in Col-0 and par2-1 plants. GUS extraction 
from 1cm2 leaf discs from Arabidopsis ICS1::GUS Col-0 and par2-1 lines 48 hrs after induction 
with 1 mM SA and incubated with the substrate 4-MUG for 16 hr at 37 ºC. GUS activity 
represented as equivalent nmol of 4-MU per leaf disc. Bars show the mean value of 3 leaf 





Robust reporter of ICS1 expression 
Here we report the utility of an ICS1::GUS transgenic line to investigate the molecular 
mechanism by which increased GSNO levels regulates SA biosynthesis in gsnor1 
plants. The full-length of the ICS1 promoter region extends over 3,173 bp. Our 
construction contains a 1,500 bp fragment of the promoter (Li, 2015), covering the 
5’UTR and the binding site for the transcription factors reported to drive ICS1 
expression, as shown in Table 3.1.  
Different ICS1::GUS constructions have been described previously. For instance, Van 
Verk et al, (2011) used a 1,000 bp fragment of the ICS1 promoter to investigate WRKY 
transcription factors related to SA biosynthesis in a protoplast assay. In different 
experiments, Lewsey et al, (2010) and Hunter et al., (2013) used a 1,500 bp fragment 
of the ICS1 promoter to study plant viral-defence mechanisms in relation to SA. This 
same construction was used by Lv et al., (2015) looking at the role of β-cyclocitral and 
SA in excessive light acclimation. Additionally, Tedman-Jones et al, (2008) conducted 
a forward mutant screening using 2,500 bp of the ICS1 promoter (ICS::LUC) to identify 
constitutive ICS1 expression in a mutagenized Arabidopsis population, finding that 
the constitutive ICS1 expression 1 (cie1) mutant exhibit enhanced resistant to 
Hyalonperonospora parasitica, correlating with higher SA accumulation. The cie1 
mutation was mapped to the xyloglucan galactosyltransferase MUR3 gene involved 
in cell wall biosynthesis. This mutant also showed deregulation of ICS1 expression, 
identified using an ICS1::GUS construction employing the same sequence of the ICS1 
promoter. These reports highlight the utility of the ICS1::GUS transgene and that a 
1,500 bp fragment of the ICS1 promoter contains the core regulatory elements for 
ICS1 expression.  
Also, we observed congruent ICS1 temporal and spatial expression patterns as those 
in previous reports, showing significant ICS1 accumulation 24 hrs after Psm infection 
and reduction in transcript levels toward 72 HPI (Wildermuth et al, 2001; Wang et al, 
2015). 
ICS1 expression in vascular tissue 
We observed strong GUS activity in the vasculature of the infected leaves at 24 HPI 
which could relate with priming of SAR upon infection. Additionally, we observed a 
different ICS1 spatial profile in distal leaves to that of the primary infected leaves, 
42 
 
characterised by lower GUS activity and localised GUS spots. A similar spatial profile 
was observed in plant leaves treated with exogenous SA, which mimics the SA spatial 
profile during SAR. The pattern observed in distal leaves is consistent with SA 
accumulated during SAR, which has been described to occur at lower rates than at 
the primary infection site (Dempsey & Klessig, 2017; Singh et al, 2017).  
Mounting evidence highlight the importance of the vascular tissue in the transport and 
amplification of SAR-associated signals. Specifically, phloem loading of SAR signals 
can occur via the apoplast or the symplast. SAR signals are rapidly generated within 
four to six hours after infection and translocate presumably via the phloem to distal 





























(Zhang et al, 
2010) 
WRKY 28 Positive W-Box 4 -445, -460 (van Verk et 
al, 2011b) 
 
TCP8/TCP9 Positive GGGCCCAC 1, 0 -150 (Wang et al, 
2015) 
 
NTL9 Positive NAC-core binding site 
TTNCGTA  








(Zheng et al, 
2015) 
CHE Positive Class I TCP binding site 
GGNCC- CAC 

























(Chen et al, 
2009a) 
Table 3.1. Binding site of ICS1 related transcription factors   
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Different mobile SAR inducers have been identified, including SA and its derivative 
Methyl-SA (MeSA), azelaic acid (AzA), diterpenoid dehydroabietinal (DA),  glycerol-
3-phosphate (G3P), pipecolic acid (Pip), and the free radicals NO and ROS (Gao et 
al, 2015; Kachroo & Kachroo, 2018). MeSA has been detected in the phloem. 
However SAR kinetic studies suggest the time frame for MeSA requirement in distal 
tissue are within 48 to 72 hours (Park et al, 2009), suggesting it to be a secondary 
mobile SAR signal (Singh et al, 2017; Dempsey & Klessig, 2017). 
ICS1 expression and SA accumulation in both local and distal tissue is a critical 
requirement for SAR. SA and Pip act synergistically to activate SAR. Pip has been 
identified in high concentrations in phloem exudates during early SAR events, 
preceeding SA accumulation in distal leaves. Additionally, agd2-like defence 
response protein 1 (ald1) mutants, deficient in Pip synthesis, failed to accumulate SA 
in distal leaves 48 HPI with Psm and ics1 plants could accumulate Pip in local leaves 
but show compromised Pip accumulation in distal leaves following Psm infection 
(Bernsdorff et al, 2016). Suggesting that ICS1 activity is necessary for proper Pip 
translocation through the vasculature, corresponding with the ICS1 spatial profile we 
observed (Navarova et al, 2012).  
Transcriptional repression of ICS1 by high GSNO concentrations   
We analysed the effect of high total cellular S-nitrosylation on ICS1 expression. No 
GUS activity was detected after pathogen infiltration or exogenous SA application on 
ICS1::GUS par2-1 plants following histological GUS staining. The GUS protein 
sequence is composed of 603 amino acids, containing nine cysteines in the 
sequence. The GUS sequence analysis using the S-nitrosylation prediction tool 
SNOSITE (Lee et al, 2011) identified six cysteines as potential S-nitrosylation targets. 
Therefore potentially inhibiting GUS activity.  
Interestingly, Shi et al, (2015) investigated the relationship between auxin signalling 
and NO using a DR5::GUS construct in Col0 and gsnor1-3 plants. They observed 
impaired auxin signalling in the gsnor1-3 background as reported by reduced GUS 
activity. However, they could observe GUS activity by histological staining in the 
gsnor1-3 plants. They confirmed the effect using a DR5::GFP  construction, indicating 
that GUS is a suitable tool to study promoter activity under a high S-nitrosylation 
background. Thus, the observed impairment on ICS1 expression in ICS1::GUS par2-
1 plants may be due to transcriptional repression of the ICS1 promoter rather than 
inhibition of GUS activity by S-nitrosylation.  
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This observation is consistent with unpublished results from Li (2015) where reduced 
and delayed ICS1 transcript accumulation was observed in gsnor1-3 plants 12 hrs 
after infection with Psm ES4326 compared to wild-type. Further, significantly reduced 
GUS activity was observed in the GUS quantitative assay. Collectively, these data 
support the hypothesis of repression of the ICS1 promoter by enhanced GSNO levels, 
likely via S-nitrosylation.  
One possibility to explain the transcriptional repression of ICS1 and the reduced and 
delay expression of SA-dependent genes in the gsnor1 background could be related 
to S-nitrosylation modulating the transcriptional activity of the Mediator complex. 
Notably, MED14 and MED16 which play a central role in the transcriptional regulation 
of SA-mediated immunity which contain 25 and 27 Cys residues, respectively 
(Shaikhali et al, 2015; Zhang et al, 2013c, 2012). The fact that med14 plants exhibited 
reduced SA accumulation and downregulation of central SA-biosynthesis genes, 
including ICS1, EDS5 and PBS3, suggests a direct link of this MED14 with SA 
biosynthesis (Zhang et al, 2013c). Contrary, med16 plants showed normal SA 
accumulation but compromised SA-dependent gene expression (Zhang et al, 2012). 
The genetic evidence and the high number of Cys residues within MED14/MED16 
amino acid sequence suggests the possibility of a REDOX-based mechanism for 
transcriptional regulation of SA biosynthesis and signalling. Potentially through 
modulation of the interaction between the Mediator complex and SA-associated TFs, 
such as SARD1 and CBP60g. 
A similar possibility to explain the transcriptional repression on ICS1 promoter can be 
related with modulation of the DNA-binding by S-nitrosylation of the ICS1-specific 
TFs. For instance, the DNA-binding of the Arabidopsis zinc finger (ZF) TF SRG1 to 
the promoter of immune repressors is reduced upon S-nitrosylation preferentially at 
Cys87. SRG1 is induced by the nitrosative burst after pathogen challenge and binds 
to its target promoters where it recruits the transcriptional repressor TOPLESS to 
promote the establishment of the immune response. Accumulation of NO leads to S-
nitrosylation of SRG1 and promotes its release from the promoter (Cui et al, 2018). 
Additionally, S-nitrosylation has been shown to regulate the DNA-binding of the plant-
specific transcription factors atMYB2 and atMYB30. These TFs were found to be S-
nitrosylated in vitro and in vivo at the conserved Cys-53 resulting in inhibition of its 
DNA-binding activity (Serpa et al, 2007; Tavares et al, 2014). In mammals, the DNA-
binding of the ZF-TF Ying Yang 1 (YY1) to the Fas promoter was inhibited upon S-
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nitrosylation of YY1 (Hongo et al, 2005). Similarly, the DNA-binding of the yeast TF 
LAC9 was also shown to be regulated by S-nitrosylation (Kröncke et al, 1994). 
Therefore, emerging evidence suggests a relationship between S-nitrosylation and 
the modulation of DNA-binding activity. 
To explore these possibilities, it would be interesting to use a yeast-two hybrid 
approach or Bimolecular Fluorescence Complementation (BiFC) assay to look for 
MED14/MED16 interacting proteins among the TFs associated with ICS1 and SA-
signalling and evaluate if MED14 and MED16 are targets for S-nitrosylation in vitro 
using the biotin switch assay, followed by characterisation of the effect of S-
nitrosylation on these proteins interactions. Additionally, SARD1 and CBP60g play a 
central role driving ICS1 expression (Zhang et al, 2010). Importantly, they contain 4 
and 11 Cys residues within their sequence, respectively. To address if S-nitrosylation 
can modulate its DNA-binding activity to the ICS1 promoter, it will be necessary to 
undertake in vitro characterisation of their DNA-binding activity and biotin switch to 
evaluate if they are targets of S-nitrosylation.  
Our data support the possibility of transcriptional repression of the ICS1 promoter by 
S-nitrosylation. However, some proteins have been shown to be subjected to 
transcriptional and posttranscriptional regulation. For instance, the Arabidopsis TF 
NFYA5 which is involved in drought tolerance was found to be subjected to partial 
transcriptional regulation using a NFYA5::GUS reporter line (Li et al, 2008). 
Additionally, the NFYA5 transcript contains a target site for miRNA169 which 
mediates posttranscriptional silencing during basal conditions. Downregulation of 
miRNA169 during drought allows rapid accumulation of NFYA5 in leaves and guard 
cells to prevent water loss (Li et al, 2008). 
Interestingly, the RBP-defence related 1 (RBP-DR1) which is associated with 
posttranscriptional regulation in plants was linked with ICS1 expression after the 
observation that rbp-dr1 plants exhibit enhanced resistance to Pseudomona syringae 
pv tomato DC3000 infection together with higher ICS1-dependent SA accumulation 
and increased PR1 expression (Qi et al, 2010). The atRBP-DR1 amino acid sequence 
contains 6 Cys residues, and 5 predicted S-nitrosylation sites according to the 
SNOSITE prediction tool (Lee et al, 2011). Additionally, a quick search on the 
Arabidopsis MPSS Plus Database (Nakano et al, 2005) for small-RNA signatures that 
matches the ICS1 mRNA sequence showed five potential miRNA that target the ICS1 
transcript. It may be possible that S-nitrosylation of RBP-DR1 in the gsnor1 
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background contributes to additional posttranscriptional mechanisms to repress ICS1 
expression.  
To investigate this possibility, it will be necessary to prepare an additional ICS1::ICS1-
GUS translational fusion and compare GUS activity with the transcriptional fusion 
ICS1::GUS and with mRNA levels in both WT and gsnor1 backgrounds (Lee et al, 
2006). A correlation between the mRNA and protein level could represent 
transcriptional repression of ICS1. Alternatively, a mismatch between mRNA and 
protein levels could hint the activation of posttranscriptional mechanisms (Lee et al, 
2006). Also, it will be interesting to test if these predicted miRNAs are involved in 
posttranscriptional repression of ICS1 and if S-nitrosylation is involved in the 
expression of these miRNA.   
The accumulated evidence highlights the critical role S-nitrosylation plays in modifying 
transcription dynamics and protein function. Our data suggest the existence of a 
transcriptional repression mechanism of ICS1 expression mediated by S-nitrosylation, 
possibly contributing to explain the significant transcriptional repression of ICS1 in 
gsnor1-3 plants. However, further research is needed to elucidate the molecular 




Chapter 4 In vitro S-nitrosylation of SARD1 impacts its DNA-binding affinity  
 
Introduction 
The plant hormone salicylic acid (SA) is known to coordinate different biological 
processes and its accumulation is an essential requirement for the expression of 
pathogenesis-related genes and the deployment of systemic acquired resistance 
(SAR) in uninfected leaves (Loake & Grant, 2007; Spoel & Dong, 2012; Dempsey & 
Klessig, 2017). Similarly, nitric oxide (NO) is considered as a critical signalling 
molecule that can regulate gene expression and signalling pathways via post-
translational modifications to target proteins (Kovacs et al, 2016). S-nitrosylation, the 
reversible covalent binding of a NO molecule to the thiol group to a rare, highly 
reactive Cysteine residue can modulate protein bioactivity allowing specific proteins 
to act as molecular switches sensing changes in the cellular redox state (Yu et al, 
2014). 
GSNOR1 
Additionally, S-nitrosoglutathione (GSNO), formed by S-nitrosylation of glutathione 
(GSH), acts as stable storage of NO bioactivity and can function as a potent NO- 
donor to trans-nitrosylating other proteins. The cellular level of GSNO is governed by 
the activity of the enzyme GSNO Reductase 1 (GSNOR1), which catalyses the 
reduction of GSNO into oxidised glutathione (GSSG) and ammonium (NH3) ( Feechan 
et al, 2005 Frungillo et al, 2014;).  
Arabidopsis plants with impaired GSNOR1 activity showed increased total SNO 
cellular levels and compromised basal, non-host and R-gene resistance and reduced 
SA biosynthesis and accumulation (Feechan et al, 2005). However, the molecular 
mechanisms by which elevated S-nitrosylation mediates repression of SA 
biosynthesis is not known. Our previous observations with the ICS1::GUS transgene 
in gsnor1 impaired plants suggest transcriptional repression of the ICS1 promoter, 
probably contributing to explain the reduction of SA accumulation in gsnor1-3 plants.   
SARD1 and CBP60g 
To date, several transcription factors (TFs) that modulate ICS1 expression have been 
reported. Among these, SARD1 and CBP60g have been linked with a significant role 
in driving ICS1 expression. The sard1 cbp60g double mutant is severely impaired in 
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SA biosynthesis and displays reduced basal and systemic immunity (Zhang et al, 
2010; Wang et al, 2011; Sun et al, 2015). SARD1 and CBP60g share 39% identity at 
the protein level and contain a highly conserved DNA-binding domain (DBD) in the 
middle region and are entirely diverged at the N- and C- terminal domains (Zhang et 
al, 2010). Both proteins share a preference for the binding domain GAAATTT and 
were shown in a ChIP-SEQ experiment to bind to the promoter region of a vast array 
of immune-related genes, including positive and negative immune regulators (Sun et 
al, 2015).  
Also, It was recently shown that the SARD1 and CBP60g C-terminal domain is 
targeted by the Verticillium secreted effector protein VdSCP41 to promote Verticillium 
wilt disease, suggesting the existence of a trans-activation domain located at the C-
terminal end of the DBD, compromising the activation of immune responses (Qin et 
al, 2018). One possibility to explain this effect could be a direct alteration of 
SARD1/CBP60g DNA-binding capabilities upon interaction with the effector protein, 
possibly mediated by conformational changes at the C-terminal end.  
S-nitrosylation 
A critical requirement for protein S-nitrosylation to occur is the availability of a surface 
exposed Cys residue exhibiting a low pKa sulfhydryl group (Yu et al, 2014). Both 
SARD1 and CBP60g contain cysteine residues in their amino acid sequence, 4 and 
11 cysteine residues, respectively, making them attractive candidates to investigate 
the effect of S-nitrosylation on their activity. Moreover, S-nitrosylation has been shown 
to modulate the DNA-binding capabilities of the plant-specific TF Myb-2, and Myb-30, 
in which reduced DNA-binding upon S-nitrosylation of a conserved Cys residue was 
observed (Serpa et al, 2007; Tavares et al, 2014). 
Biotin switch 
The Biotin-switch assay is a biochemical technique to identify S-nitrosylation targets 
in vitro. The principle of the assay relies on three main steps. First, the recombinant 
protein is incubated with a NO-donor to promote S-nitrosylation. Secondly, the un-
nitrosylated thiols groups are irreversibly blocked with N-ethylmaleimide (NEM) and 
finally, the nitrosothiols are reduced with sodium ascorbate and the nascent thiol 
groups are labelled with a biotin molecule. The biotinylated protein can be detected 
by western blot (Jaffrey & Snyder, 2001).  
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In vitro S-nitrosylation of SARD1 
In previous work from our lab, Li (2015) expressed recombinant SARD1 with an N-
terminal Maltose Binding Protein (MBP) tag (MBP-SARD1) and evaluated its DNA 
binding activity to a 181 bp fragment of the ICS1 promoter in an electromobility shift 
assay (EMSA) after incubation with the NO-donors, CysNO and GSNO. Reduced 
DNA-binding of SARD1 was observed after the NO-donor treatment. The effect could 
be reversed by the addition of the reducing agent dithiothreitol (DTT) (Li, 2015), 
consistent with the reports of S-nitrosylation on Myb-2 and Myb-30 DNA-binding 
indicating that a reduced state in the proteins is necessary for optimal DNA binding 
(Serpa et al, 2007; Tavares et al, 2014).  
In subsequent experiments, Li found that SARD1 can be S-nitrosylated in vitro using 
the biotin-switch assay in a NO-concentration dependent fashion. Furthermore, he 
generated four SARD1 mutants with an individual Cys to serine (Ser) substitution 
(C211S, C311S, C333S and C438S) and identified C438 as the target for S-
nitrosylation.   
The data generated by Yuan Li (Li, 2015) indicated that Cys-438 of SARD1 is the 
target for S-nitrosylation and that this post-translational modification reduces its DNA-
binding efficiency. To further investigate the relevance of S-nitrosylation of SARD1 in 
the modulation of SARD1 DNA-binding activity, we performed a quantitative DNA-
binding assay and calculated the binding affinity of wild-type SARD1 and SARD1 with 
a Cys-438 to Ser-438 mutation to the ICS1 promoter. We hypothesised that a Cys to 
Ser substitution at amino acid residue 438 would render SARD1 less sensitive to 





SARD1 DNA-binding to the ICS125bp promoter sequence  
We performed EMSA using recombinant SARD1 and SARD1C438S after S-
nitrosylation. Previously, we used a 181 bp ICS1 promoter fragment reported by 
Zhang (2010). A more recent publication showed that SARD1 could bind to a 56 bp 
fragment of the ICS1 promoter containing the binding motif GAAATTT and drive the 
expression of Luciferase in a promoter activity assay in Arabidopsis protoplasts (Sun 
et al, 2015). Using a smaller DNA probe can offer advantages by reducing background 
noise and unspecific binding in an EMSA (Hellman & Fried, 2007). Therefore, we 
prepared a 25 bp ICS1 promoter fragment flanking the specific DNA wild-type (WT) 
binding motif and a mutant 25 bp version where the GAAATTT motif was mutated to 
GAAGGGT, as described by Sun et al (2015).  
We first labelled the ICS125bp WT and ICS125bp MT probes 5’-ends with a radioactive 
phosphorus isotope (γ-32P) and expressed recombinant MBP-SARD1 and MBP-
SARD1C438S fusion proteins and purified them by affinity chromatography (Fig 
4.1A). We measured the protein concentrations by the Bradford assay. Subsequently, 
we titred increasing protein concentrations in EMSA using the radiolabelled ICS1 
probes. No shift was observed for the free probe lanes and a strong band indicating 
DNA-protein binding was observed for both SARD1 and SARD1C438S when 
incubated with the WT ICS1 probe but not for the mutant version. This experiment 
confirmed that the recombinant proteins could bind to the 25 bp ICS1 probe in vitro 
and show specificity for the shorter probe (Fig 4.1B). 
Interestingly, we could detect DNA-binding with lower SARD1C438S concentration 
relative to that of SARD1 (Fig 4.1B). Therefore, we optimised the protein 
concentration calculations by confirming Bradford data through running an SDS-
PAGE of the purified fractions together with a BSA standard followed by analysis of 
the bands intensities using ImageJ and selecting fractions with equal intensity of the 
fusion protein to guarantee equal protein loading. 
Effect of S-nitrosylation of SARD1 in DNA-binding activity 
We then proceed to evaluate the effect of S-nitrosylation on DNA binding. To do this, 
we performed EMSA after incubating equimolar concentrations of the recombinant 
SARD1 and SARD1C438S protein samples with increasing concentrations of GSNO, 
a natural NO donor, ranging from 0.1 to 5 mM before undertaking the DNA-binding 
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reaction. We could observe reduced binding in wild-type SARD1 in a GSNO 
concentration-dependent effect between 0.5 – 5 mM which could be reversed by the 
addition of DTT (Fig 4.2A and 4.2B), consistent with the effect reported for Myb protein 
before  (Serpa et al, 2007; Tavares et al, 2014). Conversely, we noted less DNA-
binding inhibition in the mutant SARD1C438S by S-nitrosylation (Fig 4.2A and 4.2B), 
supporting our hypothesis of a regulatory effect of S-nitrosylation of Cys-438 on 
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ICS1 25 bp WT (GAAATTT) 
ICS1 25 bp MT (GAAGGGT) 
E1     E2     E3     E4     E5     E6     E7 E1     E2     E3      E4     E5     E6     E7 
SARD1 SARD1C438S A 
B 
Figure 4.1. SARD1 and SARD1C438S DNA binding assay. A) Coomasie staining after SDS-
PAGE of affinity chromatography purified recombinant MBP-SARD1 and MBP-SARD1C438S. 
The upper arrow indicated the expected size of the MBP-SARD1 fusion protein (93 KDa). B) 
Electromobility shift assay using a 25 bp ICS1 promoter fragment containing the specific 
binding motif GAAATTT and the mutated GAAGGGT version. EMSA performed in a 6% poly-
acrylamide TGE native resolving gel pH8.3 and 4% stacking gel. The upper and bottom arrows 
represent the DNA-protein shift and free probe, respectively. The gel was cropped for 
presentation purposes.       
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Equilibrium dissociation constant (KD) of SARD1 and SARD1C438S 
We proceed to calculate the equilibrium dissociation constant (KD) of wild-type MBP-
SARD1 and MBP-SARD1C438S. This parameter represents the binding affinity of a 
protein for its DNA substrate, defined by the protein concentration at which fifty per 
cent of the DNA is found as a DNA-protein complex. A lower KD value indicates a 
higher affinity of the protein for its substrate (Heffler et al, 2012).  
To calculate KD, we titrated increasing concentrations of both recombinant proteins in 
non-radioactive EMSA using a constant concentration of the ICS1 25 bp promoter 
probe labelled with a near-infrared fluorophore. After the binding reactions and non-
denaturing PAGE, the gels were scanned using a LI-COR Odyssey system at 700 nm 
wavelength. We subsequently calculated the DNA-protein and free-DNA fluorescence 
intensities using the software ImageJ. To remove background noise, we subtracted 
the baseline signal from blank regions of the gel from the DNA band intensities. We 
calculated the fraction of DNA bound using the expression: bound/[bound + unbound] 
and plotted the fraction bound with respect to the SARD1 concentration. We then 
fitted the data in a non-linear regression to the equation: Fraction Bound= 
BMax([SARD1]/(KD+[SARD1])) using MATLAB to calculate KD and BMax values, as 
described by Heffler et al, (2012).  We observed similar KD values for both proteins, 
being 219.5 nM and 247.3 nM for SARD1 WT and SARD1C438S, respectively. This 
experiment suggests that the mutation of Cys438 does not affect the DNA binding 
(Fig 4.3A and B). 
Effect of S-nitrosylation on SARD1 KD 
Subsequently, we calculated KD after S-nitrosylation of the protein samples with 1mM 
GSNO for 20 minutes, considering that from previous experiments we observed a 
reduction in DNA binding using this NO-donor concentration.   
Interestingly, we observed a two-fold increase in SARD1 KD after S-nitrosylation, 
rising from 219.5 nM to 494.2 nM concerning the control assay (Fig 4.3A). However, 
SARD1C438S KD was not strongly affected by S-nitrosylation (Fig 4.3C), showing KD 
values of 240.5 nM for the untreated sample and 276.8 nM after S-nitrosylation (Fig 
4.3C), suggesting that NO can regulate the affinity of SARD1 to the ICS1 promoter by 
S-nitrosylation of Cys-438 in vitro. Furthermore, the observation that SARD1 DNA-
binding activity is reduced upon treatment with GSNO but not wholly abolished could 
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represent a NO-mediated regulatory mechanism for SARD1 bioactivity sensing the 
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Figure 4.2. Concentration dependant effect of S-nitrosylation on DNA-binding of 
SARD1.  A and B) Radioactive EMSA after S-nitrosylation of recombinant MBP-SARD1 and 
MBP-SARD1C438S. Protein samples were incubated with increasing GSNO concentrations 
covering a range from A) 0.1, 0.25, 0.5 and 1mM and B) 0.5, 1.0 and 5.0 mM with or without 
the addition of DTT. +VE indicated protein loading. The DNA-protein shift and free-ICS1 probe 
is indicated by the upper and bottom arrows.  
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SARD1 and CBP60g play a critical role in modulating ICS1 expression (Zhang et al, 
2010). Also, they were proposed as master regulators of plant immunity on the 
grounds of their ability to bind to the promoter region of different immune-related 
genes, including both positive and negative regulators (Sun et al, 2015). The fact that 
the effector protein VdSCP41 from Verticillium dahliae targets SARD1 and GBP60g 
to promote virulence by inhibiting their ability to drive ICS1 expression via direct 
interaction with their c-terminal domain highlights their relevance in immunity (Qin et 
C 
Figure 4.3. Binding affinity of SARD1 and SARD1C438S to the ICS1 promoter.  Titration 
of recombinant SARD1 proteins in non-radioactive EMSA after S-nitrosylation with 1 mM 
GSNO and control treatment. A) SARD1 and B) SARD1C438S. Upper and bottom arrows 
indicate protein-DNA shift and free probe, respectively. Protein concentrations range from 30 
to 600 nmol. C) Plot shows the fraction of DNA bound as SARD1 and SARD1C438S are 
titrated. The binding intensities were calculated using ImageJ. The values of KD and BMAX 
were calculated in MATLAB using the general equation (x)=(a*x^3)/(k^3+x^3). Coefficient with 
95% confidence bounds: The KD and BMAX values are: SARD1 control and GSNO (141.3 











al, 2018). However, our current understanding of how are SARD1 and CBP60g are 
regulated to activate the transcription machinery is limited. Also, the observed 
transcriptional repression on ICS1 expression in ICS1::GUS par2-1 plants, together 
with the previous finding from our lab regarding the repression of SARD1 binding to 
the ICS1 promoter by S-nitrosylation at Cys-438, suggests the possibility of a NO-
mediated regulatory mechanism of SARD1 bioactivity.    
Effect of S-nitrosylation on DNA-binding 
Here, we confirmed that S-nitrosylation of Cys-438 reduced the ability of SARD1 to 
bind to the ICS1 promoter in a NO-donor concentration-dependent effect. We 
performed radioactive EMSA after incubating SARD1 and SARD1C438S samples 
with different concentrations of GSNO, ranging from 0.1 to 5 mM. Consistent with the 
NO-donor concentration used in different reported S-nitrosylation in vitro studies 
(Hussain et al, 2016; Jaffrey & Snyder, 2001). We observed compromised DNA 
binding in the WT protein, which was reversible by reduction with 5 mM DTT. 
Conversely, SARD1C438S binding was not strongly affected by incubation with the 
NO-donor, which indicated that S-nitrosylation at cysteine 438 could be responsible 
for the decrease in affinity and that a reduced state of the protein is necessary for 
DNA-binding.  
A similar effect was reported for the plant proteins MYB-2 and MYB-30, where S-
nitrosylation of Cys49 and Cys53 inhibited DNA-binding (Serpa et al, 2007; Tavares 
et al, 2014). In follow up experiments, different Myb30 Cys to Alanine (Ala) mutants 
(C49A and C53A) were used to calculate KD values to evaluate if the formation of 
disulphide bonds was critical for Myb30 DNA-binding activity and if S-nitrosylation of 
these residues could mediate changes in the secondary structure to explain the 
inhibitory effect on DNA-binding. The authors observed similar KD values for all 
proteins: Myb30, Myb30C49A and Myb30C53A, indicating that the formation of 
disulphide bonds between Cys-49 and Cys-53 was not critical for DNA binding of 
MYB-30 and supporting the idea that a reduced state in the protein was necessary for 
binding (Tavares & Terenzi, 2016). However, the authors did not measure changes 
in KD after S-nitrosylation. 
KD of plant TFs 
We quantified the extent of S-nitrosylation on SARD1 DNA-binding by calculating the 
dissociation constant for both proteins before and after S-nitrosylation. We obtained 
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a KD value of 219.5 nM for WT SARD1 and 240 nM for SARD1C438S, indicating that 
the mutation of this amino-acid has a minimum effect on DNA-binding and that C438 
is not involved in the formation of a disulphide bond necessary for DNA-binding 
(Tavares et al, 2014). The reported KD for plant TFs varies from pM to µM 
concentrations (Gusewski et al, 2018), ranging from 15 to 500 nM for MYB proteins 
(Tavares & Terenzi, 2016), 2 µM for DOF zinc fingers (ZF) (Moghaddas Sani et al, 
2018), and 13 to 500 nM for SEP3 proteins (Gusewski et al, 2018). The calculated 
values for SARD1 and SARD1C438S fall within the stated range. However, the value 
is relatively high compared to other TF families. 
Notably, ZF-TF show the lowest KD from the available reported data. The effect of S-
nitrosylation on ZF-TF DNA-binding has been reported for mammals (Hongo et al, 
2005), yeast (Kröncke et al, 1994) and plants (Cui et al, 2018). It is proposed that S-
nitrosylation disrupts the zinc core leading to significant conformational changes and 
reduction in DNA-binding activity (Kröncke et al, 1994). We observed a significant 
reduction in DNA-binding after S-nitrosylation of Cys438. Therefore, we propose that 
S-nitrosylation promotes a significant structural change that can modulate SARD1 
bioactivity. 
To evaluate if the calculated KD for SARD1 using recombinant MBP-SARD1 is 
physiologically relevant it will be necessary to measure SARD1 concentrations in vivo. 
Urquiza-Garcia and Millar (2018) published a method to measure protein levels in vivo 
using the reporter protein Nano luciferase (NanoLUC). The method relies on 
generating transgenic Arabidopsis lines with a translational NanoLUC protein-of-
interest fusion and measuring the bioluminescence in vivo or from protein extracts. 
The readings can be extrapolated into a NanoLUC standard curve to estimate the 
fusion protein present in the sample at specific times (Urquiza-García & Millar, 2018). 
To investigate in vivo concentration of SARD1 we will need to generate 
SARD1::SARD1-NanoLUC reporter lines and characterise the relative and total 
bioluminescence under basal conditions and upon activation of immune responses.  
Effect of S-nitrosylation on SARD1 KD   
We observed a KD of 494.2 nM in SARD1 after S-nitrosylation, which represents a 
2.25 folds increase with respect to the untreated protein but only a 0.15-fold increase 
for SARD1C438S. The reduction in affinity by S-nitrosylation of wild type SARD1 
could be due to conformational changes in the secondary protein structure upon the 
formation of the S-nitrosothiol group at Cys438. However, we did not observe a 
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significant reduction in affinity of the C438S mutant, supporting the role of Cys438 as 
the target for S-nitrosylation (Tavares & Terenzi, 2016).   
Interestingly, this Cys residue is located close to the C-terminal end and outside the 
DNA-binding domain of SARD1. Qin et al, (2018) reported that the effector protein 
VdSCP41 from the fungal pathogen V. dahliae targets a conserved region of CBP60g 
ranging from amino acids 211 to 440 at the C-terminal chain of the DNA-binding 
domain, which harbours a proposed transcription activation domain. The binding of 
the effector protein to this conserved region of CBP60g and SARD1 compromises the 
expression of ICS1, potentially affecting SARD1 three-dimensional structure or 
preventing the interaction with cofactors (Qin et al, 2018). Notably, Cys438 locates 
within the region reported to be targeted by VdSCP41, close to the activation domain. 
S-nitrosylation of this residue may affect the activation domain via structural changes 
or reducing interactions with coactivators and comprise an additional regulation step 
to activate the transcription machinery. 
KD dynamic interplay of SARD1 model 
Interestingly, even though SARD1 DNA-binding is reduced upon S-nitrosylation, the 
protein can still bind to its target DNA but at a lower rate. SARD1 and CBP60g have 
overlapping functions in plant immunity. CBP60g is thought to be involved in early 
stages of immunity and SARD1 is thought to participate at later stages (Wang et al, 
2011a). Currently, the molecular mechanism regulating the interplay and appropriate 
timing to drive ICS1 expression by these two transcription factors is not clear. It may 
be possible that modulation in affinity mediated by the level of S-nitrosylation 
according to the cellular REDOX state during the immune response can help fine-
tune the dynamics between SARD1 and CBP60g, resulting in a dynamic interplay of 
increased and decreased affinities for the ICS1 promoter at different stages of the 
immune response. To evaluate this hypothesis, it is necessary to generate 
Arabidopsis SARD1 and SARD1C438S reporter lines with Human influenza 
hemagglutinin (HA) tag to confirm in vivo S-nitrosylation of SARD1 and Chromatin 
Immunoprecipitation (ChIP) and investigate the changes in bioactivity in response to 








The plant's immune system is organised in different layers of defence. As an initial 
step, plants posess physical barrier to prevent the entrance of pathogen into the cells. 
Above this layer, plants evolve pathogen recognition receptors (PRR) which 
recognise conserved pathogen-associated molecular patterns (PAMPs) and induce 
an immune response upon activation, termed PAMP-triggered immunity (PTI). Some 
pathogens have evolved specialised virulence proteins (effectors) aimed to highjack 
PTI, resulting in effector-triggered susceptibility (ETS). As an escalated level of 
defence, plant developed functional cytoplasmic receptors termed R-proteins that 
recognise pathogen effector and induce effector-triggered immunity (ETI), 
characterised by a fast and robust immune response and localised cell-death 
(hypersensitive response) at the infection site. Above these layers of defence, plants 
evolved the systemic acquired resistance (SAR), in which plants prime their immune 
mechanisms in uninfected leaves after primary infection in order to respond quickly 
and efficiently against secondary infections (Dodds & Rathjen, 2010; Spoel & Dong, 
2012; Walters, 2015). 
Salicylic acid (SA) is a plant hormone that plays a critical role in the establishment of 
immune responses against biotrophic pathogens and a key player for the 
development of SAR (Loake & Grant, 2007; Vlot et al, 2009; Fu & Dong, 2013). In a 
reverse genetic screening testing Arabidopsis thaliana T-DNA insertion lines for 
compromised development of SAR, Zhang et al, (2010) identified a mutant 
significantly compromised in SAR, defined as SAR-deficient 1 (SARD1).  
SARD1 
The T-DNA insertion was mapped to the transcription factor (TF) SARD1. Further 
structural analysis demonstrated that SARD1 belongs to a family of plant-specific TFs 
and plays a pivotal role in the regulation of salicylic acid biosynthesis through direct 
regulation of the Isochorismate Synthase1 (ICS1) gene (Zhang et al, 2010). The 
relevance of SARD1 and its homologue CBP60g in immunity has been demonstrated 
by the fact that the sard1 cbp60g double mutant is severely impaired in SA 
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biosynthesis and accumulation, and exhibits compromised basal and SAR, 
demonstrated by enhanced susceptibility to Pseudomonas syringae pv maculicula 
ES4326 infection (Zhang et al, 2010).  
SARD1 and CBP60g 
SARD1 shares 33% similarity with CBP60g at the amino acid level. These proteins 
contain a novel DNA-binding domain and share the binding motif GAAATT. Both 
proteins have been shown to have nuclear localisation and binding to the ICS1 
promoter upon pathogen infection in vivo (Zhang et al, 2010). SARD1 and CBP60g 
play partially redundant roles in mediating immunity. CBP60g can bind calmodulin 
and sense changes in calcium concentrations, and it is suggested to play a role during 
the early stages of the immune response, while SARD1 is proposed to participate at 
later stages (Wang et al, 2011a). Both SARD1 and CBP60g are rapidly induced upon 
treatment with salicylic acid, and they participate in the regulation of different nodes 
of plant immunity, including positive and negative regulation (Sun et al, 2015). Also, it 
was reported that the vascular pathogen Verticillium dahliae targets a conserved 
region toward the C-terminal of SARD1 and CBP60g to promote infection in roots (Qin 
et al, 2018). 
Regulation of SARD1 
Upon pathogen infection, SA accumulation mediates transcriptional reprogramming 
to activate the expression of defence genes. Recent studies described the role of 
NPR1, NPR3 and NPR4 as SA receptors, with NPR1 acting as a transcriptional 
activator and NPR3/NPR4 as transcriptional repressors. The transcriptional regulation 
of these proteins is dependent on the interaction with the TFs TGA2, TGA5 and TGA6 
(Ding et al, 2018). Under basal conditions and low SA concentrations, NPR3/4 repress 
the expression of SA-dependent genes. At high SA concentrations, NPR1/3/4 bind 
SA with high affinity and activate or de-repress the expression of immune-related 
genes, respectively. Interestingly, NPR4 was found to repress the expression of 
SARD1 and WRKY70 via direct interaction with TGA elements in their promoters 
during low SA levels, but it was not found to regulate CBP60g (Ding et al, 2018).  
Additionally, the TF TGA1 and TGA4 regulate SA and Pipecolic acid (Pip) synthesis 
by controlling SARD1 and CBP60g expression. The tga1 and tga4 plants showed 
higher susceptibility to pathogen infection, compromised PTI and SAR linked with 
impaired SARD1/CBP60g expression and reduced SA and Pip biosynthesis (Sun et 
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al, 2018). SA and Pip mediate one branch for the activation of SAR (Gao et al, 2015; 
Shine et al, 2018). Notably, the transcription factor CCA1-Hiking Expedition (CHE) 
was reported to regulate the circadian oscillation of SA levels and the activation of 
SAR. The che plants showed compromised SAR and exhibited impaired 
SARD1/CBP60g expression levels. However, no CHE cis-binding elements are found 
within SARD1/CBP60g promoters, suggesting an indirect mechanism to regulate 
these proteins (Zheng et al, 2015). 
The accumulating evidence indicates a complex network fine-tuning SA biosynthesis 
and accumulation to guarantee a rapid activation of defences and prevent spurious 
activation. Notably, SARD1 and CBP60g play a critical role in this tight regulation 
(Zhang et al, 2010; Wang et al, 2011a; Sun et al, 2015, 2018; Ding et al, 2018; Qin et 
al, 2018). However, the molecular mechanisms that regulate SARD1 bioactivity are 
not fully understood.  
The evidence that under a high S-nitrosylation background SA biosynthesis is 
reduced (Feechan et al, 2005), together with our observations of transcriptional 
repression of the ICS1 promoter by S-nitrosylation and the reduction in DNA-binding 
affinity to the ICS1 promoter upon S-nitrosylation of SARD1 at Cys-438 in our in vitro 
study suggests an important regulatory mechanism of SARD1 bioactivity by S-
nitrosylation, possibly contributing to integrate REDOX mediated posttranslational 
modification into the regulatory network of SA biosynthesis.   
Here, we report the generation of Arabidopsis thaliana reporter lines to investigate the 




Generation of transgenic Arabidopsis thaliana plants 
To evaluate the biological relevance of S-nitrosylation of cysteine-438 of SARD1 we 
generated Arabidopsis thaliana transgenic plants expressing a fusion of  SARD1 
protein with a C-terminal Human influenza hemagglutinin (HA) or Nanoluciferase 
(nLUC) tag under the control of the native SARD1 promoter and terminator using the 
same genomic region previously described by Zhang et al (2010). We designed 
primers to amplify the SARD1 genomic region (Fig 5.1A) and flank the promoter + 
5’UTR, the SARD1 coding sequence (without stop codon) and the 3’UTR + terminator 
region with Bpi I restriction site and four base pair overhang for DNA assembly using 
the MoClo toolkit. The SARD1 genomic region was domesticated removing internal 
Bsa I and Bpi I restriction sites according to established protocols (Engler et al, 2009). 
We simultaneously prepared a mutant version of SARD1 with a cysteine to serine 
substitution at position 438.  
After confirmation of correct amplification, we used the MoClo protocol to assemble 
standard parts and confirm sequence integrity by Sanger sequencing. We then 
assembled independent transcriptional units containing SARD1::SARD1-HA or 
SARD1::SARD1-nLuc for both SARD1 and SARD1C438. The constructions were 
tested in a transient expression assay in Nicotiana benthamiana (not shown) and were 
subsequently transformed into the sard1 genetic background by floral dipping using 
the Agrobacterium strain GV3101. T1 transformant plants were identified for BASTA 
resistance and selected to obtain T3 homozygous plants.  
Complementation of the sard1 phenotype 
The sard1 knock out plants exhibits loss of basal and systemic resistance against 
different pathogens, including Hyaloperonospora arabidopsidis Noco 2 (H.a.Noco2) 
and P.s. pv maculicula ES4326 (P.s.m ES4326) (Zhang et al, 2010). Therefore, we 
evaluated the bioactivity of the fusion protein scoring for restored resistance to Psm 
infection and complementation of the sard1 phenotype.  To evaluate this, we infiltrated 
three-week-old plants with P.s.m. ES4326 O.D.600 =0.0002 and monitored the 
bacterial growth three days after infection. As expected, sard1 plants showed 
compromised basal resistance to the bacterial pathogen indicated by a bacterial titre 
of nearly 2 logarithmic scales higher than wild type (WT) plants. We did not find 
significant differences between the HA and nLUC lines with respect to the control, 
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indicating that the SARD1::SARD1 transgene is bioactive and complemented the 


















Expression of SARD1-HA 
To further evaluate the significance of cysteine 438 we proceed to evaluated if SARD1 
could be S-nitrosylated in vivo. We anticipated that the Cys to Ser substitution of 
Cys438 should result in less or no detectable S-nitrosylation in SARD1C438S. We 
first evaluated the protein expression levels in the HA lines in response to exogenous 
SA application by extracting total protein from plants twelve hours after foliar treatment 
with SA. After western blot using α-HA antibodies, we were able to detect a protein of 
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Figure 5.1. Complementation of sard1 plants. A) Schematic representation of DNA 
constructions. The genomic region of SARD1 was amplified covering 1,820 bp of the promoter 
+ 5UTR and 914 bp of the 3UTR + terminator as described by Zhang et al, (2010). The stop 
codon was removed for C-terminal fusion with HA-tag and nLUC-tag. Independent 
constructions were prepared for SARD1 and SARD1C438S with each tag. B) Pathogen growth 
assay 72 hours after infiltration with Psm ES4326 O.D.600 =0.0002. The values presented are 
the mean value of 6 biological replicates per genotype and 6 technical repetitions. Error bars 
represent the standard error. One way ANOVA followed by Tukey’s Multicomparison of means 



























































































































band was not detectable in the Col-0 and sard1 controls, confirming the identity of the 
SARD1-HA protein. Notably, we could observe a faint band in the un-induced SARD1-
HA lane and a significant increase in the intensity of the band after induction with SA. 
Conversely, the SARD1C438S line analysed showed a band in the absence of SA 
and a minimal increase after induction (Fig 5.2A). We then tested more 
SARD1C438S-HA lines at different time points after SA treatment and observed a 
consistent SARD1C438S-HA band before SA induction in several lines. However, the 
intensity of the band increased significantly after SA (Fig 5.2B), consistent with 
previous reports showing increased SARD1 transcription from 3 hours after induction 
with P.s.m. ES4326 and significant transcript accumulation after 12 hrs (Li, 2015; Sun 
et al, 2018). The presence of a band without induction in the different SARD1C438S 
lines tested may be related with constitutive SARD1C438S expression due to the 
integration location of the transgene in the genome or by the possibility of negative 















Figure 5.2. Characterisation of SARD1::SARD1HA lines. Western blot to detect SARD1-
HA protein. Total protein was extracted in HEN buffer (250mM HEPES pH7.2, EDTA 1mM, 
0.1mM Neucoproine) + 1mM PMSF + 0.5% Triton X100 and spun at 14,000G for 15 min. 20µL 
per sample were used for western blot analysis with primary mouse α-HA (1:3,000) and   
secondary α-mouse-HRP conjugated (1:3,000) antibodies. The nitrocellulose membrane was 
incubated with SuperSignal West Pico chemiluminescent substrate prior to exposure of X-ray 
films. A) Total protein extract from Col-0, sard1, SARD1::SARD1-HA and 
SARD1::SARD1C438S-HA 12 hours after induction with SA (1mM SA in 10mM Sodium 
phosphate buffer pH 7.2 + Triton X-100 0.01%). B) Total protein extract from SARD1::SARD1 
C438S-HA lines (1, 37 and 42) at 0, 6, 12 and 24 hours post induction with SA.   
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In vivo S-nitrosylation of SARD1 
After confirmation of expression and detection of the SARD1-HA and SARD1C438S-
HA fusion proteins, we performed biotin switch from leaf extracts to evaluate if SARD1 
could be S-nitrosylated in vivo. To do this, we first induced SARD1 expression with 
exogenous SA treatment. After 12 hours post SA we infiltrated some leaves with 1 
mM GSNO in MgCl2 as positive control according to reported protocols (Albertos et 
al, 2015; Feng et al, 2013). After one hour incubation with GSNO, we harvested the 
leaves and ground them in liquid nitrogen. We performed the biotin switch assay from 
the leaf protein extract (Jaffrey & Snyder, 2001). The protocol was performed in the 
dark with the occasional use of indirect light. Notably, we could only observe a band 
on the SARD1-HA test samples without GSNO infiltration and not in the positive 
control (GSNO infiltrated) or any SARD1C438S samples (Fig 5.3A). The input control 
indicates that all the samples contain HA-tagged protein before pull-down of the 
biotinylated proteins. However, it is possible that the biotinylated proteins did not bind 
to the streptavidin beads probably due to incorrect biotin labelling. To confirm and 
expand these results we performed the biotin switch assay using total protein extract 
from SA-induced plants incubated with GSNO as positive and GSNO plus 
Dithiothreitol (DTT) as a negative control. We observed a strong S-nitrosylation band 
for the SARD1-HA line when incubated GSNO, and a reduction in the signal with the 
addition of DTT. The SARD1C438S-HA extract only produced a faint band on the 
sample treated with GSNO, and no signal was detected after reduction of the sample 
with DTT (Fig 5.3B). This result indicates that SARD1 can be S-nitrosylated from a 
total protein. However, the band observed on the SARD1C438S sample could 
indicate a secondary S-nitrosylation target, suggesting that SARD1 is S-nitrosylated 
preferentially at Cys438.  
SARD1 temporal profile 
To further investigate the biological relevance of Cys438 of SARD1 we prepared 
transgenic lines expressing a SARD1-nLUC fusion protein. nLUC is a small enzyme 
with an emerging potential for bioluminescent assays in vivo covering a wide range of 
application, from receptor-ligand binding to transcriptional regulation (Zhang et al, 
2013b; Basu et al, 2017; Urquiza-García & Millar, 2018). In our study, the SARD1-
nLUC fusion allows us to monitor the de novo synthesis of SARD1 to elucidate the 














We first characterise the SARD1-nLuc lines to select plants with similar expression 
levels. We induce the expression of the fusion protein with SA 1 mM for 12 hours and 
subsequently harvested three leaf discs from independent leaves per plant and four 
plants per genotype. The discs were placed at the bottom of the well from a black 96-
wells plate and covered with 100 µL of a 1:50 furimazine in distilled water + 0.01% 
Triton X-100 solution. The bioluminescence was read in a Tecan luminometer (Fig 
5.4A). We observed a base bioluminescence level for the untreated plants and a 
significant increase in response to SA treatment. We selected lines that exhibited 
similar luciferase activity and used them in an in vivo bioluminescence essay to 
evaluate changes in SARD1 dynamics in a time-course.  
To do this, we germinated SARD1-nLuc and SARD1C438S-nLuc seeds in a black 96-
well plate containing 100µL MS media per well under long-day conditions. 
Subsequently, we sprayed the one-week-old seedlings with SA plus furimazine 
solution and monitored the emittance of light each hour for an additional week. We 
noticed an increase in bioluminescence within 3 to 6 hours after SA treatment (Fig 
5.4C), consistent with what we observed for the HA lines (Fig 5.2B). Also, we noticed 
stronger bioluminescence in response to SA in the SARD1C438S lines compared to 
that of the wild-type SARD1 line. The luminescence dropped to a baseline level within 
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Figure 5.3. In vivo S-nitrosylation of SARD1. Biotin switch assay from leaf extract. A) 
SARD1-HA and SARD1C438S infiltrated with 1mM GSNO in 10mM MgCl2 12 hours after 
induction with 1mM SA. After 1-hour incubation with GSNO, the samples were collected in the 
dark and frozen. DTT was added to the negative control. Protein extracted from GSNO 
untreated samples were homogenized in buffer containing 25mM NEM and blocked directly. 
B) Biotin Switch after incubating the total protein extract with GSNO with or without DTT.   
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We observed the same dynamic after a second SA-induction, characterised by the 
stronger signal for the SARD1 mutant lines and a drop to the baseline level within 20 
hours after SA. We noticed that after the third induction with SA, the initial 
SARD1C438S-nLuc accumulation was reduced compared to the previous treatments, 
while the SARD1-nLuc wild type line retained the same amplitude.  
Interestingly, the expression level of SARD1-nLuc did not drop to the baseline and 
followed a prolonged oscillatory pattern (Fig 5.4C), which we speculated could be 
related to the activation of SAR and the critical regulatory role of SARD1 in this 
process (Zhang et al, 2010). The observation that the SARD1C438S lines did not 
show this oscillatory pattern could suggests a potential role for S-nitrosylation of 







Figure 4. Characterisation of SARD1::SARD1-nLuc lines. Quantitative analysis of 
bioluminescence after SA induction. The substrate (furimazine) was diluted 1:50 in distilled 
water with 0.01% Triton X-100. A) Mean luminescence value of leaf discs collected from T3 
SARD1::SARD1-nLuc plants 12 hours after induction with SA 1 mM. Three leaf discs collected 
per plant and four plants analysed per treatment. Error bars represent the standard error. B 
and C) In vivo bioluminescence assay. SARD1::SARD1-nLuc seeds were germinated in a 96-
wells plate. The seven days old seedlings were sprayed with a 1 mM SA + 1:50 furimazine 
solution. Luminescence measurements were collected every hour for 1 week. B) Individual 
comparison of lines SARD1-nLuc 7 and C438S-nLuc 44. C) Mean value of three SARD1-nLuc 
and three SARD1C438S-nLuc lines with 12 seedlings per line. Error bars represent the 
standard error. The yellow shadow indicates light period, the blue dotted line represents SA 



























































































































Role of C439 in systemic acquired resistance 
To assess the possible involvement of C438 in SAR establishment, we monitored 
bacterial growth in the SARD1 transgenic lines in a SAR assay. We first induced SAR 
by infiltrating a bottom leaf of three-week-old plants with a high dose (O.D.600 =0.025) 
of P.s.m ES4326 carrying the avirulent gene avrB. Three days after the primary 
infection, we inoculated three different leaves per plant with virulent P.s.m. ES4326 
O.D.600 = 0.0002 of both SAR-induced and control plants to compare local and 
systemic immunity. We monitored the bacterial growth at 0, 24 and 72 hours post 
infection. As expected, the sard1 plants showed the highest bacterial load at 24 and 
72 HPI for both local and systemic immunity (Fig 5.5A).                     
In local immunity, we observed similar bacterial growth in Col 0 and the SARD1 HA 
lines at 24 and 72 HPI, confirming that the SARD1::SARD1-HA transgene 
complements the sard1 phenotype. No significant difference was found at any time 
point indicating that S-nitrosylation of C438 does not have a significant impact in local 
immunity.  
Interestingly, we observed in the distal leaves of the SAR-induced plants a higher 
bacterial load in the SARD1C438S-HA plants with respect to that of the SARD1-HA 
line at 24 HPI. We noticed this same effect in additional SARD1C438S lines tested. 
However, no statistically significant difference was found between the HA lines and 
the Col 0 control at this time point. At 72 HPI all lines showed comparable bacterial 
level with no significant difference found between any of the genotypes tested. The 
higher susceptibility at 24 HPI in the SARD1C438S-HA with respect to the SARD1-
HA plants during SAR possibly suggests the requirement of S-nitrosylation of SARD1 
for the proper establishment of the systemic response. Further experiments are 
required using a bigger sample size to confirm this possibility.  
Discussion 
In vivo S-nitrosylation of SARD1 
We generated SARD1 and SARDC438S transgenic Arabidopsis plants expressing 
SARD1 as C-terminal HA and nLUC fusion to evaluate if SARD1 can be S-nitrosylated 
in vivo and evaluate what is the biological relevance of this modification. We confirmed 
that the transgenic SARD1 proteins are bioactive by complementing the sard1 
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phenotype which exhibit compromised basal immunity and systemic acquired 
resistance (Zhang et al, 2010; Wang et al, 2011a).   














We showed that SARD1 can be S-nitrosylated in vivo and from plant extracts 
preferentially at Cys438. Interestingly, when we promoted S-nitrosylation by infiltration 
of GSNO according to previous reports (Albertos et al, 2015; Feng et al, 2013) we 
could only observe S-nitrosylation of SARD1 for the WT sample without GSNO 
infiltration and no signal was detected for any SARD1C438S sample. We expected to 
detect S-nitrosylation in the WT SARD1 after GSNO treatment. A possible explanation 
relates to the activation of de-nitrosylation mechanisms by GSNO infiltration and 
endogenous SA application. Quick transcriptional reprogramming occurs in response 
to NO-donor infiltration (Polverari et al, 2003; Begara-Morales et al, 2014; Hussain et 
al, 2016; Sharma et al, 2016) involving a high number of upregulated genes 
associated with REDOX counter-responses, including Thioredoxin-h5 (TRXh5), 
which was increased by over 30-fold shortly after NO-donor infiltration (Hussain et al, 
2016). TRXh5 mediates selective denitrosylation of S-nitrosylated proteins both in 
Figure 5.5. Systemic Acquired Resistance assay SARD1::SARD1HA lines. Pathogen 
growth assay 0, 24 and 72 hours after infiltration with Psm ES4326 O.D.600 =0.0002. Local 
infection or SAR. The virulent pathogen was infiltrated 3 days after induction of systemic 
acquired resistance with Psm ES4326 (avrB) O.D. 600 = 0.025. Two leaf discs collected from 
independent leaves and ground together per sample. Error bars represent the standard error 
for 6 biological replicates and 6 technical replicates. The statistical difference within groups 
was analysed with one-way ANOVA followed by Tukey HSD test to identify pairs of treatments 
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vitro and in vivo. Arabidopsis protoplast treated with CysNO (2mM) exhibited rapid 
TRXh5 accumulation and significant de-nitrosylation activity within 20 minutes after 
Cys-NO treatment, resulting in SNO level comparable to the negative control without 
ascorbate (Kneeshaw et al, 2014). It is possible that GSNO infiltration promoted 
upregulation of de-nitrosylation mechanisms resulting in the identification of 
nitrosylated protein only in the SARD1-HA sample without GSNO treatment.  
Self-regulation of SARD1  
The SARD1-nLUC line allow us to investigate if cysteine 438 mediates changes in the 
dynamics and timing of SARD1 expression. The SARD1-nLUC lines does not show 
constitutive bioluminescence, therefore our approach of supplying the plants with SA 
and furimazine mix allowed us to observe the de novo synthesis of SARD1 in 
response to SA. Notably, all the Nano luciferase lines analysed showed induction by 
SA with a peak in luminescence within 4 to 6 hours after SA, consistent to the SARD1 
transcript levels reported by Wang et al, (2011) in response to flg22. We also 
observed that C438S mutants produced a higher luminescence peak compared to 
that of the SARD1 WT lines in response to SA. Also, we observed higher 
accumulation of SARD1C438S-HA protein in different lines analysed. S-nitrosylation 
commonly mediates negative regulation of protein function, including the DNA-binding 
of the TF DNA-binding of MYB-2, MYB-30 and SRG1 (Serpa et al, 2007; Tavares et 
al, 2014; Cui et al, 2018).   
SARD1 regulates gene expression preferentially through the GAAATTT motif, which 
is absent in the SARD1 promoter. However, the related sequence G(A/T)AATT(T/G) 
was enriched within the promoter of genes identified as SARD1 target in a chromatin 
immunoprecipitation sequencing (ChIP seq) study (Sun et al, 2015). We analysed the 
SARD1 promoter using the Plant Promoter Analysis Navigator 2.0 (PlantPAN 2.0, 
Chow et al, 2016) and identified two GAAATTG motifs within 700 to 800 bp from the 
start site which suggests SARD1 could be self-regulated. We could not access the 
reported ChIP-seq data (Sun et al, 2015) to confirm if SARD1 promoter was enriched 
within the SARD1 sample. However, the higher induction of SARD1 expression in 
SARD1C438S lines together with the presence of alternative cis-elements in SARD1 
promoter suggest the involvement of S-nitrosylation in a negative self-amplification 
mechanism or promoting protein stability. To evaluate this hypothesis it is possible to 
perform a trans-activation assay in Arabidopsis protoplast overexpressing SARD1 
and SARD1C438S using a SARD1::LUC construction in response to SA and GSNO 
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treatments. Additionally, it is possible to evaluate the binding of SARD1 to its own 
promoter using ChIP with the SARD1-HA lines.  
Role of Cys438 in SAR 
We observed a persistent expression pattern of SARD1-nLUC after consecutive 
induction with SA, which we speculated could be related to the establishment of SAR. 
Interestingly, this pattern could not be observed in the SARD1C438S-nLUC line, 
which could suggest a role for S-nitrosylation mediating this process. However, the 
SAR assay did not show significant difference in susceptibility to Psm infection in the 
SARD1C438S lines with respect to the WT.  
During SAR, plants prime defences in order to respond faster in case of secondary 
infections. The systemic response encompass the systemic accumulation of SA 
following the translocation of a chemical signal from the primary infection site towards 
systemic leaves (Fu & Dong, 2013; Shine et al, 2018). It is known that NO plays a 
central role for proper SAR establishment (Wang et al, 2014a). However, the 
molecular mechanisms behind the role of NO in SAR are not known. It is necessary 
to re-evaluate if S-nitrosylation of SARD1 has an effect on SAR. It will be interesting 
to compare gene expression in the SARD1 and SARD1C438S line during SAR and 
increase the sample size in the SAR assay.  
Additionally, it is critical to evaluate if the oscillation observed in the SARD1-nLUC 
line follows a circadian rhythm during SAR to link S-nitrosylation of SARD1 with this 
process. Different immune associated genes are known to be under regulation by the 
circadian clock, which allows plants to synchronise immune responses according to 
pathogenic signals (Wang et al, 2011b; Zheng et al, 2015; Karapetyan & Dong, 2018). 
The TF Circadian Clock Hiking Expedition (CHE/TCP21) is a known component of 
the circadian clock (Pruneda-Paz et al, 2009) and is known to regulate the circadian 
expression of ICS1 and SA accumulation during SAR. Arabidopsis plants deficient in 
che display compromised SAR and showed reduced expression of SARD1 and 
CBP60g (Zheng et al, 2015). However, no CHE cis-binding elements are located 
within the SARD1 and CBP60g promoters, suggesting that CHE indirectly regulates 
SARD1/CBP60g during SAR. 
Our analysis of the SARD1 and CHE promoter using the PlantPAN 2.0 tool (Chow et 
al, 2016) showed that both promoters contain binding sites for the TF circadian-clock 
associated 1 (CCA1). Moreover, the SARD1 and CHE promoters were identified as a 
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potential targets of CCA1 in the data from the ChIP-Seq study by Nagel et al, (2015). 
CCA1 is a central regulator of circadian immunity. Affections on CCA1 expression 
result in higher susceptibility to Pseudomonas infection (Zhang et al, 2013a). TOC1 
is known to repress CCA1 expression. However, TOC1 does not contain a DNA-
binding domain. Therefore, TOC1 interacts with the N-terminal domain of CHE, which 
recruits TOC1 to the CCA1 promoter (Pruneda-Paz et al, 2009).  
The CHE promoter contains two alternative SARD1 cis-elements GTAATTT, together 
with cis-elements for CCA1, TGA2/6, WRKY TFs, EIN3/EIL1, ANAC TFs and Myb2, 
which are also involved in the regulation of ICS1 expression. Notably, SARD1 has not 
been associated with the clock and the SARD1 transcripts could not be detected in 
the transcriptomic analysis of circadian genes undertaken by Covington et al, (2008), 
probably because SARD1 is only expressed in response to specific stimuli and not 
under basal conditions (Zhang et al, 2010). However, proteins that do not follow a 
circadian rhythm can also regulate clock components (Spoel & van Ooijen, 2013).  
We observed a potential SARD1 accumulation peak during the day, consistent with 
the timing of CHE accumulation. Also, both proteins display nuclear localization 
(Pruneda-Paz et al, 2009, Zhang et al, 2010), indicating spatiotemporal coincidence. 
SARD1 contains a SAM-like domain in its sequence, which is usually involved in 
protein-protein interactions (Denay et al, 2017). It will be interesting to investigate if 
SARD1 and CHE can physically interact with each other and if this interaction affects 
TOC1-CHE mediated regulation of CCA1 during SAR and if this interplay could be 
mediated by S-nitrosylation of SARD1.  
Similarly, it will be relevant to explore if S-nitrosylation of SARD1 can regulate the 
expression of other SAR regulators. For instance, the pathogen-induced expression 
of Agd2-like Defense Response Protein 1 (ALD1) and SARD4, involved in the 
biosynthesis of pipecolic acid (Pip) is suppressed in sard1 plants. Pip is proposed to 
be a central intermediary and movable signal for SAR establishment (Navarova et al, 
2012; Bernsdorff et al, 2016) and the ALD1 and SARD4 promoters have been 
identified as SARD1 targets (Sun et al, 2015). 
The fact that specific NO concentrations are necessary for optimal SAR establishment 
could suggest a role for S-nitrosylation in this process. However further research is 
needed to determine if S-nitrosylation of Cys-438 of SARD1 is relevant in this process. 
If this is confirmed, it could contribute to integrate S-nitrosylation SAR establishment.  
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Chapter 6 Purification of recombinant SARD1 
 
Introduction 
DNA binding domain of SARD1 
SARD1 and CBP60g are plant-specific transcription factors containing a novel DNA-
binding domain (DBD) and play a vital role in modulating plant immunity. Since their 
first report nearly 10 years ago (Wang et al., 2009; Zhang et al., 2010) significant 
research has demonstrated their importance in salicylic acid biosynthesis and 
immunity (Kong et al, 2016; Truman et al, 2013; Truman & Glazebrook, 2012; Sun et 
al, 2015; Qin et al, 2018; Wang et al, 2009a; Zhang et al, 2010). However, the crystal 
structure of this novel family of transcription factors and this DBD remains elusive.  
Protein crystallography 
Obtaining protein crystals allow the identification of the three-dimensional 
conformation of the protein and provide significant information about the physiological 
processes these proteins are involved. Protein function is fundamentally tied to their 
three-dimensional conformation and understanding the interactions taking place at 
the molecular level can help to elucidate enzymatic reactions, recognition of 
substrates and interactions with other proteins and macromolecules (Zhang et al, 
2007).  
For instance, the obtention of the crystal structure of the MYC transcription factor and 
JAZ proteins allowed us to understand the molecular dynamics involved in the 
repression of the transcription factor MYC3 by JAZ proteins in the absence of 
jasmonate. In the presence of jasmonate, JAZ proteins function as a co-receptor for 
jasmonate and forms a complex with COI1, this interaction promotes a significant 
conformation change of MYC3 which mediate ubiquitination and subsequent JAZ 
proteins’ proteasome-mediated degradation, resulting in the release of MYC3 to 
activate defence genes against herbivorous and microbial pathogens (Zhang et al, 
2015). 
An essential requirement for crystallography studies of a protein involves the 
production of high-purity and high concentrations of the target protein samples in 
conditions that do not perturb its natural state and allow the formation of 
supersaturated solutions (McPherson & Gavira, 2014).  
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The expression of recombinant protein in E. coli is a well-established platform for in 
vitro biochemical assays and structural biology studies. In general terms, the process 
is straightforward, involving cloning of the gene of interest in an expression plasmid 
and the subsequent transformation of an E. coli expression strain (Rosano & 
Ceccarelli, 2014). However, the expression of the protein can be affected by toxicity 
to the host, formation of inclusion bodies or misfolding affecting solubility and function. 
Different strategies to optimise protein production are available (Chen, 2012; Rosano 
& Ceccarelli, 2014). However, the success of the recombinant protein expression 
depends on the intrinsic properties of each protein and require a systematic 
optimisation process.  
Recombinant full-length SARD1 and truncated versions of SARD1 have been 
successfully expressed before. However, they have been expressed as fusion 
proteins using GST or MBP tags, which are a known strategy to increase protein 
solubility and are efficient for in vitro biochemical and DNA-binding studies (Zhang et 
al, 2010; Wang et al, 2011a; Li, 2015). Nevertheless, crystallography studies require 
removal of the solubility tag to obtain the desired resolution.   
Here we report the systematic optimisation process for recombinant expression of 
untagged SARD1 and a purification strategy with the aim to solve the three-






Expression of MBP-FXA-SARD1 for tag removal 
The crystallisation of proteins relies on the obtaining a highly-pure supersaturated 
solution of the protein of interest in conditions that do not alter its native conformation 
and functionality (McPherson & Gavira, 2014).  
To obtain SARD1 in the required concentration and purity for crystallography studies 
we first expressed recombinant SARD1 with an N-terminal MBP-tag flanked by the 
recognition site of the Factor XA protease for tag cleavage. Previous experiments in 
the lab have shown that the N-terminal MBP tag provides good solubility to the fusion 
protein and it does not affect its DNA-binding ability. We first amplified SARD1 
sequence from Col 0 cDNA adding restriction sites for cloning into the pMAL C5X 
vector. The pMAL C5X SARD1 vector was introduced into the expression E. coli strain 
BL21(DE3) (NEB 2527). The fusion protein was expressed overnight at room 
temperature after induction with IPTG 0.5 mM. The cells were harvested and lysed by 
sonication, and the MBP-FXA-SARD1 fusion protein was purified by affinity 
chromatography. We subsequently incubate the protein with the Factor XA protease 
to remove the solubility tag. However, our attempts to remove the MBP-tag by 
protease cleavage were unsuccessful due to unspecific cleavage within the SARD1 
protein. The efficiency and cleavage of Factor XA can be affected by the accessibility 
of the cleavage site, the degree of protein aggregation and the digestion conditions 
including protease concentrations, temperature and buffer composition. We followed 
an optimisation protocol for tag-cleavage but observed consistent unspecific cleavage 
on SARD1. 
Expression of untagged SARD1 and SARD1-His  
Previously, full-length and truncated SARD1 has been successfully expressed as an 
N-terminal GST-fusion protein. Also, fragments of SARD1 (aa 1-214, aa149-270 and 
aa 215-451) were expressed as His-tag protein and used in EMSA (Zhang et al, 2010) 
but no full-length SARD1 had been expressed with a histidine tag. To circumvent the 
unspecific cleavage of SARD1, we decided to express SARD1 without a tag and 
designed a strategy to purify the protein by ion-exchange chromatography and screen 
its DNA-binding activity to the ICS1 promoter.  
We first cloned the full-sequence of SARD1 with or without the stop codon into a 
modified pET28 vector compatible with Goldendale assembly to generate the 
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expression plasmids pET28CD-SARD1-NT (NT, untagged) and pET28CD-SARD1-His. 
The plasmids were introduced into E. coli BL21(DE3) (NEB 2527).  
We then performed a small-scale expression assay to test expression conditions 
varying expression temperature, time and IPTG concentrations. To do this, we grew 
an overnight culture and used it to inoculate 50 ml of LB media. The culture was grown 
at 37ºC until it reached an optical density at 600 nm of 0.7. The culture was induced 
with 0.5 mM IPTG and separated into 5 ml fractions in 50 ml falcon tubes. The tubes 
were incubated at different temperatures and for different times. The cells were 
collected by centrifugation and resuspended in lysis buffer based on 20mM Tris pH 
7.5. The cell suspension was sonicated and centrifuged at 20,000 G for 15 min to 
separate the soluble and insoluble fractions. The insoluble protein pellet was 
dissolved in 8M urea, and the protein fractions were loaded in SDS-PAGE and 
visualised by Coomassie staining.      
Notably, a band corresponding to the expected recombinant protein size could be 
found only in the insoluble fraction despite the optimisation of the expression 
conditions (Fig 6.1A). The abundance of insoluble SARD1 could be related to partially 
folded protein and the formation of inclusion bodies. We hypothesised that SARD1, 
as a REDOX sensitive protein, could require oxidising expression conditions for 
proper protein folding or the formation of disulphide bonds to stabilise the protein 
structure. 
The expression strain BL21(DE3) is not suitable for the formation of disulphide bonds 
in the cytoplasmic region, so we switched to the E. coli BL21 Shuffle T7 express strain 
(NEB C3029J) which has been engineered to promote disulphide bonds formation in 
the cytoplasm. This strain carries deletions on the glutaredoxin reductase and 
thioredoxin reductase (Δgor ΔtrxB) genes in addition to the constitutive cytoplasmic 
expression of the periplasmic disulphide bond isomerase DsbC to aid protein folding 
(Lobstein et al, 2012). 
After introducing the SARD1 plasmids into the Shuffle strain, we tested expression 
conditions as previously described. We could observe a stronger band in the soluble 
fraction for SARD1 (NT) concerning the empty vector, although a significant 






Different strategies to increase protein solubility have been reported (Wang et al, 
2014b; Santos et al, 2012; Rosano & Ceccarelli, 2014; Chen, 2012) including 
switching expression strains, co-expression of chaperones and foldases, reducing 
protein expression rate, modification to culture conditions, protein 
refolding/solubilisation of inclusion bodies, and the use of additives in lysis buffer 
(Leibly et al, 2012). We took a systematic approach combining these strategies to 
increase the solubility of SARD1.  
SARD1 has an estimated isoelectric point (IP) of 7.161 which is very close to neutral. 
Therefore we increased the pH in the lysis buffer to 1.5 points above the IP to 
guarantee the protein will show a net negative charge.  
To further increase the solubility of SARD1 we tested independent modifications to 
the expression media, as shown in table 6.1. We grew the culture until it reached an 
OD600 of 0.75 and induced the culture with 0.5 mM IPTG and simultaneously 
supplement independent cultures with glucose (1%), sucrose (1%), glycerol (1%) and 
EtOH (3%). We could observe an increase in the intensity of the SARD1 band after 
expressing the protein in the presence of glucose, sucrose and glycerol in the Shuffle 
(Fig 1D) but not in the BL21(DE3) strain (Fig 1C). Conversely, a considerable fraction 
of insoluble protein was also present under these treatments.  
Subsequently, we tried two different approaches to increase SARD1 solubility. The 
first approach consisted in modifying the lysis buffer including components to stabilise 
protein structure as described by Leibly et al, (2012) in which they screened the effect 
of 144 additives to solubilise 44 insoluble proteins. They found that the addition of 750 
mM trehalose in the lysis buffer had a positive effect on the solubilization of 21 out of 
44 insoluble proteins and was suitable for large-scale purification. We tested the 
trehalose enriched lysis buffer and observed an increase in the solubility of SARD1 in 
both SARD1(NT) and SARD1-His (Fig 6.2A). To guarantee that the solubilised protein 
was functional, we used the trehalose soluble fraction in EMSA to evaluate the ability 
of the protein to bind to the ICS1 promoter. However, these fractions did not produce 
any visible shift, indicating the protein was not able to bind to the ICS1 promoter, 
possibly due to the interference of the buffer components with the binding buffer (Fig 
6.2C).   
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The second approach we followed consisted in promoting the formation of non-
classical inclusion bodies and subsequently solubilising the protein under mild-
solubilising conditions described by Jevševar (2005). Non-classical inclusion bodies 
refer to the aggregation of properly-folded and functional protein (Jevševar et al, 
2005). We induced the formation of non-classical inclusion bodies by expressing the 
protein in LB media + 1% sucrose and 0.5 mM IPTG at 16 ºC for 16 hours.  
 
  
Figure 6.1. Optimisation of recombinant SARD1 expression. SDS-PAGE gels after 
Coomassie staining. 12% acrylamide gel. The recombinant protein was expressed in 5 ml 
cultures in 50ml Falcon tubes. The E. coli expressions strain were grown at 28°C until reaching 
O.D.600 = 0.7. The protein expression was induced with 0.5 mM IPTG for 16 hours at 16°C. 
The cells were collected by centrifugation at 4,000 RPM for 15 min. The pellet was lysed by 
sonication and the soluble fraction recovered after centrifugation at 20,000 G for 15 min. The 
insoluble pellet was resuspended in 8M Urea.  A and B) Expression test of untagged SARD1 
and SARD1His tag. Empty = pET28CD, NT = SARD1 no Tag, His = SARD1His. A) BL21 T7 
express, B) BL21 Shuffle t7 express. C and D) Modifications to culture media. 1) Control empty 
pET28CD, 2) Control SARD1 (NT), 3)1% Glucose, 4)1% sucrose, 5)1% glycerol and 6) 3% 
ethanol. C) BL21 (DE3), D) BL21 Shuffle t7 express.       
Soluble Soluble Insoluble Insoluble 
BL21 (DE3) BL21 SHuffle T7 Express A B 
Empty   NT     His   Empty  NT     His Empty   NT     His     Empty  NT     His 
   1    2   3   4    5   6   1    2   3    4   5   6     1   2   3   4   5   6        1   2   3   4   5    6 
Soluble Soluble Insoluble Insoluble 
C D BL21 (DE3) BL21 SHuffle T7 Express 
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Table 1. Modification to culture media 
Additive Mechanism Reference 
 
1% Glucose Repress lac promoter to avoid unspecific 




1% Sucrose Increase osmotic pressure to promote the formation 
of osmoprotectant inside the cell and increase 
protein stability and native conformation 
 
(Reyes et al, 
2017) 
1% Glycerol Alternative carbon source. Induce alkalisation by 
acetate production  
 
(Wang et al, 
2014b) 
3% Ethanol Modification to membrane fluidity and increase 
DNA-synthesis rate 
(Chhetri et al, 
2015) 
  
After harvesting the cells, the pellet was resuspended in lysis buffer with pH 8.5. After 
centrifugation, the soluble fraction was recovered, and the non-classical inclusion 
bodies pellet washed twice with sterile water.   
We subsequently tested five mild-solubilising agents, including 5% N-propanol, 2M 
urea, 0.5% Triton X-100 and 5% DMSO. The washed insoluble protein pellet was 
resuspended in 20 mM Tris buffer pH 8.5 supplemented with the mild-solubilising 
agent. We noticed a significant recovery of SARD1 using this approach (Fig 2B). 
Following, we evaluated the ability of the solubilised SARD1 protein fractions to bind 
to the ICS1 promoter in EMSA. Notably, the addition of Triton X-100 had the most 
significant effect on DNA-binding for both SARD1(NT) and SARD1-His, producing a 
shift only in the SARD1 fractions and not in the empty pET28CD control, suggesting 
the recovery of soluble and functional SARD1 (Fig 6.2C). Interestingly, when we test 
the previously recovered soluble fractions we found a considerable proportion of 
SARD1, indicating that expressing the protein at low rate (low IPTG and 16 ºC) in LB 
media supplemented with 2% sucrose using the BL21 Shuffle strain and using a lysis 
buffer with a pH 1.5 points above the IP can increase the solubility of the protein. 
Ion exchange chromatography  
Next, we proceed to purify the SARD1 protein by ion exchange chromatography (IEX). 
SARD1 has a calculated isoelectric point of 7.161; we previously adapted the lysis 
buffer to a pH of 1.5 units above the isoelectric point. Therefore the protein would be 
expected to have a net negative charge. A requirement for ion exchange 
chromatography and crystallography is to obtain the protein in a buffer with a minimal 
composition to avoid interference of the buffer components with the ion exchange 
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resin. We removed the salt from the lysis buffer and confirmed the solubility of the 
protein in the minimal lysis buffer consisting of only 20mM Tris pH 8.5 compatible with 
IEX. We express one litre of culture using the conditions defined before. The cells 
were harvested by centrifugation, and the pellet was lysed in 10 ml of lysis buffer, 
followed by centrifugation at 30,000 G for 20 min, and the lysate was filtered using a 






















    F    NT     H     1     2      3     4      5       1     2     3      4      5    1      2      3      4    5 
SARD1 SARD1-His pET28CD Tre 
Figure 6.2. Solubilisation of SARD1. SDS-PAGE gels after Coomassie staining. A) Lysis 
buffer adapted according to the solubilisation protocol by Leibly et al, (2012) Standard buffer  
(25mM HEPES pH 7.4, 500mM NaCl, 10% glycerol, 0.025% Na Azide, 0.5% CHAPS, 10 mM 
MgCl2, 0.1% lysozyme, 750mM trehalose, 1mM PMSF). NT= SARD1NT, His=SARD1-His, + 
and – indicate induction with IPTG. The red dotted box indicates the region of interest.  B) Mild 
solubilisation of non-classical inclusion bodies. After removal of soluble protein, the insoluble 
pellet was washed with sterile water and resuspended overnight in 20mM Tris pH 8.5 + 1) 5% 
N-propanol, 2) 2M Urea, 3) 0.5% Triton X-100, 4) 5% DMSO and 5) Control 20mM Tris pH 
8.5. C) Electro mobility Shift Assay to test DNA-binding of the solubilised SARD to a fragment 
of the ICS1 promoter. F) free probe, Tre indicates trehalose solubilisation. 1 to 5) Solubilised 
reactions according to B. Upper arrow indicated SARD1 binding, differential shift concerning 
the empty vector control. Bottom arrow indicates free probe.    
    1     2    3    4    5     1    2    3    4    5      1    2    3    4    5 
Soluble Insoluble A Empty pET28 SARD1NT SARD1-His B 
    -   +   -   +   -   +   -   +  IPTG




We used a 5ml HiTrap Q HP column (GE Healthcare) for anion exchange 
chromatography. The column was equilibrated with degassed lysis buffer. After 
binding the protein to the column, we performed the elution using a stepwise ionic 
strength gradient, covering an initial 20% salt gradient step followed by 5% increasing 
steps. We recovered 5ml fractions from the protein peaks in the chromatogram (Fig 
6.3A). The fractions containing protein were loaded on SDS-PAGE followed by 
Coomassie staining. We identified bands corresponding to the expected size of 
SARD1 eluting before reaching the 20% salt gradient and within the 25 to 45% interval 
(Fig 6.3B). We had noticed before the existence of a native E. coli protein with a very 
similar size to that of the SARD1 size. Therefore we proceed to screen the fractions 
in EMSA. 
To confirm the identity of the protein. We used the fractions showing a band within 
the SARD1 size range in non-radioactive EMSA to test for specific binding to the ICS1 
promoter. We could observe a shift indicating binding to the ICS1 probe in the 
samples that eluted before the 20% salt gradient (Fig 6.3C), indicating a weak 
interaction of SARD1 to the resin. We have observed before a high molecular weight 
unspecific binding of the native E. coli proteins to the ICS1 probe in previous EMSA. 
Therefore we included an empty pET28CD BL21 T7 express SHuffle lysate as a 
negative control. Notably, the shift related to SARD1 was visible only in the positive 
crude extract control (pET28CD SARD1NT BL21 T7 express Shuffle) and in the 
purified fractions that eluted within 20% of the salt gradient but not in the negative 
control or other protein fractions, confirming the identity of SARD1.  
On a subsequent IEX purification, we further characterised the optimal ionic gradient 
for the release of SARD1 from the column by repeating the analysis with stepwise 
ionic strength gradient in 5% intervals covering the range from 0 to 20% salt 
concentration, followed by analysis of the fractions by SDS PAGE and EMSA. We 
found a band corresponding to the expected size eluting from the column within the 5 
to 10% salt interval, which can bind to the ICS1 promoter in EMSA (Fig 6.4). The 
fraction obtained from IEX showed a well-defined band of the expected size, 
consistent with the empty and SARD1 crude extract controls. The samples also 




Size exclusion chromatography   
To fine-tune the purification and remove the rest of the unspecific bands from the 
SARD1 sample, we combined the fractions containing the band of interest and that 
showed positive binding in EMSA and concentrated them using a Vivaspin column 
with a molecular cut-off of 30 kDa to a final volume of 2.2 ml. We proceed to load the 
sample into a Sephacryl S400 column (GE Healthcare) for gel filtration. We 
equilibrated the column with lysis buffer and loaded 2ml of the concentrated protein 
fraction. We recovered 4 ml fractions from the protein peaks in the chromatogram (Fig 
6.5A). The fractions were analysed on SDS-PAGE. We could observe a protein band 
of the size we expected, together with additional unspecific bands on the SDS-Page 
gel (Fig 6.5B). Notably, the chromatogram showed three protein peaks, but the 
proteins were only detected in the first fractions collected. The S400 column has a 
resolution between 20 to 8000 kDa which should allow the separation of SARD1 from 
the other proteins.  
To increase the resolution of the gel filtration, we expressed more protein and 
repeated the purification strategy using a Sephacryl S200 column, which has a 
resolution between 5 to 250 KDa. Similarly, we noticed a single protein peak in the 
chromatogram, and we observed unspecific bands in the purified samples (Fig 6.5C) 
after the SDS-PAGE analysis, suggesting possible protein aggregation during the 
purification steps resulting in a high-weight protein complex eluting faster from the 
column. To evaluate this, we loaded the concentrated protein fractions on a native 
PAGE. After Coomassie staining, we could observe a well-defined band above the 
100 KDa protein marker, which indicates the formation of a protein complex. Here we 
showed that untagged SARD1 could be expressed in vitro after optimisation of the 
expression conditions and designed a strategy to purify the protein purified by ion 
exchange and size exclusion chromatography while preserving its biological activity. 
However, further fine-tuning using reducing conditions to eliminate unspecific protein 
interactions is needed before scaling-up the production for protein crystallography 
assays.   
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Figure 6.3. Ion exchange chromatography (IEX). Ion exchange chromatography to purify 
un tagged SARD1. The recombinant protein was expressed in a 250 ml culture. After 
harvesting the cells, the pellet was lysed in 20mM Tris pH 8.7 containing 1mg/ml lysozyme, 
1mM PMSF. After clarification at 30,000G, the soluble fraction was filtered through a 0.22 µm 
syringe filter. The protein of interest was separated using a 5 ml Hi-Trap Q HP column in an 
Äkta Prime following an elution with stepwise ionic strength gradients method. A) 
Chromatogram of ion exchange. 5 ml fractions were collected for each protein peak 
corresponding to a 5% increase in the ionic strength gradient. B) SDS-PAGE after Coomassie 
staining of the iEX fractions. The dotted line indicates the region of interest for the expected 
SARD1 size. C) DNA-binding to a fragment of the ICS1 promoter in Non-radioactive EMSA. 
The upper arrow indicates the expected binding for SARD1. The bottom arrow shows the free 
ICS1 probe.      
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Figure 6.4. Fine-tuning Ion exchange chromatography. IEX chromatography to analyse 
elution of proteins within the 0 to 20% NaCl concentration. Chromatogram of ion exchange. 5 
ml fractions were collected for each protein peak corresponding to a 5% increase in the ionic 
strength gradient. B) SDS-PAGE after Coomassie staining of the iEX fractions. The dotted line 
indicates the region of interest for the expected SARD1 size. C) DNA-binding to a fragment of 
the ICS1 promoter in Non-radioactive EMSA. The upper arrow indicates the expected binding 

























Predicted model of SARD1 
To further understand the structure of SARD1, we used the Protein 
Homology/analogY Recognition Engine V 2.0 (Phyre2, Kelly et al, (2015), 
www.sbg.bio.ic.ac.uk and www.predictprotein.org) to build a predictive model of 
SARD1. The predicted model only showed a partial structure for 51 amino acids (aa 
259 to 310) with high similarity to a SAM-like domain. Additionally, the software 
predicted a highly disordered region towards the C-terminal end of SARD1, which 
suggests considerable flexibility in this region of the protein (Fig 6.6A). We 
subsequently used the Swiss Model homology-modelling server to build a three-
+   18 19 20 22 23 24 25 26 27 32 33 35  +  C1 C2  5  6  7  8   9   10 11  12  13 14  15  
SEC Fractions S400 SEC Fractions S200 
1   -   2   3 
IEX 
Figure 5. Size Exclusion Chromatography. The fractions obtained from IEX showing a band 
of the expected size and positive DNA-binding to the ICS1 promoter were pooled and 
concentrated in a Vivaspin column (molecular cut-off of 30 KDa) to a final volume of 2.2ml. 
After column equilibration, 2 ml of concentrated protein sample were loaded for SEC at a flow 
rate of 0.5ml*min-1. A) Chromatogram of SEC with Sephacryl S-400 column. B and C) SDS-
PAGE gel after Coomassie staining of SEC using a Sephacryl column B)S-400 and C)S-200. 
D) Native gel after Coomassie staining of IEX fractions before SEC.    
A) 
B) C) D) 
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dimensional model of SARD1. Interestingly, the result only showed a small fragment 
of the protein, covering from amino acids 250 to 310, composed of a five alpha-helix 
conformation (Fig 6.6B), consistent with the classical SAM domain structure (Camille 
Sayou et al, 2016; Denay et al, 2017). 
Interestingly, the proteins used as templates to build the model are involved in DNA-
repair, transcription elongation and the alpha subunit of RNA polymerase. The 
characteristics inferred from the partial model suggest SARD1 is a highly dynamic 
protein with a relevant biological function. Solving the crystal structure will allow us to 
understand the biological role of SARD1.  
Discussion  
Solubility of SARD1  
SARD1 and CBP60g are members of a plant-specific family of transcription factors 
containing a novel structure of a DNA-binding domain. They play a pivotal role in plant 
immunity. However, nearly one decade after their discovery the three-dimensional 
structure of this family of TF remains elusive. Although full-length SARD1 has been 
successfully expressed as a fusion protein with GST and MBP tags, only truncated 
versions have been reported with a histidine tag (Wang et al, 2009a; Zhang et al, 
2010; Wang et al, 2011a; Li, 2015). One possibility for this is the low solubility 
exhibited by SARD1 when expressed in vitro, requiring the fusion with bigger tags to 
increase solubility. Here we report the expression of full-length SARD1 and a 
purification strategy by anion exchange chromatography and gel filtration suitable to 
scale-up and subsequent fine-tuning to express functional SARD1 for crystallography 
studies.  
We hypothesised that the formation of inclusion bodies when expressing SARD1 
without a tag or with a histidine tag could be due to protein misfolding, potentially 
related to the requirement of oxidising conditions to preserve the tridimensional 
protein structure. Therefore, the rationale in the strategy to express SARD1 focused 
on generating specific expression condition to promote proper protein folding in an 




























Recombinant SARD1 expression 
The SARD1 expression strategy combines well-documented strategies for protein 
expression (Chen, 2012; Rosano & Ceccarelli, 2014). It comprises the use of an 
engineered E. coli expression strain with oxidising cytoplasmic conditions and the 
cytoplasmic coexpression of a periplasmic disulphide bond isomerase DsbC 
(Lobstein et al, 2012). Also, the addition of sucrose to induce the formation of 
intracellular osmoprotectants to aid in proper protein folding (Reyes et al, 2017). 
Finally, the use of low IPTG concentration and low expression temperature to reduce 
Figure 6.6. Predicted model of SARD1. A) Result of disorder prediction using the software 
Phyre2 (Protein Homology/analogy Recognition Engine 2.0) 
http://www.sbg.bio.ic.ac.uk/~phyre2 from the Structural Bioinformatics Group in Imperial 
College London. B) Cartoon from the partial model obtained from the SWISS-MODEL 
Homology Modelling server, showing the five alpha-helix structure comprising amino acids 





the protein expression rate (Rosano & Ceccarelli, 2014), high pH in the lysis buffer 
and the use of additives to solubilise proteins (Leibly et al, 2012). The fact that SARD1 
formed a protein complex under native PAGE conditions, similar with previous 
observations in the lab and in previous reports (Zhang et al, 2010), together with the 
elution of a high molecular weight protein complex from the size exclusion column 
could indicate oligomerisation of SARD1 or protein aggregation.  
SAM-like domain of SARD1 
Furthermore, a predicted model using SARD1 amino acid sequence and analysis of 
order and flexibility within the sequence supports the hypothesis of a dynamic C-
terminal region on SARD1 and potential homodimerisation. The predicted model of 
SARD1 showed a domain with 93% similarity to a SAM-like domain. The sterile α-
motif (SAM) represents a protein module, around 70 to 80 amino acids in length, 
generally composed of a five α-helix array, associated with protein-protein interactions 
and the formation of dimers, oligomers and polymers. Structural studies suggest the 
SAM domain is involved in the regulation of a diverse array of functional protein 
including transcription factors, enzymes and receptors (Denay et al, 2017)  
In Saccharomyces cerevisiae, the SAM-domain of the Serine/Threonine-protein 
kinases (STE) 11 and STE 50 mediates a reversible homo/heterodimerization which 
modulates efficient signal transduction in MAPK cascades (Bhattacharjya et al, 2005). 
Additionally, functional characterisation of the SAM-like domain of the Arabidopsis 
transcription factor TFCP2L1, which participates in the establishment and 
maintenance of pluripotency in embryonic stem cells, showed that TFCP2L1 
undergoes hexamerization through the C-terminal SAM-like domain and that this 
conformation promotes DNA-binding through the CP2-like domain at the N-terminal 
of TFCP2L1 (Kim et al, 2016). Similarly, the Tankyrase 1 (TNKS1) and TNKS2 
proteins, members of the poly(ADP-ribose) polymerase enzymes participate in the 
regulation of a plethora of cellular processes, including signalling. These TNKS 
proteins were found to oligomerise via SAM-like domain interactions, which could 
represent an inhibitory mechanism for substrate binding (DaRosa et al, 2016).  
In Arabidopsis, the structural analysis of the transcription factor LEAFY, a master 
regulator of flower development, showed the presence of a 50 residues SAM domain 
located at the N-terminal end of the TF. The SAM domain mediates LEAFY 
oligomerisation which allows the TF to bind to low-affinity DNA regions, including 
89 
 
closed chromatin regions (Camille Sayou et al, 2016). An additional eleven SAM-
containing Arabidopsis proteins have been annotated, involved in diverse processes 
(Denay et al, 2017). The SAM-like domain is present in essential biologically active 
proteins, suggesting a regulatory role for oligomerisation in the bioactivity of these 
proteins conserved in different organisms. The SAM-like domain in SARD1 could 
indicate a similar mechanism regulating its bioactivity. However, the role of the SAM-
like domain of SARD1 and its biological implications potentially promoting SARD1 
oligomerisation remains to be investigated. 
C-terminal of SARD1 
Interestingly, the predicted model of SARD1 also showed disordered regions along 
the C-terminal domain of the protein and specifically flanking cysteine 438. The 
disordered regions refer to fragments of proteins that do not have a stable, permanent 
secondary structure in solution but assume a specific structure in a precise functional 
state (Zhang et al, 2007). Additionally, proteins containing intrinsically disorder 
regions and hybrid ordered/disordered regions are recognised as dynamic functional 
proteins or protein domains that fulfil essential biological functions (Lieutaud et al, 
2016). The disordered regions are likely to be located in loops and turns rather than 
in stable α-helix and β-sheets conformations (Zhang et al, 2007), suggesting flexibility 
in the C-terminal of SARD1, potentially allowing the formation of disulphide bonds with 
other cysteines. However, our observation that SARD1C438S from the in vitro DNA-
binding assay that SARD1 and SARD1C438S show similar KD suggests Cys 438 is 
not directly involved in the formation of a disulphide bond, or that this bond is not a 
requirement for DNA-binding.  
Moreover, protein regions with a predicted ~50% disorder probability can exist as 
semi-disorder regions (interplay order/disorder) and have been shown to participate 
in protein aggregation, protein-protein interactions and folding (Lieutaud et al, 2016). 
Notably, around 70% of semi-disorder sequences are predicted to be involved in post-
translational modifications, and specifically, amino acids located within five residues 
away from semi-disorder regions are 20% more likely to be modified by post-
translational modification (Zhang et al, 2007).  
According to the predicted model and estimation of disorder of SARD1, Cys 438 which 
was identified by Li (2015) as the target for S-nitrosylation is located five amino acids 
away from a disordered region, supporting the hypothesis of an essential regulatory 
mechanism at the C-terminal of SARD1, potentially mediated by S-nitrosylation.          
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The fact that SARD1 showed to be insoluble in E. coli BL21 (DE3) indicates the 
requirement of an oxidant cellular environment for proper folding, possibly aided by 
the formation of disulphide bonds or different interaction to promote protein stability 
and supported by the predicted disorder and flexibility at the C-terminal domain of 
SARD1, containing cysteines 311, 333 and 438. The prediction of a SAM-like domain 
opens the possibility of SARD1 oligomerisation, potentially contributing to regulate 
SARD1 bioactivity. However, to confirm this possibility, it is necessary to solve the 
SARD1 crystal structure. The next steps in the purification process include IEX and 
SEC in a reducing buffer to eliminate unspecific protein interaction and 
monomerisation of SARD1 to increase the resolution of gel filtration, followed by 
scaling-up and structural analysis. Alternatively, the gel filtration could be optimised 
to promote SARD1 oligomerisation and reduce the resolution of the resin to promote 
the elution of the SARD1 oligomer faster that other smaller proteins. Understanding 
the structure of SARD1 alone, as a DNA-protein complex and after S-nitrosylation will 
shed some light on the molecular regulatory interactions coordinating the activation 








Chapter 7 Forward genetic screening of mutagenized PR1::LUC par2-1 lines 
 
Introduction 
Arabidopsis thaliana genome annotation 
Arabidopsis thaliana is the most studied model organism in plant science due to its 
fast generation time and relatively small diploid genome. Besides, the whole genome 
has been fully sequenced, and significant progress has been made in gene annotation 
(Arabidopsis Initiative, 2000). The availability of transcriptomic sequencing techniques 
and databases set the ground for understanding the function of all types of transcripts, 
expanding over mRNA, non-coding RNA and small RNA, allowing a comprehensive 
annotation of the Arabidopsis genome. A recent effort to update and maintain the 
accuracy of the annotation used 113 datasets from RNA-seq libraries and constructed 
48,359 transcripts models of protein-coding genes. The analysis resulted in the 
Araport11 annotation update, consisting in 37,686 genes, out of which 27,655 are 
protein-coding, 5,178 non-coding, 956 pseudogenes, and 3,901 transposable 
element-related loci (Cheng et al, 2017). Although many genes have been associated 
with a particular function, the function of a significant proportion of genes remains 
unknown.  
Genetic screenings 
A common strategy for the functional characterisation of genes is the design of 
forward and reverse genetic screenings (Page & Grossniklaus, 2002). The approach 
is to generate a mutant population with altered phenotypes and physiological 
responses. Different mutagenesis methods have been described, including chemical, 
irradiation and insertional methods. The alkylating agent ethylmethane sulphonate 
(EMS) induce chemical modification of nucleotides resulting in mispairing and base 
substitutions randomly distributed throughout the genome. Commonly, EMS induces 
C-to-T mutations resulting in C/G to A/T substitution, which can introduce a stop 
codon within the coding sequence or the replacement of crucial amino acids, allowing 
the identification of gain- or loss-of-function mutants (Kim, YongSig, Karen, 
Schumaker, Zhu, 2006).     
Forward genetic screening allows the direct study of specific biological processes. 
The screen relies on determining a genetic background that allows the identification 
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of a phenotype of interest through a smooth and tight screening procedure. Next, 
random mutations are artificially induced by chemical or physical means and the 
plants are screened for a particular phenotype. Subsequently, the underlying mutation 
responsible for the phenotype is mapped to a specific location in the genome (Page 
& Grossniklaus, 2002). To further dissect a biological process, a second screen can 
be done to identify second-site-mutations that can suppress or enhance the primary 
phenotype. Typically, suppressor mutations uncover alternative pathways or 
interacting proteins that became activated by the second mutation (Page & 
Grossniklaus, 2002). 
PR1::LUC line 
To investigate the molecular components of the defence signalling network, Murray 
et al, (2002) generated a transgenic Arabidopsis line expressing luciferase under the 
control of the PR1 promoter. The PR1::LUC transgenic line was mutagenized with 
EMS and screened for mutations that caused miss-expression of the PR1 gene, 
leading to the identification of the constitutive induction of resistance(cir) mutants cir1, 
cir2, and cir3 which exhibit constitutive and broad-spectrum resistance against at least 
one of the virulent pathogens Pseudomonas syringae pv. Tomato, Hyaloperonospora 
parasitica NOCO2 and the necrotrophic pathogen Botrytis cinerea. Interestingly, each 
of the cir alleles displayed different defence mechanisms  (Murray et al, 2002, 2005). 
In a different experiment, Grant et al, (2003) used an activation tagging approach with 
the PR1::LUC reporter line and identified the gene Activated Disease Resistance 1 
(ADR1) which encodes an NBS-LRR disease resistance protein. The ADR1 mutant 
showed elevated SA and ROS levels and expression of defence related genes. The 
PR1::LUC line was shown to accurately reports the engagement of SA-mediated 
immunity      
S-nitrosylation is known to play a central role in the regulation of plant immunity and 
other physiological processes. In Arabidopsis, a loss-of-function mutation of the S-
nitrosoglutathione (GSNO) reductase 1 (GSNOR1) gene resulted in high cellular S-
nitrosylation, severe developmental impairments and reduced basal, non-host and R-
mediated immunity, together with compromised salicylic acid biosynthesis and 
signalling (Feechan et al, 2005). Currently, the only known mechanisms in plants that 
directly control GSNO turnover involves the activities of the enzymes GSNOR1 and 
Thioredoxins (Kneeshaw et al, 2014). 
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We speculated that the expression of PR1::LUC would be reduced and delayed in a 
gsnor1 background as a result of compromised SA-signalling by the high S-
nitrosylation level (Feechan et al, 2005). Therefore, we designed a forward mutant 
screening using the line PR1::LUC in the gsnor1 background of par2-1 to search for 
second site modifiers that can suppress the par2-1 phenotype and restore PR1 
expression under high S-nitrosylation and potentially, uncover additional molecular 




Characterisation of PR1::LUC transgene 
To screen for second site mutations that can suppress/enhance the overall 
accumulation of GSNO in the gsnor1 background, we designed a forward mutant 
screening based on transgenic Arabidopsis thaliana plants carrying a chimeric 
PR1::LUC transgene previously generated in the lab (Murray et al, 2002). This 
reporter line was shown to act as a robust reporter of the engagement of the 
endogenous PR1 gene and the establishment of defence mechanisms (Murray et al, 
2002; Grant et al, 2003; Murray et al, 2005).  
We first characterised the expression level of PR1::LUC in response to exogenous 
SA in the PR1::LUC plants to confirm that the temporal expression of PR1 and LUC 
was consistent with the reported PR1 expression profile in response to Pst DC3000 
(avrB) infection (Murray et al, 2002). 
To do this, PR1::LUC Col 0 seeds were germinated on MS plates. The one-week-old 
seedlings were sprayed with salicylic acid 1 mM and were subsequently sprayed with 
a 5 mM luciferin solution and captured the resulting bioluminescence using an ultra-
low-light EM-CCD (Electron Multiplier Charged Coupled Device) camera system. The 
pictures were collected at different time-points following SA induction. We observed 
low bioluminescence without SA induction and an increase in luminescence following 
SA application, with a significant increase from 12 hours and a peak in luminescence 
at 48 hours post-SA. Notably, our observation is consistent with the temporal profile 
of PR1 expression reported by Murray et al, (2005), where they noticed PR1 transcript 
accumulation within six to twelve hours after infection with avirulent Pst and a peak of 
expression after 24 hours (Fig 7.1A).      
Characterisation of PR1::LUC par2-1 plants 
We proceed to cross the PR1::LUC transgene into the gsnor1 background of par2-1. 
After crossing the lines, we selected F2 plants carrying the PR1::LUC transgene by 
screening seedlings for kanamycin resistance and then selecting adult plants 
displaying the par2-1 phenotype. We then selected F3 double homozygous and 
characterise the bioluminescence in both lines after induction with SA 1 mM. To 
quantify the effect of S-nitrosylation on PR1 expression, we did a time course assay 
using a Berthold luminometer which provides higher resolution compared to the EM-
CCD system. We germinated PR1::LUC Col 0 and par2-1 seeds in a 96-well black 
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plate containing 100 µL of MS media per well. The one-week-old seedlings were 
sprayed with luciferin solution and the resulting luminescence was recorded in the 













After defining the background luminescence level, we induced PR1 expression by 
spraying the plants with SA 1 mM and collect luminescence readings every hour for 
three additional days. We could observe strong bioluminescence in the PR1::LUC Col 
0 from nine hours after SA. Interestingly, the PR1::LUC par2-1 line showed reduced 
and delayed luciferase expression with respect to the expression in the Col-0 
background. The PR1::LUC par2-1 line showed a maximum bioluminescence level 
around forty hours after SA. The most striking difference between the Col 0 and par2-
1 lines occur within 12 hours after PR1 induction with SA, when PR1 expression 
increases significantly in the Col 0 background (Fig 7.2A). Therefore, this time point 
was suggested as a potential screening parameter.   
To confirm the suitability of this time-point for the luciferase screening, we germinated 
seeds on MS plates and sprayed the PR1::LUC Col 0 and par2-1 plants with SA and 
captured the bioluminescence in the EM-CCD system. As expected, the wild type 
(WT) line showed strong luminescence at 12 and 24 hours after SA, while significantly 
lower luminescence was detected in the par2-1 plants at these time-points (Fig 7.2B).      
 
0 hr                 1 hr                         3hr                          6hr 
12 hr                  24 hr                      48hr                       72hr 
Figure 7.1. Expression pattern of PR1::LUC Colombia 0. Ultra-low light imaging of 
PR1::LUC Colombia 0 plants after exogenous SA application. The images were collected 
using a Hamamatsu EM-CCD C9100 camera. Pictures taken with 10 seconds exposure-time 



























To identify second site modifiers that can suppress the par2-1 phenotype, we sought 
mutations that could reduce the delay in LUC expression in response to SA or 
mutations that result in constitutive PR1 expression in the high S-nitrosylation 
background. We mutagenized a batch of PR1::LUC par2-1 seeds (.75 g ~ 35,000 
seeds) with 0.4% EMS solution for 16 hr at room temperature. The mutagenized M0 
seeds were split into ~100 seeds/pool and let the plants to set seeds in a glass house. 
We could observe discolouration and irregular phenotypes in some pools suggesting 































Figure 7.2. PR1::LUC expression in par 2-1 background. Bioluminescence measurements 
of PR1::LUC plants in Col-0 and par2-1 backgrounds. A) Relative light measurements of 
PR1::LUC seedlings after induction with SA 1mM. The plot represents the mean relative light 
units (RLU) value for Col-0 and par2-1 lines following SA application, indicated by the dotted 
line in the plot. Reading collected in a Berthold luminometer. Error bars represent the standard 
error for approximately 30 plants per genotype.  B) Ultra-low light imaging of PR1::LUC plants 
twelve and twenty-four hours after SA. Images captured with 10 seconds exposition time and 
+217 gain calibration.  









pools. We were not able to identify any dominant suppressor mutation on M1 plants 
that could restore the WT phenotype. 
First round screening 
For the first round of screening to select for suppressor mutants of the par2-1 
phenotype approximately 5,000 of the resulting M2 plants were screened via 
luciferase imaging. The first stage aimed to identify mutants expressing PR1 in 
response to SA. To do this, we sprayed the seedlings first with SA 1mM. Twelve hours 
later, we sprayed the plants with luciferin and incubated them for five minutes in the 
dark before collecting images using the EM-CCD camera. The M2 pools were imaged 
under low-light conditions and plants exhibiting strong luciferase activity were 
transferred to soil and let to set seeds. Also, we selected plants that showed long 
roots and displayed physical characteristics similar to WT at the seedling stage, 
regardless of their luciferase expression profile.  
Subsequently, we scored the M2 plants for visible WT phenotype at the bolting stage, 
considering that the gsnor1 phenotype encompasses distinctive physical 
characteristics such as loss of apical dominance, a high number of lateral shoots, 
stunted growth and short roots (Feechan et al, 2005). This specific phenotype 
facilitated the screening for plants that exhibit WT morphology.  
We scored the phenotype of the selected M2 plants at different physiological stages 
and classified the pools according to their luciferase activity and their morphological 
characteristics. We genotyped the M2 plants using primers targeting the G-to-A par2-
1 mutation to confirm the presence of the par2-1 allele. 
From the original 47 pools, the plants from eight pools failed to produce seeds, either 
because they did not survive after the screening or infertility. Notably, a considerable 
number of plants selected for high luciferase activity showed significantly stunted 
growth and infertility, probably related to constitutive activation of defence 
mechanisms.  
Second round screening 
To differentiate between mutants expressing inducible PR1 in response to SA 
treatment form those plants expressing constitutive PR1 expression we prepared M3 
seeds in MS plates and perform a two-phase sequential screen. First, the one-week-
old seedlings were sprayed with a mix of SA and luciferin and were scanned after 5 
minutes incubation in the dark to select plants showing constitutive PR1 expression. 
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Subsequently, the plates were rescreened 12 hours later to select SA-inducible 
mutants. The plants exhibiting strong luciferase activity at 0 and 12 hour post SA were 
transferred to soil. We identified plants from four different pools that exhibit strong 
luciferase activity in response to SA and four pools with strong constitutive LUC 
expression (Fig 7.3). Interestingly, all these plants display a par2-1 phenotype. The 
selected plants were let to set seeds, and we confirmed the luciferase phenotype in 
M4 plants.    
Further characterisation of the selected candidate mutants is required to shorten the 
number of mutants and proceed to identify the underlying mutation responsible for the 
observed phenotypes.  
  
M1 PR1::LUC par2-1 
First-round screening 
PR1::LUC (Col-0) par2-1 (gsnor1 EMS mutant) 
PR1::LUC par2-1 
EMS mutagenesis 
0.4% 16 hours 
M2 PR1::LUC par2-1 LUC activity 
21 pools 100% par2-1 phenotype (8 plants) 
12 pools ~75% par2-1 phenotype (30 plants) 
 6 pools <50% par2-1 phenotype (38 plants) 
M2 WT phenotype 
 2 pools 100% WT phenotype   (28 plants) 
 6 pools ~75% WT phenotype   (40 plants) 
12 pools <50% WT phenotype   (14 plants) 
Second-round screening 
M3 SA-inducible LUC expression 
Pool 27, Line 334:  Selected initially for WT 
phenotype at seedling stage 
Pool 38, Line 429 and 438: Strong luminescence 
Pool 42, Line 468: Uniform bright luminescence 
Pool 45, Lines 480, 484 and 488: Selected for WT-
like phenotype at seedling stage, long roots.   
 
M3 Constitutive LUC activity 
Pool 2, Line 36: Strong uniform LUC activity 
Pool 24, Lines 284 and 290: Uniform bright 
luminescence 
Pool 27, Line 335: Strong LUC 
Pool 28, Line 354: Selected initially for WT 
phenotype at seedling stage 
 
Figure 7.3. Schematic representation of first and second round of screening. First round 
aimed to select mutants exhibiting strong luciferase activity twelve hours after induction with 
SA 1 mM. Second round screen designed to discriminate between constitutive and SA-




Here we report the basis for a PR1::LUC par2-1 second-site suppressor mutant 
screening. We first characterised the expression pattern of luciferase under the 
control of the PR1 promoter in a high S-nitrosylation background and observed 
reduced and delayed PR1 expression with respect to WT plants, which was more 
evident at 12-hour post SA induction. It is well documented that the expression of SA-
dependent genes is reduced and delayed in gsnor1-3 plants which contain high 
cellular S-nitrosylation concentration (Feechan et al, 2005). Additionally, nitric oxide 
(NO) has been shown to be required for proper activation of SAR (Wang et al, 2014a) 
and that a partial reduction in GSNOR1 activity promotes the expression of PR1 in 
response to SA induction (Espunya et al, 2012). We hypothesise that a mutation that 
can upregulate GSNO turnover and decrease global S-nitrosylation level to the extent 
that favours immunity could correlate with restored timing of PR1 expression in 
response to SA. 
A previous atgsnor1-3 suppressor mutant screening conducted in the lab led to the 
identification of two alleles of the gene CAT3, termed spl7  and spl8, which could 
partially revert the gsnor1-3 phenotype (Brezezek, 2013). Further characterisation of 
the role of cat3 suggested that GSNO may be decomposed by reacting with the 
hydroxyl radical (OH-) in the absence of CAT3, thus reducing GSNO concentration 
(Chang, 2017). Notably, PR1 expression was delayed in the spl7 and spl8 mutants 
compared to Col-0 plants, but it was faster than in gsnor1-3, correlated with the partial 
suppression of the atgsnor1-3 phenotype (Brezezek, 2013), supporting the suitability 
of our screening methodology. 
Phenotype of gsnor1 suppressor EMS mutants  
We have currently identified two main types of mutant phenotypes; 1) plants with 
inducible luciferase expression in response to SA and 2) plant constitutive Luc activity.  
We speculate that inducible PR1 mutants could contain mutations involved with NO 
and GSNO turnover, potentially reducing cellular SNO-level, allowing SA-signalling. 
Similarly, we hypothesize that the mutants exhibiting constitutive PR1 expression 
could carry mutations that reactivate SA-signalling under low SA concentrations or in 




NO and GSNO turnover 
We expect to identify genes involved in GSNO turnover. GSNO is formed by the 
reaction on NO with the thiol group of glutathione (GSH). Therefore an indirect 
mechanism to regulate GSNO formation may involve the upregulation of genes 
involved in NO metabolism. For instance, oxyphytoglobins catalyse the oxygenation 
of NO into nitrate (NO3-). Additionally, NO can react with superoxide (O2-) to form 
peroxynitrite (ONOO-), which is further detoxified by the activity of thioredoxins (TRXs) 
(Igamberdiev et al, 2016). Additionally, GSNO can be depleted by reacting with OH- 
derived from H2O2 metabolism (Chang, 2018). 
In mammals, Calcium (Ca2+)-dependent NO-release mechanism was observed in 
pancreatic cells. It was found that Ca2+ promotes the NO release from intracellular 
SNO groups, contributing to mediate NO responses (Chvanov et al, 2006). Also, the 
REDOX state of copper (Cu+) can promote the formation or scavenging of SNO in 
vitro (Stubauer et al, 1999). It will be interesting to search for mutations that can 
promote the accumulation or reactive intermediaries that can prevent NO and GSNO 
formation or depletion.  
Also, an important characteristic of GSNO is its ability to trans-nitrosylate other 
proteins. A direct mechanism for denitrosylation of proteins involves the activity of 
TRXs. For instance, TRH-h5 (TRXh5) has selective protein-SNO activity and was 
shown to restore immunity in nox1 plants accumulating high NO levels (Kneeshaw et 
al, 2014; Karapetyan & Dong, 2018). TRXs are highly conserved across the plant 
kingdom. The Arabidopsis genome contains 46 TRXs and TRX-like genes with a big 
proportion of them with no biochemical data available (Meyer et al, 2005). It is possible 
that this screen would discover a gain-of-function mutation of a TRX family member 
which can ameliorate the gsnor1 phenotype. 
SA-signalling 
A relevant characteristic of gsnor1 plants is the reduced SA-biosynthesis and 
accumulation in response to pathogen infection (Feechan et al, 2005). SA 
accumulation is a central step for the downstream expression of defence genes 
(Loake & Grant, 2007; Dempsey & Klessig, 2017). The protein non-expresser of PR 
genes 1 (NPR1) plays a critical role in SA-signalling. It is proposed to locate in the 
cytoplasm in an oligomer state stabilised by S-nitrosylation and requires SA-mediated 
conformational changes for nuclear translocation (Tada et al, 2008). However, NPR1 
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has been reported to translocate into the nucleus independent of SA during 
Endoplasmic Reticulum (ER) stress where it interacts with bZIP transcription factors 
(TF) (Lai et al, 2018). Furthermore, NPR1 activity driving PR1 expression depends on 
SA-binding as plants expressing NPR1R432Q, impaired in SA-binding, shows 
expression of SA-dependant genes to a similar level than npr1 plants (Ding et al, 
2018). Additionally, PR1 was significantly expressed in plants defective in SA 
biosynthesis after infection with avirulent Pseudomonas as a result of sustained 
activation of mitogen-activated protein kinases (MAPK) MAPK3 and MAPK6 (Tsuda 
et al, 2013). Taken together, the evidence suggest the existence of compensatory 
mechanisms to add robustness and specificity to the immune response. Our 
screening can facilitate the identification of additional components of the immune 
signalling network.  
Future work 
We have currently identified four PR1-inducible mutants and four constitutive-PR1 
mutants. It is important to confirm that the phenotype observed is not the result of a 
revertant mutation that reactivates GSNOR1 activity. The par2-1 plants carry a G-to-
A mutation in exon six which converts a highly conserved glycine (Gly) into aspartic 
acid (Asp) at position 236. This mutation was found to significantly affect GSNOR1 
stability (Chen et al, 2009b). The WT codon GGC was changed to GAC in the par2-1 
allele. EMS induce G-to-A substitutions, it is unlikely that a GAA or AAC mutation that 
would convert Asp into glutamic acid (Glu) or asparagine (Asp) would restore protein 
stability and activity given the physicochemical differences between them; Gly is a 
nonpolar, Asp and Glu are acidic electrically charged and Asp is a polar amino acid 
(Gromiha et al, 1999). 
Biochemical characterisation 
The main objective of our mutant screening is to identify genes that can reduce the 
total S-nitrosylation level. A critical experiment to perform is to evaluate the total S-
nitrosylation level in the mutant candidates. This experiment can be performed from 
total protein and subsequent biotin switch. If the mutation upregulates GSNO turnover 
or activates a denitrosylation mechanism we would expect a reduction in total S-
nitrosylation in the mutants compared to the parental PR1::LUC par2-1 lines. 
Additionally, the base of our screening relies on the restoration of PR1 expression 
under the high S-nitrosylation background. Therefore, it is essential to confirm that 
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the observed LUC expression accurately reports the endogenous PR1 expression in 
the mutant plants. We speculate that a mutation that reduces general S-nitrosylation 
level could restore SA-biosynthesis and SA-signalling. It will be interesting to measure 
the total and free SA-level. The identification of a mutant candidate that shows 
reduced total protein S-nitrosylation together with increased SA biosynthesis and 
restored PR1 expression could represent an interesting candidate for further 
characterisation.  
Genetic characterisation of mutants 
We have confirmed the inducible and constitutive phenotype in M2 and M3 
generations, which suggests the mutation is heritable. We started generating an 
Arabidopsis ecotype Landsberg erecta (Ler) PR1::LUC par2-1 introgression line to 
generate a mapping population. After crossing the mutant candidates into the Ler 
ecotype, we will be able to assess if the mutation is dominant or recessive on the F1 
population (Li-Jia & Genji, 2006). We plan to use the F2 mapping population to 
perform rough mapping of the mutation using 22 molecular markers which will allow 
us to map the mutation to a specific genomic location (Lukowitz et al, 2002; Brezezek, 
2013). Additionally, new protocols are available to identify the causal mutation using 
next-generation sequencing (Schneeberger, 2014; Uchida et al, 2011; Austin et al, 
2011) which can accelerate the identification of the specific mutation. After linking the 
mutation to a specific gene, it will be interesting to characterise the function of this 
gene in GSNO metabolisms by undertaking biochemical and genetic analysis.  
We have developed a forward mutant screening to search for second-site 
suppressors that can reduce the increased cellular S-nitrosylation in gsnor1 
background. We have identified eight candidate mutants that show inducible PR1 
expression or constitutive PR1 expression which could contain mutations that 
upregulate GSNO/NO turnover, activate denitrosylation mechanisms or activate 
components of the defence network independent of SA. Further characterisation of 
the mutant candidates is required to identify the underlying mutation and link the gene 
with a function.  




Chapter 8 General Discussion 
S-nitrosylation in plant immunity 
Plants have evolved different ways to perceive environmental and biological stimuli, 
interpret these signals and efficiently modify their metabolism accordingly. Salicylic 
acid (SA) is a critical hormone that mediates different aspects of plants development 
and the activation of defence responses against biotrophic pathogens (Dempsey & 
Klessig, 2017). In plants, the major proportion of SA in response to pathogens is 
produced via the activity of the enzyme Isochorismate Synthase 1 (ICS1) (Wildermuth 
et al, 2001).   
It is well accepted that the concentration and localisation of reactive and nitrosative 
species (ROS and NOS)  play an essential role in mediating protein modifications with 
the outcome of triggering signal cascades (Mittler, 2017; Wrzaczek et al, 2013). Nitric 
oxide (NO) stands as a central signalling molecule. NO transfer its bioactivity via S-
nitrosylation (Lamotte et al, 2015; Yu et al, 2014). The cellular levels of S-nitrosylation 
are partially regulated by the activity of the enzyme S-nitrosoglutathione (GSNO) 
Reductase 1 (GSNOR1) (Feechan et al, 2005). Arabidopsis thaliana plants impaired 
in GSNOR1 activity and show a dramatic increase in total cellular S-nitrosylation, 
together with compromised SA biosynthesis and signalling, which affects different 
modes of plant immunity (Feechan et al, 2005). Recent studies show the effect of S-
nitrosylation on SA-signalling (Tada et al, 2008; Cui et al, 2018). However, the 
molecular mechanisms by which S-nitrosylation regulates SA biosynthesis are not 
known.  
Transcriptional repression of ICS1 by S-nitrosylation 
To investigate if ICS1 could be subjected to transcriptional or posttranscriptional 
regulation by S-nitrosylation, we prepared the reported line ICS1::GUS and crossed 
it into the gsnor1 genetic background (ICS1::GUS par2-1). Our data support the 
hypothesis of transcriptional repression of ICS1 mediated by S-nitrosylation.  
NO is a well-established global regulator of gene expression during plant immunity 
(Bellin et al, 2012) and exert quick transcriptional reprogramming (Polverari et al, 
2003; Begara-Morales et al, 2014; Hussain et al, 2016; Sharma et al, 2016). However, 
how this molecule controls the transcriptional dynamics in the nucleus remains 
elusive. It was recently shown that the DNA-binding of the zinc-finger transcription 
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factor (ZF-TF) SRG1 is abolished by S-nitrosylation of Cys87. Additionally, the DNA-
binding of the TFs MYB2 and MYB30 is blocked upon S-nitrosylation at Cys49 and 
53, respectively (Serpa et al, 2007; Tavares et al, 2014). Contrary, it was reported 
that S-nitrosylation of Cys172/287 of TGA1 enhances the DNA-binding of the complex 
TGA1-NPR1 (Mengel et al, 2013; Lindermayr et al, 2010).  
The observed effect on ICS1 expression could be the result of inhibition of the DNA-
binding of the TFs that positively regulate ICS1 by S-nitrosylation. The main TFs 
driving ICS1 expression are SARD1 and CBP60g. Both proteins contain Cys residues 
within their amino acid sequence, suggesting the possibility of S-nitrosylation. We 
showed that S-nitrosylation of Cys438 of SARD1 reduces its DNA-binding affinity to 
the ICS1 promoter in vitro (Fig 8.1). Additionally, a central process in transcriptional 
regulation relies on the assembly of the transcriptional complex between RNA 
polymerase II, general TFs and the Mediator complex. The Mediator complex 
orchestrates transcriptional reprogramming against both biotrophic and necrotrophic 
pathogens and its proposed to facilitate the hormonal crosstalk (Caillaud et al, 2013; 
Kidd et al, 2009; Dhawan et al, 2009). Importantly, the mediator subunits Med14 and 
Med16 were found to play a pivotal role in the regulation of SA biosynthesis and 
signalling, respectively (Zhang et al, 2013c, 2012). Both proteins are rich in Cys 
residues, suggesting the possibility of transcriptional REDOX regulation by S-
nitrosylation (Fig 8.1). 
It is possible that in a high S-nitrosylation environment, SARD1 and possibly CBP60g 
will be S-nitrosylated, resulting in inhibition of their binding activity to the ICS1 
promoter. Additionally, the complex subunits Med14 and Med16 which are rich in 
cysteine residues could also be S-nitrosylated in this context, potentially affecting the 
assembly and interaction with ICS1-specific TFs (including SARD1 and CBP60g), 
thus contributing to explain the significant transcriptional repression observed in the 
ICS1::GUS par2-1 lines (Fig 8.1). 
To explore this possibility, it is necessary to investigate if SARD1 and MED14/16 can 
physically interact by performing in vitro protein-protein assays, such as yeast-two-
hybrid assay. Moreover, it is possible to investigate if S-nitrosylation blocks this 
interaction. Confirming this hypothesis could represent a novel mechanism to 
integrate S-nitrosylation mediating the transcriptional reprogramming during SA-
mediated immunity.   
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Additional mechanisms regulating transcription can be the upregulation of 
posttranscriptional mechanisms. A quick search on the Arabidopsis database for 
miRNA that matches the ICS1 transcript identified six-candidate miRNAs. However, 
the line ICS1::GUS reporter line only allows us to evaluate transcriptional changes. It 
will be interesting to prepare an additional reporter line ICS1::ICS1-GUS or 
ICS1::ICS1-nLUC line to investigate if ICS1 expression can also be regulated at the 
posttranscriptional level and if this process is modified by S-nitrosylation. The 
regulation of ICS1 expression at both transcriptional and posttranscriptional level 
could contribute to understanding the mechanisms fine-tuning the temporal dynamics 
for SA accumulation during plant immunity.  
Biological relevance of S-nitrosylation of Cys438 of SARD1 
Our in vitro data suggests that the binding of SARD1 to the ICS1 promoter is reduced 
upon S-nitrosylation of Cys438. We confirmed that SARD1 could be S-nitrosylated in 
vivo and investigated the biological relevance of this modification. We assumed that 
SARD1C438S would be insensitive to regulation by S-nitrosylation, showing a 
constant affinity for the ICS1 promoter. We observed in the SARD1::SARD1C438S-
nLUC stronger accumulation of SARD1 compared to SARD1-nLUC plants. Our 
analysis of the SARD1 promoter showed the presence of two SARD1 cis-elements 
within the SARD1 promoter (Chow et al, 2016), suggesting a self-regulatory 
mechanism (Fig 8.2). It is possible that SARD1C438S remain bound to its own 
promoter resulting in an amplification effect.  
In addition, we observed a persistent accumulation of SARD1-nLUC after sustained 
induction with SA. SARD1 play a critical role for the establishment of systemic 
acquired resistance (SAR) and SA-biosynthesis (Zhang et al, 2010). Interestingly, 
Arabidopsis plants deficient in the circadian regulator TF CHE showed impaired SAR 
(Zheng et al, 2015), similar to the observed phenotype in sard1 plants (Zhang et al, 
2010). The effect of CHE in SAR correlates with impaired SARD1 expression in che 
plants. However,  no CHE cis-regulatory elements are found within SARD1 promoter, 
suggesting an indirect regulatory mechanism of CHE for SARD1 expression   (Zheng 




The apparent rhythm of SARD1 expression could suggests the possibility of circadian 
regulation on SARD1 during SAR. Notably, the SARD1 promoter contains CCA1 
binding site and the SARD1 promoter was identified as a potential CCA1 target in a 
genome-wide search for CCA1 targets study (Nagel et al, 2015). CCA1 is considered 
as an activator of immunity against bacteria and oomycetes and synchronises 
immune mechanisms at times with higher pathogenic activity (Wang et al, 2011b). 
Importantly, CCA1 expression is negatively regulated by TOC1 via physical 
interaction with CHE (Pruneda-Paz et al, 2009). SA mediates REDOX changes that 
result expression of SA-dependent genes via NPR1 signalling (Tada et al, 2008). 
NPR1 follows a circadian rhythm regulated by CCA1 and act as a negative regulator 

















Figure 8.1. Schematic representation of transcriptional repression of ICS1 expression 
by S-nitrosylation. Proposed mechanism by which S-nitrosylation may regulate ICS1 
expression under high cellular SNO concentrations. S-nitrosylation of the transcription factor 
SARD1 reduces its DNA-binding affinity, potentially having a similar effect on CBP60g. 
Additionally, it is possible that S-nitrosylation of the Mediator complex subunits Med14 and 
Med 16 regulates the interactions with ICS1 specific TFs, including SARD1 and CBP60g 
resulting in transcriptional repression of ICS1.  
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A possible mechanism to explain the apparent rhythmic expression pattern observed 
in the SARD1-nLUC lines and not in SARD1C438S could result from a mechanism 
that requires S-nitrosylation of SARD1, possibly involving protein-protein interactions. 
It may be possible that after the release of SARD1 from its target promoters upon S-
nitrosylation at Cys438 the concentration of unbound SARD1 will increase, allowing 
SARD1 to interact with other protein, including CHE and possibly compete with TOC1 
for CHE interactions. In this scenario, the formation of SARD1-CHE complex would 
prevent the repression of CCA1 by TOC1, allowing the expression of criticl immune 
genes, including SARD1 and NPR1, amplifying the immune response. The release of 
SARD1 from its own promoter by S-nitrosylation of Cys438 could act as a negative 
feedback loop to switch the defence off. Less SARD1 concentration would favour 
CHE-TOC1 interaction to repress CCA1 (Fig 8.2).  
In this scenario, SARD1C438S would remain bound to its target promoters and would 
be unable to interact with CHE. Additionally, SARD1C438S constant DNA-binding 
could sequester its promoters preventing the interaction of additional TFs, thus 
affecting the timing and extent of the immune response. Furthermore, it has been 
shown that NO accumulation is a critical requirement for the optimal establishment of 
SAR and activation of immune responses (Wang et al, 2014a; Kachroo et al, 2016). 
Further research is needed to confirm the role of S-nitrosylation of SARD1. However, 
if the role is identified it could contribute to integrate nitric oxide signalling during SAR.  
To validate our model, it is necessary to investigate if SARD1 and CHE can physically 
interact in vitro and in vivo and test if this interaction is regulated by S-nitrosylation. It 
will be interesting to cross the SARD1::SARD1 lines into che and cca1 background to 
evaluate if SARD1 rhythm is lost in the absence of CCA1 and CHE, together with the 
effect in SAR. Additionally, we started preparing SARD1::SARD1 lines in the par2-1 
background to compare if S-nitrosylation regulates the specificity of SARD1 to its 
target promoters, which includes both positive and negative regulators of immunity 



























Novel regulators of S-nitrosylation and GSNO turnover 
We designed a forward genetic screening to look for second-site modifiers that can 
suppress the gsnor1 phenotype, potentially representing an alternative pathway for 
GSNO metabolism. The screening used the Arabidopsis line PR1::LUC par2-1 in 
which the expression of PR1 is reduced and delayed as a consequence of the high 
cellular S-nitrosylation. We have currently identified mutants that exhibit restored 
Figure 8.2. Proposed model for the role of S-nitrosylation of Cys438 in SAR. S-
nitrosylation of Cys438 of SARD1 may regulate the DNA-binding affinity of SARD1 to its target 
genes. The presence of SARD1 binding motif within SARD1 promoter suggests a self-
regulatory mechanism for SARD1 expression. CCA1 is proposed as a transcriptional activator 
of defence genes. CCA is negatively regulated by TOC1 mediated by the interaction with the 
N-terminal end of CHE. The S-nitrosylation-mediated release of SARD1 from its target 
promoters may facilitate protein-protein interactions between SARD1 and CHE, preventing the 
interaction between CHE and TOC1 and allowing the transcriptional activation of defence 
genes by CCA1, including SARD1. Dotted arrows represent potential mechanisms.   
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expression of PR1 in response to SA induction and mutants displaying constitutive 
expression of PR1. From the inducible lines, we expect to identify genes that can 
reduce the cellular S-nitrosylation level potentially by activating denitrosylation 
mechanisms, upregulating of GSNO turnover or promoting GSNO degradation. From 
the constitutive lines, we expect to identify regulators of PR1 expression which act 
independently of SA. 
Further characterisation of the candidate mutants is required to confirm that the 
underlying mutation reduces total S-nitrosylation. This can be performed by analysing 
total protein S-nitrosylation from plant extract. Additionally, it is necessary to evaluate 
if the reduction in cellular S-nitrosylation correlates with SA biosynthesis and the 
expression of SA-dependent genes.  
The identification of new genes involved in GSNO turnover or denitrosylation 
mechanism can help us to understand S-nitrosylation better. S-nitrosylation plays a 
fundamental role in signalling and regulation of central processes. It has important 
implications in plant immunity (Karapetyan & Dong, 2018; Frederickson Matika & 
Loake, 2014; Yun et al, 2016). Understanding the molecular mechanisms behind S-
nitrosylation, we will be able to engineer crops to be more resistant to disease and 
tolerant to abiotic stress (Hussain et al, 2019).  
Furthermore, S-nitrosylation has been shown to regulate changes in transcriptional 
dynamics and regulate the function of transcription factors (Cui et al, 2018; Begara-
Morales et al, 2014; Hussain et al, 2016; Tavares et al, 2014). It may be possible to 
exploit our knowledge on how posttranslational modifications regulate gene 
expression to generate synthetic TF to fine-tune gene expression in biological 
systems.  
Additionally, S-nitrosylation is a critical factor if human disease. It has been implicated 
in pulmonary, cardiovascular, musculoskeletal, and neurological dysfunction. Also it 
correlates with different types of cancer (Foster et al, 2009). Targeting dysregulation 
of S-nitrosylation is emerging as a novel therapeutic target (Nakamura & Lipton, 
2016). The identification of new mechanisms to regulate S-nitrosylation in plants could 
be transferred to animal system if these mechanisms are conserved. If it is conserved 
among species, it will be possible to use a pharmacological approach to use this 
mechanism for therapeutic applications. Further characterisation of the mutant 
candidates is necessary, but it can have important implications for both plant and 




The objective of the project was to investigate the molecular mechanisms by which 
S-nitrosylation regulates salicylic acid biosynthesis. Our findings suggest that ICS1 is 
subjected to transcriptional regulation by S-nitrosylation of Cys438 of SARD1, which 
reduces its DNA-binding affinity for the ICS1 promoter. Consistent with SARD1 role 
in SAR, we hypothesise that S-nitrosylation of Cys438 is necessary for the correct 
establishment of SAR, probably mediating interactions with other SAR regulators, 
such as CHE. However, in vitro and in vivo experiments are necessary to fully 
understand the mechanisms behind S-nitrosylation of SARD1 in SAR. In addition, it 
is necessary to solve the crystal structure of SARD1 to elucidate the molecular 
changes on SARD1 structure by S-nitrosylation. We developed a strategy to express 
recombinant SARD1 and purify it by ION exchange and gel filtration. Further 
optimizations is necessary to obtain the concentration and purity for crystallography 
studies. Moreover, we used a forward mutant screening to identify genes involved in 
GSNO turnover. We have identified interesting mutant candidates which can contain 
mutations that can probably regulate S-nitrosylation.  
Our findings can contribute to integrate NO cues into SA biosynthesis and SAR and 
provide a basis to further understand S-nitrosylation regulation and the molecular 
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